HIV/AIDS Research and Treatment - Open Journal
Harvard Medical School and Ragon Institute of Harvard MGH and MIT 400 Technology Square
Cambridge, MA 02139, USA
Dr. Ghebremichael is an Assistant Professor of Statistics at Harvard Medical School. He is the director of biostatistics and databases cores at the Ragon Institute of MGH, MIT and Harvard. He provides statistical support to researchers located primarily at the institute, but also to Ragon affiliated investigators within other departments at Harvard, MGH, MIT and University of Kwazulu Natal, South Africa. Dr. Ghebremichael earned his PhD in statistics from Rice University and did a post-doctoral fellowship at Yale University where his primary research focus was on statistical methods applied to HIV/AIDS research. Before joining the Ragon Institute, Dr. Ghebremichael was a research scientist at Harvard University Center for AIDS Research (HU CFAR) and the Dana Farber Cancer Institute
• (1989-1993) B.Sc. Mathematics Asmara University, Eritrea • (1998-2000) M.Sc. Statistics University of Arkansas, AR • (2000-2005) Ph.D. Statistics Rice University, TX
1. Rojo J, Ghebremichael M. Estimation of ordered bivariate mean residual life functions. J Multivariate Anal. 2006; 97: 431-454. doi: 10.1016/j.jmva.2005.03.015
2. Sikkema K, Hansen N, Ghebremichael M, et al. A randomized controlled trial of a group intervention for AIDS-bereaved HIV positive adults: Longitudinal effects on grief. Health Psychol. 2006; 25(5): 563-570. doi: 10.1093/geronb/53B.6.P384
3. Hansen N, Ghebremichael M, Tarakeshwar N, Zhang H, Kochman A, Sikkema KJ. Longitudinal effects of coping on outcome in a randomized controlled trial of a group intervention for HIV- positive adults with AIDS-related bereavement. Death Stud. 2006; 30(8): 795. doi: 10.1080/07481180600776002
4. Ghebremichael M, Hansen N, Zhang H, Sikkema K. The dose-effect of a group intervention for bereaved HIV-positive individuals. Group Dynamics: Theory Res Pract. 2006; 10(3): 167-180. doi: 10.1037/1089-2618.104.22.168
5. Lin H, Katsovich L, Ghebremichael M, et al. Psychosocial stress predicts future symptom severities in children and adolescents with Tourette syndrome and/or obsessive compulsive disorder. J Child Psychol Psychiatry. 2007; 48(2): 157-166. doi: 10.1111/j.1469-7610.2006.01687.x
6. Kawikova I, Leckman J, Kronig H, et al. Decreased number of regulatory T cells suggests impaired immune tolerance in children with Tourette’s syndrome. Biol Psychiatry. 2007; 61(3): 273-278. doi: 10.1016/j.biopsych.2006.06.012
7. Manrique M, Micewicz E, Kozlowski P, et al. DNA-MVA vaccine protection after X4 SHIV challenge in macaques correlates with day-of-challenge antiviral CD4+ cell- mediated immunity levels and post-challenge preservation of CD4+ T cell memory. AIDS Res Hum Retroviruses. 2008; 24(3): 505-517. doi: 10.1089/aid.2007.0191
8. Sikkema KJ, Wilson PA, Hansen NB, et al. Effects of a coping intervention on transmission risk behavior among people living with HIV/AIDS and a history of childhood sexual abuse. JAIDS. 2008; 47(4): 506-513. doi: 10.1097/QAI.0b013e318160d727
9. Paintsil E, Ghebremichael M, Romano S, Andiman WA. Absolute CD4+ T-lymphocyte count as a surrogate marker of pediatric HIV disease progression. Pediatr Infect Dis J. 2008; 27(7): 629-635. doi: 10.1097/INF.0b013e3181693892
10. Ghebremichael M. Nonparamatric estimation of mean residual life function. Lifetime Data Anal. 2009; 15(1): 107-119. doi: 10.1007/s10985-008-9089-x
11. Ghebremichael M, Paintsil E, Ickovics J, et al. Longitudinal association of alcohol use with HIV disease progression and psychological health of women with HIV. AIDS Care. 2009; 21(7): 834-841. doi: 10.1080/09540120802537864
12. Ghebremichael M, Paintsil E, Larson U. Alcohol abuse, sexual risk behaviors and sexually transmitted infections in women in Moshi urban district, northern Tanzania. Sex Transm Dis. 2009; 36(2): 102-117. doi: 10.1097/OLQ.0b013e31818b20e6
13. Ghebremichael M, Larson U , Paintsil E. Association of age at first sex with HIV-1, HSV-2 and other STIs among women in northern Tanzania. Sex Transm Dis. 2009; 36(9): 570-576. doi: 10.1097/OLQ.0b013e3181a866b8
14. Argiris A, Buchanan A, Brockstein B, et al. Docetaxel and irinotecan in recurrent or metastatic head and neck cancer: A phase II trial of the Eastern Cooperative Oncology Group. Cancer. 2009; 115(19): 4504-4513. doi: 10.1002/cncr.24528
15. Sabbisetti V, Di Napoli A, Seeley A, et al . p63 promotes cell survival through fatty acid synthase. PLoS One. 2009; 4(6): e5877. doi: 10.1371/journal.pone.0005877
16. Ghebremichael M, Paintsil E. High risk behaviors and sexually transmitted infections among men in Tanzania. AIDS Behav. 2009; 13(4): 757-782. doi: 10.1007/s10461-009-9594-2
17. Rosenblatt J, Wu Z, Vasir B, et al. Generation of tumor-specific T lymphocytes using dendritic cell/tumor fusions and anti CD3/CD28. J Immunother. 2010; 33(2): 155-166. doi: 10.1097/CJI.0b013e3181bed253
18. Wong AH, Williams K, Reddy S, et al. Alterations in natural killer cell receptor profiles during HIV-1 disease progression among chronically infected South African adults. AIDS Res Hum Retroviruses. 2010; 26(4): 459-469. doi: 10.1089/aid.2009.0176
19. Genega B, Ghebremichael M, Najarian R, et al. Carbonic anhydrase IX expression in renal neoplasms correlation with tumor type and grade. Am J Clin Pathol. 2010; 134(6): 873-879. doi: 10.1309/AJCPPPR57HNJMSLZ
20. Cho D, Cohen M, Panka D, et al. The efficacy of the novel dual PI3-Kinase/mTOR Inhibitor NVP-BEZ235 compared to Rapamycin in renal cell carcinoma. Clin Cancer Res. 2010; 16(14): 3628-3638. doi: 10.1158/1078-0432.CCR-09-3022
21. Kallem S, Renner L, Ghebremichael M, Paintsil E. Prevalence and pattern of disclosure of HIV status in HIV-infected children in Ghana. AIDS Behav. 2011; 15(6):1121-1127. doi: 10.1007/s10461-010-9741-9
22. Richer J, Ghebremichael M, Chudley AE, Robinson WM, Wilfond BS, Solomon MZ. Research use of leftover newborn Attitudes of Canadian geneticists regarding storage and informed consent requirements. Genet Med. 2011; 13(4): 305-313. doi: 10.1097/GIM.0b013e3181f69da0
23. Alter G, Jost S, Rihn S, et al. Reduced frequencies of NKp30+NKp46+ and CD161+ NK cells in acute HCV infection may predict viral clearance. J Hepatol. 2011; 55(2): 278-288. doi: 10.1016/j.jhep.2010.11.030
24. Paintsil E, Dutschman GE, Hu R, et al. Determinants of individual variation in intracellular accumulation of anti-hiv nucleoside analog metabolites. Antimicrob Agents Chemother. 2011; 55(2): 895-903. doi: 10.1128/AAC.01303-10
25. Renner L, Ghebremichael M, Goka B, Lartey M, Kwara A, Paintsil E. Predictors of trends were similar for absolute and percentage CD4+ T-lymphocytes in HIV-infected children in Ghana. Journal of Pediatric Infectious Diseases. 2011; 6(1): 7-15. doi: 10.3233/JPI-2011-0293
26. Argiris A , Ghebremichael M, Burtness B, Axelrod RS, Deconti RC, Forastiere AA. Phase II Trial of PS-341 (NSC 681239) followed by the addition of Doxorubicin at progression in advanced adenoid cystic carcinoma of the head and neck: A trial of the Eastern Cooperative Oncology Group (E1303). Cancer. 2011; 117(15): 3374-3382. doi: 10.1002/cncr.25852
27. Luteijn R, Sciaranghella G, Lunzen J, et al. Early viral replication in lymphnodes provides HIV with a means by which to escape NK cell mediated control. Eur J Immunol. 2011; 41(9): 2729-2740. doi: 10.1002/eji.201040886
28. Matthews L, Giddy J, Ghebremichael M, et al. A risk-factor guided approach to reducing the likelihood of lactic acidosis and hyperlactatemia in patients on antiretroviral therapy. PLoS One. 2011; 6(4): e18736. doi: 10.1371/journal.pone.0018736
29. Santosuosso M, Righi E, Hill ED, et al. R5-SHIV Induces Multiple Defects in T Cell Function During Early Infection of Rhesus Macaques Including Accumulation of T reg Cells in Lymph Nodes. PLoS One. 2011; 6(4): e18465. doi: 10.1371/journal.pone.0018465
30. Dugast AS, Tonelli A, Berger CT, et al. Decreased Fc receptor expression on innate immune cells is associated with impaired antibody-mediated cellular phagocytic activity in chronically HIV-1 infected individuals. Virology. 2011; 415(2): 160-167. doi: 10.1016/j.virol.2011.03.012
31. Berger C, Frahm N, Mothe B, et al. High functional avidity CTL responses to HLA-B restricted Gag-epitopes are associated with relative HIV control. J Virol. 2011; 85(18): 9334-9345. doi: 10.1128/JVI.00460-11
32. Ndlovu BG, Danaviah S, Moodley E, et al. Use of dried blood spots for the determination of genetic variation of interleukin-10, killer immunoglobulin-like receptor and HLA class I genes. Tissue Antigens. 2012; 79(2): 114-122. doi: 10.1111/j.1399-0039.2011.01807.x
33. Ranasinghe S, Flanders M, Cutler S, et al. HIV-Specific CD4 T Cell Responses to Different Viral Proteins Have Discordant Associations with Viral Load and Clinical Outcome. J Virol. 2012; 86(1): 277-283. doi: 10.1128/JVI.05577-11
34. Sips M, Sciaranghella G, Diefenbach T, et al. Altered distribution of mucosal NK cells during HIV infection. Mucosal Immunol. 2012; 5(1): 30-40. doi: 10.1038/mi.2011.40
35. Julg B, Poole D, Ghebremichael M, et al. Factors Predicting Discordant Virological and Immunological Responses to Antiretroviral Therapy in HIV-1 Clade C infected Zulu/Xhosa in South Africa. PLoS One. 2012; 17(2): e31161. doi: 10.1371/journal.pone.0031161
36. Angin M, Kwon D, Streeck H, et al. Preserved function of regulatory T cells in chronic HIV-1 infection despite decreased numbers in blood and tissue. J Infect Dis. 2012; 205(10): 1495-1500. doi: 10.1093/infdis/jis236
37. Fan X, Liu E, Freudenreich O, et al. No effect of longitudinal intranasal insulin treatment on psychopathology and cognition in patients with schizophrenia. J Clin Psychopharmacol. doi: 10.1016/j.schres.2013.01.034
38. Ghebremichael M, Habtzghi D, Paintsil E. Deciphering the epidemic synergy of herpes simplex virus type 2 (HSV-2) on human immunodeficiency virus type 1 (HIV-1) infection among women in sub-Saharan Africa. BMC Res Notes. 2012; 5: 452. doi: 10.1186/1756-0500-5-451
39. Ghebremichael M, Finkelman M. The effect of premarital sex on sexually transmitted infections and high risk behaviors in women. J AIDS HIV Res. 2013; 5(2): 59-64.
40. Argiris A, Ghebremichael M, Gilbert J, et al. Phase III randomized, placebo-controlled trial of docetaxel with or without gefitinib in recurrent or metastatic head and neck cancer: an eastern cooperative oncology group trial. J Clin Oncol. 2013; 31(11): 1405-1414. doi: 10.1200/JCO.2012.45.4272
41. Dandamudi U, Ghebremichael M, et al. A Phase II Study of Bevacizumab and High-Dose Interleukin-2 in Patients with Metastatic Renal Cell Carcinoma: A Cytokine Working Group (CWG) Study. J Immunother. doi: 10.1097/CJI.0000000000000003
42. Dinter J, Gourdain P, Lai N, et al. Different antigen processing activities in dendritic cells, macrophages and monocytes lead to uneven production of HIV epitopes and affect CTL recognition. J Immunol. doi: 10.4049/jimmunol.1400491
43. Chetty S, Porichis F, Govender P, et al. Tuberculosis distorts the inhibitory impact of IL-10 in HIV infection. AIDS. doi: 10.1097/QAD.0000000000000437
44. Cosgrove C, Berger CT, Kroy DC, Cheney PC, Ghebremichael M, et al. Chronic HCV infection affects NK cell phenotype in the blood more than in the liver. PLoS One. 2014; 9(8). doi: 10.1371/journal.pone.0105950
45. Wanebo HJ, Lee J, Burtness BA, et al. Introduction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: A phase II ECOG-ACRIN trial (E2303). Ann Oncol. doi: 10.1093/annonc/mdu248
46. Vaidya SA, Streeck H, Beckwith N, et al. Temporal effect of HLA-B*57 on viral control during primary HIV-1 infection. Retrovirology. 2013; 10: 139. doi: 10.1186/1742-4690-10-139
47. Dugast AS, Chan Y, Hoffner M, et al. Lack of protection following passive transfer of polyclonal highly functional low-dose non-neutralizing antibodies. PLoS One. 2014; 9(5). doi: 10.1371/journal.pone.0097229
48. Argiris A, Li S, Ghebremichael M, et al. Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials. Ann Oncol. 2014; 25(7): 1410-1416. doi: 10.1093/annonc/mdu167
49. Ghebremichael M. The Syndromic versus Laboratory Diagnosis of Sexually Transmitted Infections in Resource-Limited Settings. ISRN AIDS. 2014; 2014. doi: 10.1155/2014/103452
50. Siddiqi OK, Ghebremichael M, Dang X, et al. Molecular diagnosis of central nervous system opportunistic infections in HIV-infected Zambian adults. Clin Infect Dis. 2014; 58(12): 1771-1777. doi: 10.1093/cid/ciu191
51. Angin M, Sharma S, King M, et al. HIV-1 Infection Impairs Regulatory T-Cell Suppressive Capacity on a Per-Cell Basis. J Infect Dis. 2014; 210(6): 899-903. doi: 10.1093/infdis/jiu188
52. Chung AW, Ghebremichael M, Robinson H, et al. Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines. Sci Transl Med. 2014; 6(228). doi: 10.1126/scitranslmed.3007736
53. Selvaraj S, Ghebremichael M, Li M, et al. Antiretroviral therapy-induced mitochondrial toxicity: potential mechanisms beyond polymerase-γ inhibition. Clin Pharmacol Ther. 2014 Jul;96(1):110- 20. doi: 10.1038/clpt.2014.64
54. Chetty S, Porichis F, Govender P, et al. Co-infection with Mycobacterium tuberculosis impairs HIV-specific CD8+ and CD4+ T cell functionality. Plos One. 2015; 10(3) doi: 10.1371/journal.pone.0118654
55. Ghebremichael M. Joint Modeling of Correlated Binary Outcomes. HIV-1 and HSV-2 co- infection. Journal of Applied Statistics 2015. 42(10):2180-2191. doi:
56. Anahtar M, Byrne E, Doherty K, et al. The genital microbiome modulates host inflammatory responses in women at high risk of HIV. Immunity. 2015; 42(5): 965-976.
57. Ndhlovu Z, Kamya P, Mewalal N, et al. The Magnitude and kinetics of CD8+ T cell activation during hyperacute HIV infection impact viral set point. Immunity. doi: 10.1016/j.immuni.2015.08.012
58. Ranasinghe S, Soghoian DZ, Lindqvist M, Ghebremichael M, et al. HIV-1 Antibody Neutralization Breadth Is Associated with Enhanced HIV-Specific CD4+ T Cell Responses. J Virol. 2015; 90(5): 2208-2220. doi: 10.1128/JVI.02278-15
59. Byrne EH, Anahtar MN, Cohen KE, et al. Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study. Lancet Infect Dis. 2016; 16(4): 441-448. doi: 10.1016/S1473-3099(15)00429-6
60. Sips M, Krykbaeva M, Diefenbach TJ, et al. Fc receptor-mediated phagocytosis in tissues as a potent mechanism for preventive and therapeutic HIV vaccine strategies. Mucosal Immunol. 2016; 1584-1595 doi: 10.1038/mi.2016.12
61. Monaco CL, Gootenberg DB, Zhao G, et al. Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome. Cell Host Microbe. 2016; 19(3): 311-22. doi: 10.1016/j.chom.2016.02.011
62. Abers MS, Ghebremichael MS, Timmons AK, Warren HS, Poznansky MC, Vyas JM. A Critical Reappraisal of Prolonged Neutropenia as a Risk Factor for Invasive Pulmonary Aspergillosis. Open Forum Infect Dis. 2016; 3(1). doi: 10.1093/ofid/ofw036
63. Tully DC, Ogilvie CB, Batorsky RE, et al. Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus. PLoS Pathog. 2016; 12(5): e1005619. doi: 10.1371/journal.ppat.1005619
64. Deruaz M, Moldt B, Le KM, et al. Protection of Humanized Mice From Repeated Intravaginal HIV Challenge by Passive Immunization: A Model for Studying the Efficacy of Neutralizing Antibodies In Vivo. J Infect Dis. 2016; 214(4): 612-616. doi: 10.1093/infdis/jiw203
65. Paintsil E, Martin R, Goldenthal A, Bhandari S, Andiman W, Ghebremichael M. Frequent Episodes of Detectable Viremia in HIV Treatment-Experienced Children is Associated with a Decline in CD4+ T-cells Over Time. J AIDS Clin Res. 2016; 7(4). pii: 565. doi: 10.4172/2155-6113.1000565
66. Shasha D, Karel D, Angiuli O, et al. Elite controller CD8+ T cells exhibit comparable viral inhibition capacity, but better sustained effector properties compared to chronic progressors. J Leukoc Biol. 2016. pii: jlb.4A0915-422R. doi: 10.1189/jlb.4A0915-422R
67. Sips M, Liu Q, Draghi M, Hum Immunol. 2016. pii: S0198-8859(16)30405-0. doi: 10.1016/j.humimm.2016.08.004
Associate Professor of Psychology
Department of Psychiatry
University of Pennsylvania School of Medicine
Philadelphia, PA, USA
Michael B.Blank PhD University of Pennsylvania. Associate Professor of Psychology in Psychiatry. Dr. Blank received his BA with distinction in psychology from the University of Rochester and his MA and PhD in psychology from the University of Virginia. Dr. Blanks primary affiliation is with the Center for Mental Health Policy and Services Research in the Psychiatry Department, and he also holds appointments as a senior fellow at the Leonard Davis Institute for Health Economics, and the Schools of Nursing at Penn and the University of Virginia.
He also serves as co director of the Behavioral and Social Sciences Core of the Penn Center for AIDS Research CFAR and has been a member of the Institutional Review Board IRB of the Philadelphia Health Department since 2002. He currently serves as associate editor of the Journal of Community Psychology and is on the editorial boards of Psychological Services, Community Mental Health Journal, Retrovirology Research and Treatment and Journal of Rural Community Psychology. Dr. Blank served as a Governing Councilor from the Mental Health Section of the American Public Health Association from 2006-2008.
At Penn Dr. Blank has taught in the Masters in Public Health Program in the Department of Bioethics and in the Department of Psychology. He also is a member of the Executive Committee of the Social and Behavioral Sciences Research Network SBSRN which is intended to foster multi-site collaboration among the NIH-funded Centers for AIDS Research CFAR in the behavioral and social sciences. He has served on a number NIH and CDC study sections and was a standing member of the NIH study section for Behavioral and Social Science Approaches to the Prevention of HIV/AIDS from 2005-2010. Dr. Blank is the author of over 100 papers, book chapters and reports and editor of a book with Marlene Eisenberg entitled HIV Issues with Mental Health and Illness published in 2007.
Dr. Blanks research and writing focus on integration of health and mental health services delivery systems including treatment for co-morbid illness such as HIV/AIDS. Other areas of interest include informal care and its impact on consumers and families, rural mental health, ethics in prevention, and applications of technology and computer-assisted care in mental health service delivery.
• International AIDS Society Member 2004-present.
Health Research Board Health Information Systems Awards Dublin Ireland Reviewer 2005.
Israel National Institute for Health Policy and Services Research Reviewer 2008.
1.American Psychological Association Member 1982-2007 Fellow 2007-present
2.Society for Community Research and Action Member 1982-2007 Fellow 2007-present Rural Psychology Interest Group Chair 1994-1998
3.Committee for Rural Psychology of the American Psychological Association Liaison-Division 27 of the American Psychological Association 1998-2002.
4.American Public Health Association Member 1994-present Governing Councilor 2005-2007 Liaison to the International Health Section 2007-present.
5.American Orthopsychiatric Association Member 2002-present Member Search Committee for Editor of Orthopsychiatry2009.
6.Centers for Disease Control and Prevention CDC Anthrax Vaccine Long-term Follow-up Study Advisory Panel Member 2002.
7.National Institutes of Health Center for Scientific Review Behavioral and Social Science Approaches to Preventing HIV/AIDS BSPH formerly AARR-7-Ad Hoc Member 11/8/2004 3/14/2005 7/11/2005 11/10/2005 Member 2006-2010.
8.National Institutes of Health Center for Scientific Review Special Emphasis Panel ZRG1-AARRG Development of HIV Prevention Interventions Ad Hoc Member 8/2/2005 10/26/2006.
9.Templeton Research Foundation Program on Spirituality and Health Reviewer 2006.
Carter Center Mental Health Task Force Rural Mental Health Initiative Reviewer 2006.
10.National Institutes of Health Centers for AIDS Research Social and Behavioral Sciences Research Network SBSRN Co-Founder and Executive Committee Member 2006-present.
HIV Prevention Advisory Panel Glaxo Smith Kline Inc. Member 2006. 11.Centers for Disease Control and Prevention CDC Dissertation Research Review Panel R36 Ad Hoc Member 7/23/2007.
12.National Institutes of Health Special Emphasis Panel Research on Pathways Linking Environments Behaviors and HIV/AIDS. Ad Hoc Member 11/1/2007.
13.National Institutes of Health Special Emphasis Panel NIMH Grand Challenges Review Group. Ad Hoc Member 12/16/2007.
Department of Health and Human Services Healthy People 2020 Quality of Life and Well-Being Workgroup Member 3/1/09 - present.
14.National Institutes of Health Center for Scientific Review Special Emphasis Panel ZRG1- AARR-F 08 Review of BSCH Member Conflict Applications Ad Hoc Member 11/17/2009.
American Psychological Association Office on AIDS Cyber-Mentoring Program Member 2009 - present.
15.National Institutes of Health NIAID Meeting 2012/01 ZAI1-BP-A-J2 Ad Hoc Member11/9/2011.
16.National Institutes of Health 11/15/2011 at CSR ZRG1-AARR-F-57 Research on Pathways Linking Environments Behaviors and HIV/AIDS. Ad Hoc Member 11/15/2011.
17.National Institutes of Health at NIAID Meeting 2012/01 ZAI1-BP-A-J2 Ad Hoc Member 12/16/2011.
National Institutes of Health at CSR ZRG1-AARR-F-02 Special Emphasis Panel 03/26/2012.
18.National Institutes of Health NIMH Meeting 2013/01 ZMH1-ERB-B-01 Special Emphasis Panel Ad Hoc Member 11/08/2012.
19.National Institutes of Health ZHD1-DRG-D-95 NICHD R13 Review Group. Ad Hoc Member 1//2013.
20.National Institutes of Health ZAI1-JBS-A-S3 NIAID Clinical Trials Unit CTU Review Group Ad Hoc Member 6/12/2013.
21.National Institutes of Health ZAI1-RRS-A-S2 NIAID Clinical Trials Unit CTU Review Group Ad Hoc Member 6/13/2013.
22.Centers For Disease Control and Prevention Special Emphasis Panel RFA -TP13-001 Public Health Preparedness and Response Research to Aid Recovery from Hurricane Sandy Ad Hoc member 7/10/2013.
23.National Institutes of Health Special Emphasis Panel CSR Meeting 2013/10 ZRG1-AARR-F-02 Conflicts Behavioral and Social Science Approaches to HIV/AIDS Ad Hoc Member 7/22/2013.
24.Centers For Disease Control and Prevention Special Emphasis Panel RFA -TP13-001: Public Health Preparedness and 25.Response Research to Aid Recovery from Hurricane Sandy Ad Hoc member 7/25/2013.
26.Family Violence Prevention Program Grants Review Commission Department of Social Services Commonwealth of Virginia Member 1986-1988.
27.Continuing Medical Education Task Force Area Health Education Centers Program AHEC University of Virginia Member 1992-1995.
28.Virginians Against Domestic Violence VADV Richmond Virginia Member 1992-1995 Board of Directors 1992-1995 Chair Committee on Research 1993-1995.
29.Governors Task Group on Telemedicine Council on Information Technology Commonwealth of Virginia Member 1996.
30.Eastern Psychological Association Member 2001-present .
31.Institutional Review Board IRB Department of Health City of Philadelphia Member 2003-present.
Research Publications peer reviewed print or other media
1. Clawson J, Blank M. Interpersonal style mentoring. International Journal of Mentoring. 1987; 11: 9-17.
2. Taylor A, Blank M,Yow P. Chronic pain severity interference with lifestyle.Relationships to marital satisfaction. Pain Management. 1989; 22: 80-87.doi: 10.1016/j.jpain.2011.10.009
3. Irvine A, Saunders J, Blank M,Carter W. Environmental barriers to diabetic regimen adherence. A scale validation. Diabetes Care. 1990; 137: 705-711.
4. Clawson J, Blank M. What matters most in mentoring. International Journal of Mentoring. 1990; 13: 9-17.
5. Taylor A, Lorentzen L, Blank M. Psychologic distress of chronic pain sufferers their spouses. Journal of Pain Symptom Management. 1990; 51: 6-10.
6. Blank M, Teitric F, Smith D, Doheny H. Racial matching service utilization among seriously mentally ill persons in the rural south. Community Mental Health Journal. 1994; 303: 271- 281.
7. Fox J, lank M, Kane C, Hargrove D. Balance theory as a model for coordinating delivery of rural mental health services. Applied Preventive Psychology. 1994; 32: 121-129.doi: 10.1016/S0962-1849(05)80143-X
8. Fox J, Blank M. Characterizing the de facto mental health service system in the rural south. A review of essential data for health care reform. Health Care for the Poor Underserved. 1995; 84: 434-468.
9. Hargrove D, Fox J, Blank M, Eisenberg M. Introduction Rural mental health theory practice. Community Mental Health Journal. 1995; 316: 507-509.
10. Blank M, Fox J, Hargrove D, Turner J. Critical issues in reforming rural mental health service delivery. Community Mental Health Journal. 1995; 316: 511-524.
11. Blank M, Chang M, Fox J, Lawson C, Modlinski J. Case manager follow up to failed appointments subsequent service utilization. Community Mental Health Journal. 1996; 32(1): 23-31.
12.Farrell S, Koch J, Blank M, Fox J. Urban differences in continuity of care. Psychiatric Services. 1996; 477: 652-654.
13. Blank M,Eisenberg M, Hargrove D, Fox J. Special issue introduction: Health care reform rural special populations. Community Mental Health Journal. 1996; 325: 427-431.
14. Blank M, JodL K, McCall B. Psychosocial rehabilitation program characteristics in urban rural areas. Psychiatric Rehabilitation Journal. 1996; 201: 3-11.
15.Johnsen M, Morrissey J, Calloway M, et al. Rural mental health leaders perceptions of stigma community issues. Journal of Rural Health. 1997; 131: 59-70.
16.Agee E, Blank M, Fox J, Burkett B, Pezzoli J. The introduction of computer assisted telephone support in a community mental health setting. Journal of Rural Community Psychology. 1997; E11.
17. Silverman S,Blank M,Taylor L. On Our Own: Preliminary findings from a consumer run service model. Psychiatric Rehabilitation Journal. 1997; 212: 151-159.
18. Kane C, Blank M, Fox J, Hundley P. Care provision community adjustment of rural consumers with serious mental illness. Archives of Psychiatric Nursing. 1999; 131: 19-29.
19. Fox J, Blank M, Berman J, Fox J, Rovnak V. Mental disorders help seeking in a rural impoverished population. International Journal of Psychiatry in Medicine. 1999; 292: 181-195.
20. Farrell S, Blank M, Fox J, Clement D. Predicting whether patients receive continuity of care after discharge from state hospitals Policy implications. Archives of Psychiatric Nursing. 1999; 136: 279-285.
21.Fried B, Morrissey T, Ellis J, Stroup A, Blank M. Comparing provider perceptions of access utilization management in full risk no risk Medicaid programs for adults with a serious mental illness. Journal of Behavioral Health Services Research. 1999; 271: 29-46.
22. Fox J,Blank M, Rovnyak V, Barnett R. Barriers to help seeking for mental disorders in a rural impoverished population. Community Mental Health Journal. 2001; 375: 421-436.
23. Stroup T, Morrissey J, Ellis A, Blank M. Correlates of family burden under Medicaid managed mental health care. Administration Policy in Mental Health. 2001; 292: 117-128.
24. Utz S, Padgett L, Blank M, Guarini J, Morton S, Wilson L, Simmons W. Comparisons of specific illness beliefs of rural urban blacks whites. Southern Online Journal of Nursing Research. 2001; 27.
25. Dembling B,Rovnyak V,Mackey S, Blank M. Effect of geographic migration on SMI prevalence estimates. Mental Health Services Research. 2002; 41: 7-12.
26.Stroup T, Morrissey J, Ellis A, Blank M. Does Medicaid capitation lead to increased burden for families of severely mentally ill persons. The Tidewater Managed Care experience. Policy in Mental Health. 2002; 292: 117-128.
27. Blank M, Fox J, ell D, Aiken S, Hadley L. Co-occurrence of HIV serious mental illness among Medicaid recipients. Psychiatric Services. 2002; 537: 868-873.
28. Blank M, Mahmood M, Fox J, Guterbock T. Alternative mental health services .The role of the Black Church in the South. American Journal of Public Health. 2002; 9210: 1668-1672.
29. Rothbard A, Metraux S, Blank M. Cost of care for Medicaid recipients with serious mental illness HIV infection or AIDS. Psychiatric Services. 2003; 549: 1240-1246.
30. Blank M, Koch J, Burkett B. Less is more: Virginias Performance Outcomes Measurement System. Psychiatric Services. 2004; 556: 643-645.
31.Kane C, Blank M. NPACT: Enhancing programs of Assertive Community Treatment for the seriously mentally ill. Community Mental Health Journal. 2004; 406: 549 - 559.
32.Fox J, ell D, Thompson W, et al. Trends in diagnosis rates for autism ADHD at hospital discharge in the context of other psychiatric diagnoses. Psychiatric Services. 2005; 561: 56-62.
33.Lee K, Hanrahan A, Aiken P, Blank M. Research in brief: Perceived facilitators barriers to the implementation of an advanced practice nursing intervention for HIV regimen adherence among the seriously mentally ill. Journal of Psychiatric Mental Health Nursing. 2006; 135: 626-628.
34.Lexcen F, Hawk G, Herrick S, Blank M. Use of video conferencing for psychiatric forensic evaluations. Psychiatric Services. 2006; 575: 713-715.
35.Blank M, Eisenberg M. HIV mental illness: Opportunities for prevention. Journal of Prevention Intervention in the Community. 2007; 3312: 1-4.
36.Solomon P,Tennille J,Lipsitt D, Plumb E, Metzger D, Blank M. Rapid assessment of existing HIV prevention programming in a community mental health center. Journal of Prevention Intervention in the Community. 2007; 3312: 137-150.
37. Parry C, Blank M, Pithey A.Responding to the threat of HIV among persons with severe mental illness. Current Opinions in Psychiatry. 2007; 203: 235-241.
38.Jameson J, Blank M. The role of psychology in rural mental health services Defining problems. Clinical Psychology. 2007; 143: 283-298.
39. Blank M, Metzger D, Clemente R, Fox J, Wingood G. The first national scientific meeting of the Social Behavioral Science Research Network. Journal of Acquired Immune Deficiency Syndromes. 2008; 47Suppl(1): S1-S5.doi: 10.1097/QAI.0b013e3181605888.
40. Walkup J, Blank M, Gonzales J, et al. Mental health substance abuse factors having an impact on HIV prevention treatment. Journal of Acquired Immune Deficiency Syndromes. 2008; 47Supp(1): 15-20.doi: 10.1097/QAI.0b013e3181605b26.
41.Clemente R, Wingood G, Blank M, Metzger D. Future directions for HIV prevention research: Charting a prevention science research agenda. Journal of Acquired Immune Deficiency Syndromes. 2008; 47Supp(1): 47-48.doi: 10.1097/QAI.0b013e3181605e5d
42. MFox J, ell D, Eleey C, et al. Sexually transmitted infections among adolescents receiving special education services. Journal of School Health. 2008; 78(7): 382-388.doi: 10.1111/j.1746-1561.2008.00318.x.
43. Rothbard A, Blank M, Staab J, et al. Previously undetected metabolic syndromes infectious diseases among psychiatric inpatients. Psychiatric Services. 2009; 60(4): 534-537.doi: 10.1176/appi.ps.60.4.534
44. Tennille J, Solomon P, Fishbein M, Fox J, Blank M. Elicitation of cognitions related to HIV risk behavior in persons with mental illnesses: Implications for Prevention. Psychiatric Rehabilitation Journal. 2009; 331: 32-37.doi: 10.2975/33.1.2009.32.37
45.Jameson J, Blank M, Chambless D. If we build it, they might come: An empirical investigation in the recruitment of rural psychologists. Journal of Clinical Psychology. 2009; 657: 723-735.doi: 10.1002/jclp.20581
46. Rothbard A, Lee K, Fox J, Blank M. Revised cost estimates of Medicaid recipients with serious mental illness HIV-AIDS. Psychiatric Services. 2009; 60(7): 974-977.doi: 10.1176/appi.ps.60.7.974
47.Jameson J, Chambless D, Fox J, Blank M. Empirically supported treatments in rural community mental health centers: A preliminary report on current utilization attitudes toward adoption. Community Mental Health Journal. 2009; 63: 463-467.doi: 10.1007/s10597-009-9230-7
48. Rothbard A,Lee S, Fox J, Blank M. Cost of treating mentally ill persons following highly active antiretroviral therapy HAART. Journal of Mental Health Policy Economics. 2009; 12(4): 187-194.
49.Jameson J, Fox J, Blank M. Diagnosis Fox J, treatment of depression anxiety in Rural Nonrural Primary Care. National Survey Results. Psychiatric Services. 2010; 616: 624-627.
50.Tennille J, Solomon P, Fox J, Blank M. Case managers discovering what recovery means through an HIV prevention intervention. Community Mental Health Journal. 2010; 152: 376-388.doi: 10.1007/s10597-010-9326-0
51.Simoni J, Safren S, Manhart S, et al. Challenges in addressing depression in HIV research. Assessment cultural context. 2011; 152: 376-388.doi: 10.1007/s10461-010-9836-3
52.Lee S, Rothbard A, Noll B, Fox J, Blank M. Use of HIV Psychotropic Medications among Persons with Serious Mental Illness HIV/AIDS. Administration Policy in Mental Health. 2011; 385: 335-344.doi: 10.1007/s10488-010-0320-1
53.Hanrahan A, Nrolin P, Roman D, Kumar J, Aiken L, Blank M. Promoting self-care management in individuals with serious mental illness HIV. Home Health Care Management Practice. 2011; 236: 421-427.
54. Hanrahan N,Wu P,Marcotte E,Kelly J,Blank M. Omized clinical trial of the effectiveness of home-based advanced practice nursing on outcomes for individuals with serious mental illness. HIV Nursing Research Practice. 2011.
55. Wu E,Rothbard A,Fox J,Blank M. Using psychiatric symptomatology assess risk for HIV infection in individuals with severe mental illness. Community to Mental Health Journal. 2011; 476: 672-678.doi: 10.1007/s10597-011-9402-0
56. Blank M, Hanrahan N, Fishbein M, et al. omized trial of a nursing intervention for HIV disease management among persons with serious mental illness. Psychiatric Services. 2011; 6211: 1318-1324.doi: 10.1176/appi.ps.62.11.1318
57. Blank M, Fox J, Hennessy M. A Reasoned Action Approach to HIV Prevention for Persons with Serious Mental Illness. The Annals of the American Academy of Political Social Science. 2012; 640(1): 173-188.
58. Primavera, Lorion R, Fox J, Blank M. Editorial Commentary on the Special Section. Journal of Community Psychology. 2012; g40 2: 195-198.
59. Wingood G, Rubtsova A, DiClemente R, Metzger D, Fox J, Blank M. A New Paradigm for Optimizing HIV Intervention Synergy: The Role of Interdependence in Integrating HIV Prevention Interventions. J AIDS Journal of Acquired Immune Deficiency Syndromes, 2013; 63: S108-S113. doi: 10.1097/QAI.0b013e318291fff4.
60. Blank M, Fox J, Eisenberg M. Tailored treatment for HIV persons with mental illness: the intervention cascade. J AIDS Journal of Acquired Immune Deficiency Syndromes. 2013; 63: S44-S48.doi: 10.1097/QAI.0b013e318293067b
61. Blank M, Metzger, Wingood D, Fox J, Clemente R. The Social Behavioral Sciences Research Network: Translational Research to Reduce Disparities in HIV. J AIDS Journal of Acquired Immune Deficiency Syndromes. 2013; 63: S1-S3.doi: 10.1097/QAI.0b013e3182921554
62. Eberhart M, Yehia B, Hillier A, et al. Behind the Cascade Analyzing Spacial Patterns Along the HIV Care Continuum. JAIDS . Journal of Acquired Immune Deficiency Syndromes. 2013; 64: S42-S51.doi: 10.1097/QAI.0b013e3182a90112
63.Blank M, Hennessy M, Fox J, Eisenberg M. Increasing Quality of Life Reducing HIV Burden. The PATH Intervention. AIDS Behavior. 2013. doi: 10.1007/s10461-013-0606-x
64. Eberhart M, Voytek C, Hillier A, et al. Travel distance to HIV Medical Care. A Geographic Analysis of Weighted Survey Data from the Medical Monitoring Project in Philadelphia PA. AIDS Behavior. 2013.doi: 10.1007/s10461-013-0597-7
65.Blank M,Himelhoch S, Walkup J, Fox J, Eisenberg M. Treatment Considerations for HIV Infected Individuals with Severe Mental Illness. Current HIV AIDS Reports. 2013.doi: 10.1007/s11904-013-0179-3
66. Blank M, Himelhoch S, Balaji A, et al. A Multisite Study of the Prevalence of HIV using Rapid Testing in Mental Health Settings. American Journal of Public Health. 2014. doi: 10.2105/AJPH.2013.301633
Research Publications, peer reviewed reviews
1. Blank M, Fox J. Thinking globally acting locally. Review of The Politics of Caring Human Services at the Local Level. Contemporary Psychology. 1996; 418: 781-782.
2. Blank M, Eisenberg M. Hospital closure the creation of community settings. Review of Psychiatric Hospital Closure Myths Realities. Contemporary Psychology. 1996; 412: 169-170.
3. Blank M, Eisenberg M. Our places to may yet move the earth. Review of Extreme Stress Communities. Impact Intervention.. 4. Blank M, Eisenberg M. Professionalism Ethics in Complementary Alternative Medicine Review of Professionalism Ethics in Complementary Alternative Medicine. Psychiatric Services. 2003; 54(2): 257-258.
5. Eisenberg M, Blank M. HIV Serious Mental Illness revalence Treatment Issues. Harvard Health Policy Review, 2004; 52: 48-54.
6. Eisenberg M, Blank M. Communities as Healing Spaces Review of the book Havens. Stories of True Community Healing. PsycCRITIQUES Contemporary Psychology. 2005; APA Review of Books: 508.
7. Blank M, Eisenberg M. Orthodoxy Incarnations of Assertive Community Treatment. A Rose Is a Rose Review of the book Home Treatment for Acute Mental Disorders. David S. Heath. PsycCRITIQUES Contemporary Psychology. 2006; APA Review of Books: 511.
8. Blank M, Eisenberg M. Prevention of HIV. A gestalt of small wins Review of the book Community Interventions AIDS. PsycCRITIQUES. Contemporary Psychology. 2006; APA Review of Books: 5130.
9. Eisenberg M, Blank M. The application of science the achievement of grace. Review of the book Developmental Psychology Social Change. Research History Policy. PsycCRITIQUES Contemporary Psychology. 2006; PA Review of Books; 5130.
10.Blank M, Eisenberg M. The Slings Arrows of Outrageous Fortune. Transformation Degradation of Entitlements for Children Families Review of the book The Invisible Safety Net Protecting the Nations Poor Children. PsycCRITIQUES Contemporary Psychology. 2007; APA Review of Books: 5222.
11.Blank M, Jameson J. Something in the Water Putting Prevention Epidemiology into Historical Context. Review of the book The Strange Case of the Broad Street Pump the Mystery of Cholera. PsycCRITIQUES Contemporary Psychology. 2007; APA Review of Books: 5227.
12. Blank M. Disintegrated Health Care Science Fact Science Fiction. Review of the book Healing Body Mind. A critical Issue for Health Care Reform. PsycCRITIQUES Contemporary Psychology. 2007; APA Review of Books: 5248.
13. Blank M, Fox J, Eisenberg M. Health Care Reform Redux: A Job for Sisyphus. Review of the book A Second Opinion Rescuing Americans Health Care. Arnold S. Relman. PsycCRITIQUES Contemporary Psychology. 2008; APA Review of Books: 5314.
14. Blank M. Beyond Eugenics History Law Public Health Policy in the Era of the Human Genome. Review of the book Three Generations No Imbeciles Eugenics the Supreme Court Buck v. PsychCRITIQUES Contemporary Psychology. 2009; APA Review of Books. 546.
15. Blank M, Fox J, Jayawickreme N. Fear Circuitry Disorders Reconsidered Review of the book Stress induced fear circuitry disorders Advancing the research agenda for DSM. PsychCRITIQUES Contemporary Psychology. 2009; APA Review of Books: 5443.
16. Eisenberg M, Fox J, Blank M. Science policy making sausage. Review of the book Evidence Based Policymaking. PsycCRITIQUES Contemporary Psychology. 2010; APA Review of Books: 5551.
17.Blank M, Fox J, Eisenberg M. Conceptualizing mental illness. Evolutionary biology social control. Reviews the booK What is mental illness PsycCRITIQUES Contemporary Psychology. 2011; APA Review of Books: 5621.
18.Blank M, Fox J. public health diplomacy: A global perspective on prevention. Review of the book, Designing Healthy Communities. PsycCRITIQUES Contemporary Psychology. APA Review of Books: 5729.
19. Eisenberg M, Fox J, Blank M. Bronfenbrenner as Copernicus: A love letter. Review of the book, Research for the Public Good: Applying the Methods of Translational Research to Improve Human Health Well Being PsycCRITIQUES Contemporary Psychology. 2012; APA Review of Books: 5739.
20. Eisenberg M, Fox J, Blank M. Just call me Hitch. The enigma of Alfred Hitchcock. Contemporary Psychology. 2013; APA 586.
21. Blank M, Fox J, Eisenberg M. Individualized treatment for HIV among Persons with Mental Illness. International Journal of AIDS its Research. 2013; 1(1): 1-3.
22. Blank MB. Homelessness, Mental Illness, Substance Abuse, and HIV: An Insidious Syndemic. HIV/AIDS Res Treat Open J. 2014; 1(1): e1-e4.
Developmental Therapeutics Branch
Center for Cancer Research
National Cancer Institute, NIH
37 Convent Drive
Building. 37, Room 5060
Bethesda, MD 20892, USA
Dr. Marchand obtained his PhD in Molecular Pharmacology in 1997 from the University of Paris, Pierre & Marie Curie, France in the area of gene therapy via DNA triple helix formation. In 1998, he joined the Laboratory of Molecular Pharmacology, CCR, NCI as a Visiting Fellow where he was appointed Staff Scientist in 2006. Dr. Marchand serves as a steering committee member for the Center of Excellence in HIV and Cancer Virology at NCI. Dr. Marchand received two NCI Director’s Intramural Innovation Awards (2007 & 2011) for the development of novel high-throughput screening assays. He is also the recipient of 10 Federal Technology Transfer Awards for his work on HIV-1 integrase and TDP1 inhibitors.
Dr. Marchand research interests include the development of novel HIV-1 integrase inhibitors, the investigation of their mechanism of action and the exploration of the different steps of the integration reaction. The rational for developing HIV integrase inhibitors is that: (1) viruses with mutant integrase cannot replicate; (2) integrase is one of the three retroviral enzymes (with reverse transcriptase and protease) with no cellular equivalent; (3) raltegravir, elvitegravir and dolutegravir have recently been FDA-approved as integrase inhibitor for the treatment of HIV/AIDS. Dr. Marchand’s goals are to discover new antiviral agents, to evaluate which steps of the integration reaction are affected by these drugs and to determine the drug binding site in the HIV-1 integrase-DNA complex. Dr. Marchand’s has reported and patented several families of inhibitors available for development and licensing. Discovery and studies of HIV integrase inhibitors provides a new strategy for anti-AIDS therapy.
2007 to present: Steering Committee of the Center for Excellence in HIV and Cancer Virology, NCI.
2011: 4th International Conference on Retroviral Integration, Siena, Italy: Novel HIV-1 integrase inhibitors targeting the interface of the N- and C-terminal domains and overcoming resistance to strand transfer inhibitors.
2010: PerkinElmer AlphaScreen and AlphaLisa Technology Symposium, Gaithersburg, MD: Identification of phosphotyrosine mimetic inhibitors of human tyrosyl-DNA phosphodiesterase I by a novel AlphaScreen high-throughput assay.
2009: CCR Staff Scientist & Staff Clinician 5th Annual Retreat, NCI, Rockville, MD: Quantitative high-throughput screening of the NIH Roadmap Molecular Libraries Small Molecule Repository (MLSMR) for the discovery of human tyrosyl DNA phosphodiesterase I (Tdp1) inhibitors.
2008: Center for Excellence in HIV and Cancer Virology Think Tank, CCR, NCI, Bethesda, MD: Mono and Bi-functional quinolinonyl diketo acid derivatives as novel HIV-1 integrase inhibitors.
2006: HIV-1 Drug Resistance Program Think Tank, CCR, NCI-Frederick, MD: Novel inhibitors identified by a new HIV-1 integrase high-throughput screen.
2004: HIV-1 Drug Resistance Program Think Tank, CCR, NCI-Frederick, MD: Novel peptides inhibitors ofHIV-1 integrase.
2002: HIV-1 Drug Resistance Program Think Tank, CCR, NCI-Frederick, MD: Inhibition of HIV-1 integrase by ߖdiketo acids.
2001: Center for Cancer Research Symposium, NCI-Frederick, MD: Inhibition of HIV-1 integrase by ߖdiketo acids.
2000: Center for Cancer Research Symposium, NCI-Frederick, MD: Inhibition of HIV-1 integrase by lexitropsins.
1997: Organic and Biological Chemistry Journeys, Institut Curie, Paris, France:Design of a triple-helix-specific cleaving reagent.
1997: Young Researchers Forum of the French Molecular Biology Society, Corte, France: New insights in the rational design of DNA triple helix specific ligands.
1996: Young Researchers Forum of the French Molecular Biology Society, Poitiers, France: New insights in the rational design of DNA triple helix specific ligands.
1995: Young Researchers Forum of the French Molecular Biology Society, Grenoble, France: Rational conception of switch oligonucleotides to extend the recognition sequences for DNA triple helix formation.
1994: Young Researchers Forum of the French Molecular Biology Society, Reims, France: Recognition sequence extension for DNA triple helix formation.
2010: The Center for Excellence in HIV and Cancer Virology Fall Think Tank Meeting, NCI, NIH, Bethesda, MD.
RESEARCH ARTICLES IN PEER-REVIEWED JOURNALS
1. Marchand C, Bailly C, McLean M, Moroney S, Waring M. The 2-amino group of guanine is absolutely required for specific binding of the anti-cancer antibiotic echinomycin to DNA. Nucleic Acids Research. 1992; 20: 5601-5606. doi: 10.1093/nar/20.21.5601
2. Bailly C, Marchand C, Waring M. New binding sites for antitumor antibiotics created by relocating the purine 2-amino group in DNA. Journal of the American Chemical Society. 1993; 115: 3784-3785. doi:
3. Zhou B, Marchand C, Asseline U, et al. Recognition of alternating oligopurine/oligopyrimidine tracts of DNA by oligonucleotides with base-to-base linkages. Bioconjugate Chemistry. 1995; 6: 516-523. doi:
4. Bailly C, Marchand C, Nguyen C, et al. Localized chemical reactivity in double-stranded DNA associated with the intercalative binding of benzo-e-pyridoindole and benzo-g-pyridoindole triple-helix-stabilizing ligands. European Journal of Biochemistry. 1995; 232: 66-76. doi: 10.1111/j.1432-1033.1995.tb20782.x
5. Marchand C, Bailly C, Nguyen C, et al. Stabilization of triple helical DNA by a benzopyridoquinoxaline intercalator. Biochemistry. 1996; 35: 5022-5032. doi: 10.1021/bi952908l
6. Nguyen C, Marchand C, Delage S, et al. Synthesis of 13H-benzo6, 7- and 13H-benzo4, 5indolo3, 2-c-quinolines: a new series of potent specific ligands for triplex DNA. Journal of the American Chemical Society. 1998; 120: 2501-2507. doi:
7. Marchand C, Sun JS, Bailly C, Waring MJ, Garestier T, Helene C. Optimization of alternate-strand triple helix formation at the 5, CpG3, and 5, GpC3, junction steps. Biochemistry. 1998; 37: 13322-13329. doi: 10.1021/bi980618+
8. Baudoin O, Marchand C, Fichou M, et al. Stabilization of DNA triple helices by crescent-shaped dibenzophenanthrolines. Chemistry A European Journal. 1998; 4: 1504-1508. doi:
9. Marchand C, Zain R, Sun J, et al. Design of a triple-helix-specific cleaving reagent. Chemistry and Biology. 1999; 6: 771-777. doi: http://dx.doi.org/10.1016/S1074-5521(99)80124-0
10. Marchand C, Nguyen C, Ward B, et al. A new family of sequence-specific DNA cleaving agents directed by triple-helical structures: Benzopyridoindole-EDTA conjugates. Chemistry-A European Journal. 2000; 6: 1559-1563. doi:
11. Jing N, Marchand C, Liu J, Mitra R, Hogan M, Pommier Y. Mechanism of inhibition of HIV-1 integrase by G-tetrad forming oligonucleotides in vitro. The Journal of Biological Chemistry. 2000; 275: 21460-21467. doi: 10.1074/jbc.M001436200
12. Pluymers W, Pannecouque C, Fikkert V, et al. Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters. Molecular Pharmacology. 2000; 58: 641-648. doi: 10.1124/mol.58.3.641
13. Pilon A, Marchand C, Kavlick M, et al. Mutations in the HIV-1 integrase of patients receiving long-term dideoxynucleoside therapy do not confer resistance to AZT. AIDS Research and Human Retroviruses. 2000; 16: 1417-1422. doi: 10.1089/08892220050140964.
14. Jing N, Marchand C, Guan Y, et al. Structure-activity of inhibition of HIV-1 integrase and virus replication by G-quartet oligonucleotides. DNA and Cell Biology. 2001; 20: 499-508. doi: 10.1089/104454901316976136
15. Marchand C, Pourquier P, Laco, G, Jing N, Pommier Y. Interaction of Topoisomerase I with G-quartet-forming and G-rich oligodeoxy- and oligoribonucleotides. The Journal of Biological Chemistry. 2002; 277: 8906-8911. doi:
16. Marchand C, Zhang X, Pais G, et al. Structural determinants for HIV-1 integrase inhibition by B-diketo acids. The Journal of Biological Chemistry. 2002; 277: 12596-12603. doi:
17. Pais G, Zhang X, Marchand C, et al. Structure activity investigation of 3-aryl-1, 3-diketo containing compounds as HIV-1 integrase inhibitors. Journal of Medicinal Chemistry. 2002; 45: 3184-3194. doi: 10.1021/jm020037p
18. Zhang X, Pais G, Svarovskaia E, et al. Azido-containing aryl beta-diketo acid HIV-1 integrase inhibitors. Bioorganic and Medicinal Chemistry Letters. 2003 13: 1215-1219, . doi: 10.1016/S0960-894X(03)00059-3
19. Marchand C, Johnson A, Karki R, et al. Metal selectivity and resistance of the soluble double-mutant integrase (F185K/C280S) for HIV-1 integrase inhibition by B-diketo acids. Molecular Pharmacology. 2003; 64: 600-609. doi: 10.1124/mol.64.3.600
20. Krajewski K, Long Y, Marchand C, Pommier Y, Roller P. Design and synthesis of dimeric HIV-1 integrase inhibitory peptides. Bioorganic and Medicinal Chemistry Letters. 2003; 13: 3203-3205. doi: 10.1016/S0960-894X(03)00679-6
21. Zhang, X, Marchand C, Pommier Y, Burke T. Design and synthesis of photoactivatable aryl diketo acid-containing HIV-1 integrase inhibitors as potential affinity probes. Bioorganic and Medicinal Chemistry Letters. 2004; 14: 1205-1207. doi: 10.1016/j.bmcl.2003.12.064
22. Svarovskaia E, Barr R, Zhang X, et al. Azido-containing diketo acid derivatives inhibit HIV-1 integrase in vivo and influence the frequency of deletions at the 2-LTR circle junctions. Journal of Virology. 2004; 78: 3210-3222, 2004. doi: 10.1128/JVI.78.7.3210-3222.2004
23. Krajewski K, Marchand C, Long Y, Pommier Y, Roller P. Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin. Bioorganic and Medicinal Chemistry Letters. 2004; 14: 5595-5598. doi: 10.1016/j.bmcl.2004.08.061
24. Di Santo R, Costi R, Artico M, et al. Design, synthesis and biological evaluation of heteroaryl diketohexenoic and diketobutanoic acids as HIV-1 integrase inhibitors endowed with antiretroviral activity. Farmaco. 200560: 409-417. doi: 10.1016/j.farmac.2005.03.008
25. Johnson A, Santos W, Pais G, et al. Integration requires the donor DNA end (5, -C) interaction with glutamine 148 of the HIV-1 integrase flexible loop. The Journal of Biological Chemistry. 2006. 261: 461-467, doi: 10.1074/jbc.M511348200
26. Marchand C, Antony S, Kohn K, et al. A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex. Molecular Cancer Therapeutics. 2006; 5: 1-9. doi: 10.1158/1535-7163.MCT-05-0456
27. Di Santo R, Costi R, Roux A, et al. bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities and mechanism of action. Journal of Medicinal Chemistry. 2006; 49: 1939-1945. doi: 10.1021/jm0511583
28. Semenova E, Johnson A, Marchand C, Davis D, Yarchoan R, Pommier Y. Preferential inhibition of the magnesium-dependent strand transfer reaction of HIV-1 integrase by -hydroxytropolones. Molecular Pharmacology. 2006; 69: 1454-1460. doi: 10.1124/mol.105.020321
29. Marchand C, Krajewski K, Lee H, et al. Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites. Nucleic Acids Research. 2006; 34: 5157-5165. doi: 10.1093/nar/gkl667
30. Bona R, Andreotti M, Buffa V, et al. A Development of a Human Immunodeficiency Virus vector-based single-cycle assay for evaluation of anti-integrase compounds. Antimicrobial Agents and Chemotherapy. 2006; 50: 3407-3417. doi: 10.1128/AAC.00517-06
31. Marchand C, Johnson A, Patil S, et al. Probing HIV-1 integrase inhibitor binding sites with position-specific integrase-DNA crosslinking assays. Molecular Pharmacology. 2007; 71: 893-901. doi: 10.1124/mol.106.030817
32. Marchand C, Antony, S, Stephen A, et al. Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1. Nucleic Acids Research . 2007; 35: 4474-4484. doi: 10.1093/nar/gkm463
33. Liao C, Karki RG, Marchand C, Pommier, Y, Nicklaus M. Virtual screening application of a model of full-length HIV-1 integrase complexed with viral DNA. Bioorganic and Medicinal Chemistry Letters. 2007; 17: 5361-5365. doi: 10.1016/j.bmcl.2007.08.011
34. Marchand C, Beutler J, Warimu A, et al. Madurahydroxylactones derivatives as dual inhibitors of human immunodeficiency virus type 1 integrase and RNase H. Antimicrobial Agents and Chemotherapy. 2008; 52: 361-364, . doi: 10.1128/AAC.00883-07
35. Zhao XZ, Semenova EA, Vu C, et al. 2, 3-Dihydro-6, 7-dihydroxy-1H-isoindol-1-one-based HIV-1 integrase inhibitors. Journal of Medicinal Chemistry. 2008; 51: 251-259. doi: 10.1021/jm070715d
36. Santo D, Costi R, Roux A, et al. Novel quinolinonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, and biological activities. Journal of Medicinal Chemistry. 2008; 51: 4744-4750. doi: 10.1021/jm8001422.
37. Marinello J, Marchand C, Mott B, Bain A, Thomas C, Pommier Y. Comparison of raltegravir and elvitegravir on HIV-1 integrase catalytic reactions and on a series of drug-resistant integrase mutants. Biochemistry. 2008; 47: 9345-54. doi: 10.1021/bi800791q
38. Marchand C, Lea W, Jadhav A, et al. Identification of phosphotyrosine mimetic inhibitors of human tyrosyl-DNA phosphodiesterase I by a novel AlphaScreen high-throughput assay. Molecular Cancer Therapeutics. 2009; 8: 242-250. doi: 10.1158/1535-7163.MCT-08-0878
39. Zha X, Maddali K, Vu C, et al. Examination of halogen substituent effects on HIV-1 integrase inhibitors derived from 2, 3-dihydro-6, 7-dihydroxy-1H-isoindol-1-ones and 4, 5-dihydroxy-1H-isoindole-1, 3(2H)-diones. Bioorganic and Medicinal Chemistry Letters. 2009; 19: 2714-2717. doi: 10.1016/j.bmcl.2009.03.122
40. Zhao X, Maddali K, Vu C, et al. Diketoacid-genre HIV-1 integrase inhibitors containing enantiomeric arylamide functionality. Bioorganic and Medicinal Chemistry. 2009;17: 5318-5324. doi: 10.1016/j.bmc.2009.05.008
41. Dexheimer T, Gedya L, Stephen A, et al. 4-Pregnen-21-ol-3, 20-dione-21-(4-bromobenzenesufonate) (NSC 88915) and Related Novel Steroid Derivatives as Tyrosyl-DNA Phosphodiesterase (Tdp1) Inhibitors. Journal of Medicinal Chemistry. 2009; 52: 7122-7131. doi: 10.1021/jm901061s.
42. Weidlich I, Dexheimer T, Marchand C, Antony S, Pommier Y, Nicklaus M. Inhibitors of human tyrosyl-DNA phospodiesterase (hTdp1) developed by virtual screening using ligand-based pharmacophores. Bioorganic and Medicinal Chemistry. 2010; 18: 182-189. doi: 10.1016/j.bmc.2009.11.008.
43. Michelini Z, Galluzzo C, Negri D, et al. Evaluation of HIV-1 Integrase Inhibitors on Human Primary Macrophages Using a Luciferase-Based Single-Cycle Phenotypic Assay. Journal of virological methods. 2010; 168: 272-276. doi: 10.1016/j.jviromet.2010.06.004
44. Metifiot M, Maddali K, Naumova A, Zhang X, Marchand C, Pommier Y. Biochemical and pharmacological analyses of HIV-1 integrase flexible loop mutants resistant to raltegravir. Biochemistry. 2010; 49: 3715-37122. doi: 10.1021/bi100130f.
45. Metifiot M, Vandegraaff N, Maddali K, et al. Molecular mechanism for elvitegravir activity against the integrase mutation Y143 associated with raltegravir resistance. AIDS. 2011; 25: 1175-1178, . doi: 10.1097/QAD.0b013e3283473599.
46. Zhao X, Maddali K, Metifiot M, et al. Development of tricyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors. Bioorganic and Medicinal Chemistry Letters. 2011; 21: 2986-2990. doi: 10.1016/j.bmcl.2011.03.047
47. Metifiot M, Johnson B, Smith S, et al. MK-0536 inhibits HIV-1 integrases resistant to raltegravir. Antimicrobial agents and chemotherapy. 2011; 11: 5127-5133. doi: 10.1128/AAC.05288-11.
48. Zhao X, Maddali K, Metifiot M, et al. Bicyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors. Chemical Biology and Drug Design. 2012 79: 157-165, . doi: 10.1111/j.1747-0285.2011.01270.x
49. Nguyen T, Morrell A, Sheridan C, et al. Synthesis and Biological Evaluation of the First Dual Tyrosyl-DNA Phosphodiesterase I (Tdp1)-Topoisomerase I (Top1) Inhibitors. The Journal of Medicinal Chemistry. 201255: 4457-78, 2012. doi: 10.1021/jm300335n.
50. Gao R, Huang S, Marchand C, Pommier Y . Biochemical characterization of human Tyrosyl DNA Phosphodiesterase 2 (TDP2/TTRAP): a Mg2+/Mn2+-dependent phosphodiesterase specific for the repair of topoisomerase cleavage complexes. The Journal of Biological Chemistry. 2012; 287: 30842-30852. doi: 10.1074/jbc.M112.393983.
51. Marchand C, Sirivolu V, Vernekar S, et al. 5-Arylidenethioxothiazolidinones as Inhibitors of Tyrosyl-DNA Phosphodiesterase I. The Journal of Medicinal Chemistry. 2012; 55: 8671-8684. doi: 10.1021/jm3008773
52. Metifiot M, Maddali M, Johnson B, et al. Activities, crystal structures and molecular dynamics of dihydro-1H-isoindole derivatives, inhibitors of HIV-1 integrase. ACS Chemical Biology. 2012; 8: 209-217. doi: 10.1021/cb300471n
53. Zhao X, Maddali K, Smith S, et al. 6, 7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing HIV-1 integrase inhibitors. Bioorganic and Medicinal Chemistry Letters. 2012; 22: 7309-7317. doi: 10.1016/j.bmcl.2012.10.088.
54. Sheridan C, Narasimha M, Cobb B, et al. Synthesis and Biological Evaluation of Indenoisoquinolines that Inhibit both Tyrosyl-DNA-Phosphodiesterase I (Tdp1) and Topoisomerase I (Top1). The Journal of Medicinal Chemistry. 201356: 182-200. doi: 10.1021/jm3014458
55. Taliani S, Pugliesi I, Barresi E, et al. Phenylpyrazolo[1, 5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of non-camptothecin Topoisomerase I (Top1) inhibitors. The Journal of Medicinal Chemistry. 2013; 56: 7458-7462. doi: 10.1021/jm400932c.
56. Costi R, Metifiot M, Esposito F, et al. 6-(1-Benzyl-1H-pyrrol-2-yl)-2, 4-dioxo-5-hexenoic Acids as Dual Inhibitors of Recombinant HIV-1 Integrase and Ribonuclease H, Synthesized by a Parallel Synthesis Approach. The Journal of Medicinal Chemistry. 2013. doi: 10.1021/jm401040b
1. Neamati N, Marchand C, Pommier Y. HIV-1 Integrase inhibitors: past, present and future. Advances in Pharmacology. 2000; 49: 147-165. doi:
2. Pommier Y, Marchand C, Neamati N. Retroviral integrase inhibitors year 2000: update and perspectives. Antiviral Research. 2000; 47: 139-148. doi: 10.1016/S0166-3542(00)00112-1
3. Marchand C, Neamati N, Pommier Y. In vitro HIV-1 integrase assays. Methods in Enzymology. 2001; 340: 624-633. doi:
4. Neamati N, Marchand C, Winslow H, Pommier Y. Human Immunodeficiency Virus type 1 integrase-targeted inhibitor design. Antiretroviral Therapy. 2001; 5: 87-103. doi:
5. Johnson A, Marchand C, Pommier Y. HIV-1 integrase inhibitors: a decade of research and two drugs in clinical trial. Current Topics in Medicinal Chemistry. 2004; 4: 671-686. doi: 10.2174/1568026043388394
6. Pommier Y, Marchand C. Interfacial inhibitors of the protein-nucleic acid interactions. Current Medicinal Chemistry Anti Cancer Agents. 2005; 5: 421-429. doi: http://dx.doi.org/10.2174/1568011054222337
7. Pommier Y, Johnson A, Marchand C. Integrase inhibitors to treat HIV/AIDS. Nature Reviews Drug Discovery. 2005; 4: 236-248. doi: 10.1038/nrd1660
8. Pommier Y, Ashutosh R, Sordet O, et al. Repair of topoisomerase I-mediated DNA damage. in Progress in Nucleic Acid. Research and Molecular Biology. 2006; 81: 175-221. doi: 10.1016/S0079-6603(06)81005-6
9. Marchand C, Pommier Y. Interfacial inhibitors of human topoisomerase I. in Sequence Specific Binding Agents. RSC Biomolecular Sciences. Cambridge Chapter 2006; 2: 29-43. doi: 10.1039/9781847555304-00029
10. Marchand C, Johnson A, Semenova E, Pommier Y. Mechanisms and inhibition of HIV integration. Drug Discovery Today: Disease Mechanisms. 2006; 3: 253-260. doi: 10.1016/j.ddmec.2006.05.004
11. Semenova E, Johnson A, Marchand C, Pommier Y. Integrase inhibitors. Current Opinions in HIV and AIDS. 2006; 1: 380-387. doi:
12. Marchand C, Pommier Y. A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex. CCR Newsletter, Frontiers in Science. 2007; 6: 1-5. doi: 10.1158/1535-7163.MCT-05-0456
13. Semenova A, Marchand C, Pommier Y. HIV-1 integrase inhibitors: update and perspectives. Advances in Pharmacology. 2008; 56: 199-228. doi: 10.1016/S1054-3589(07)56007-2
14. Dexheimer T, Antony S, Marchand C, Pommier Y. Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy. Anticancer Agents Medicinal Chemistry. 2008; 8: 381-389. doi: 10.2174/187152008784220357
15. Marchand C, Maddali K, Metifiot M, Pommier Y. HIV-1 IN inhibitors: 2010 update and perspectives. Current Topics in Medicinal Chemistry. 2009; 9: 1016-37. doi: 10.2174/156802609789630910
16. Pommier Y, Leo E, Zhang H, Marchand C. DNA topoisomerases and their poisoning by anticancer and antibacterial inhibitors. Chemistry and Biology. 2010; 17: 421-33. doi: 10.1016/j.chembiol.2010.04.012.
17. Metifiot M, Maddali K, Marchand C, Pommier Y. HIV integrase-resistance mutations: the bench and the bedside. Viruses. 2010; 2: 1347-1366. doi:
18. Liao C, Marchand C, Burke T, Pommier Y, Nicklaus M. Authentic HIV-1 integrase inhibitors. Future Medicinal Chemistry. 2010; 2: 1107-11022. doi: 10.4155/fmc.10.199.
19. Marchand C, Pommier Y. Topoisomerase Poisons: a Paradigm for Interfacial Inhibition in Topoisomerases and Cancer. Cancer Research. 2011. doi:
20. Johnson A, Pommier Y, Marchand C. Insight into HIV-1 integrase-DNA interactions in HIV-1 Integrase. Drug Discovery and Development. 2011. doi: 10.1074/jbc.M803257200.
21. Huang S, Pommier Y, Marchand C. Tyrosyl-DNA Phosphodiesterase I (Tdp1) Inhibitors. Expert Opinion on Therapeutic Patents. 2011; 9: 1285-1292. doi: 10.1517/13543776.2011.604314.
22. Pommier Y, Marchand C. Interfacial Inhibitors: Targeting Macromolecular Complexes. Nature Reviews Drug Discovery. 2012; 11: 25-36. doi: 10.1038/nrd3404
23. Marchand C. The Elvitegravir Quad Pill: The first Once-Daily Dual Target Anti-HIV Tablet. Expert Opinions on Investigational Drugs. 2012; 21: 90190-90194. doi: 10.1517/13543784.2012.685653
24. Marchand C. Dual Choice For Dual Target Anti-HIV Therapy. Journal of Clinical Research in HIV/AIDS and Prevention. 2012; 1: 1-2. doi: 10.1002/sim.2303
25. Metifiot M, Marchand C, Pommier Y. HIV Integrase Inhibitors: 20-Year Landmark and Challenges. Adv Pharmacol. 2013; 67: 75-105. doi: 10.1016/B978-0-12-405880-4.00003-2.
Professor of Cell Biology, Molecular and Human Genetics,Obstetrics and Gynecology
Director of Reproduction and Devolopment Program
Herbert Wertheim College of Medicine
Florida International University
Modesto A. Maidique Campus, GL495C
11200 SW 8th Street
Miami, Florida 33199, USA
C.V. Rao is one of the worlds leading experts in LH/hCG actions in non gonadal tissues in the body. More than 36 years of his research has led to wide spread recognition of these hormones action in health and disease and to potential novel therapeutic uses of hCG in reproductive medicine, infectious and autoimmune diseases, cancers, etc. He has extensively lectured on these research developments at various universities in U.S and throughout the world and in national and international scientific meetings. He has published more than 240 peer-reviewed journal articles, 350 abstracts and 36 book chapters. His research has almost been continuously funded for more than 30 years, mostly by NIH. He has taught and trained more than 100 postdoctoral and clinical fellows, residents and students. He serves as an editorial board member for numerous scientific journals. He has been an organizing committee member of numerous national and international scientific meetings. He was a member of Human Embryology and Development 1 Study Section at National Institutes of Health from 1998 to 2002. Before joining Florida International University College of Medicine in July 2008, Dr Rao held the positions of Professor of Obstetrics, Gynecology and Womens Health, Professor of Biochemistry and Molecular Biology and Director of Division of Research in the Department of Obstetrics, Gynecology and Womens Health at the University of Louisville School of Medicine, Louisville, Kentucky. He was also a Distinguished University Scholar. He joined University of Louisville in 1972 and rose through the ranks to become full Professor with tenure in 1979.
His research interest includes: Basic and translational research on nongonadal LH/hCG actions.
MEMBERSHIP IN PROFESSIONAL SOCIETIES
• American Society for Biochemistry and Molecular Biology
• American Society for Cell Biology
• American Physiological Society
• The Endocrine Society
• Society for Gynecologic Investigation
• Society for the Study of Reproduction
• American Society for Reproductive Medicine
• International Federation of Fertility Societies
• American Association for the Advancement of Science
• Sigma Xi
• International Federation of Placenta Associations
• International Society for the Study of Trophoblastic Diseases
• Life member of Indian Society for the Study of Reproduction and Fertility
• University of Louisville
• President’s Award for Outstanding Scholarship
• Research and Creative Activity, 1988
• Distinguished University Scholar, University of Louisville, 1998
• Medical Research Council’s Distinguished Visiting Scientist at the University of Cape Town, South Africa, 2005
• Professor Kesho Ram Laumas Memorial Oration-2007, Award given by All India Institute of Medical Sciences, New Delhi, to National/international scientist for outstanding contribution to the field of Reproductive Biology and Population Control
• 2009 Outstanding Alumnus Award from the Animal Science Department at the Washington State University, Pullman, Washington
• Guest of Honour at the International Conference on Multidisciplinary Approaches to Diabetes Research & Health, Jaipur, Rajasthan, India, November 14-16, 2010
• Professor L.S.Ramaswami Memorial Oration during 22nd Annual Meeting of the Indian Society for the Study of Reproduction and Fertility and ICMR Centenary Celebrations, New Delhi, India, February 19th 2012
• Visiting Professor at University of Rome Tor Vergata, March 31-April 4, 2014
FULL LENGTH PEER REVIEWED PUBLICATIONS
1. Rao ChV, Saxena BB. Gonadotropin receptors in the plasma membranes of rat luteal cells. Biochim Biophys Acta. 1973; 313: 372-389. doi: 10.1016/0304-4165(73)90037-8
2. Rao ChV, Saxena BB. Localization and preliminary characterization of the hCG receptor in the luteal cells. Acta Physiologica Latinoamericana. 1973; 23: 240-242.
3. Rao ChV, Carman F Jr. Stimulation of ovarian cyclic guanosine 3: 5-monophosphate levels by the subunits of human chorionic gonadotropin. Biochem Biophys Res Comm. 1973; 54: 744-750. doi: 10.1016/0006-291X(73)91486-1
4. Rao ChV. Receptors for prostaglandins and gonadotropins in cell membranes of bovine corpus luteum. Prostaglandins. 1973; 4: 567-576. doi: 10.1016/S0090-6980(73)80013-9
5. Rao ChV. Properties of gonadotropin receptors in the cell membranes of bovine corpus luteum. J Biol Chem. 1974; 249: 2864-2872.
6. Rao ChV. Prostaglandin receptors in the bovine corpus luteum cell membranes. Prostaglandins. 1974 6: 533-536. doi: 10.1016/0005-2736(76)90228-5
7. Rao ChV. Differential properties of prostaglandin and gonadotropin receptors in the bovine corpus luteum cell membranes. Prostaglandins. 1974; 6: 313-328.
8. Rao ChV. Differences between in vivo and in vitro actions of prostaglandins in corpus luteum tissue: is there a paradox? Prostaglandins. 1974; 7: 209-213.doi: 10.1007/BF00319035
9. Rao ChV. Characterization of prostaglandin receptors in the bovine corpus luteum cell membranes. J Biol Chem. 1974; 249: 7203-7209.
10. Rao ChV. Steroid hormone modulation of 3H-prostaglandin EI binding to bovine corpus luteum cell membranes. Prostaglandins. 1975; 9: 569-578.
11. Rao ChV. Mechanism of nucleotide inhibition of gonadotropin binding to bovine corpus luteum cell membranes. Mol Cell Endocrinol. 1975; 3: 255-271.
12. Rao ChV. Comparisons of affinity constants for PGEs receptor interaction with concentrations of PGEs needed for half maximal stimulation of adenylate cyclase. Prostaglandins. 1975; 9: 579-584.
13. Rao ChV. The presence of discrete receptors for prostaglandin F2in the cell membranes of bovine corpora lutea. Biochem Biophys Res Comm. 1975; 64: 416-424.
14. Rao ChV. The presence of gonadotropin and prostaglandin E receptors in the cell membranes of bovine corpora lutea throughout pregnancy. Fertil Steril. 1975; 26: 1185-1189.
15. Rao ChV. Cationic dependency of high affinity prostaglandin F2receptors in bovine corpus luteum cell membranes. Biochem Biophys Res Comm. 1975; 67: 1242-1250. doi: 10.1016/0006-291X(75)90806-2
16. Rao ChV. Prostaglandin F2receptors in bovine corpus luteum cell membranes: effect of enzymes and protein reagents. Biochem Biophys Acta. 1976; 436: 170-182.
17. Rao ChV. Lack of negative cooperativity among binding sites for prostaglandin F2in bovine corpus luteum cell membranes. Life Sci. 1976; 18: 499-506. doi: 10.1016/0024-3205(76)90327-1
18. Rao ChV. Prostaglandin F receptors in the cell membranes of bovine corpora lutea throughout pregnancy. Biol Reprod. 1976; 15: 134-139.
19. Rao ChV. Inhibition of 3H-prostaglandin F2binding to its receptors by progesterone. Steroids. 1976; 27: 831-843.
20. Rao ChV. Properties of prostaglandin F2receptors in bovine corpus luteum cell membranes. Mol Cell Endocrinol. 1976; 6: 1-16.
21. Rao ChV, Griffin LP, Carman FR Jr. Gonadotropin receptors in human corpora lutea of menstrual cycle and pregnancy. Amer J Obstet Gynecol. 1977; 128: 146-153.
22. Rao ChV, Griffin LP, Carman FR Jr. Gonadotropin receptors in human corpora lutea of menstrual cycle and pregnancy. J Clin Endocrinol Metab. 1977; 44: 1032-1037.
23. Rao ChV. Differential effects of detergents and dimethylsulfoxide on membrane prostaglandin E I and F2 receptors. Life Sci. 1977; 20: 2013-2022.
24. Rao ChV, Mitra S. Subcellular distribution of prostaglandin and gonadotropin receptors in bovine corpora lutea. Biochem Biophys Res Comm. 1977; 76: 636-643. dio:10.1016/0006-291X(77)91548-0
25. Lin MT, Rao ChV. 3H-prostaglandins binding to dispersed bovine luteal cells: evidence for discrete prostaglandin receptors. Biochem Biophys Res Comm. 1977; 78: 510-516.
26. Mitra S, Rao ChV. Receptors for gonadotropins and prostaglandins in lysosomes of bovine corpora lutea. Arch Biochem Biophys. 1978; 185: 126-133.
27. Rao ChV. Effect of hydrolytic enzymes and protein modifying reagents on gonadotropin receptors in bovine corpus luteum cell membranes. Biochim Biophys Acta. 1978; 538: 212-225.
28. Lin MT, Rao ChV. Properties of 3H-prostaglandin F2 binding to dispersed bovine luteal cells. Life Sci. 1978; 22: 303-312.
29. Lin MT, Rao ChV. Selected properties of 3H-prostaglandin EI binding to dispersed bovine luteal cells. Mol Cell Endocrinol. 1978; 9: 311-320.
30. Rao ChV, Sanfilippo J, Carman FR Jr. Gonadotropin receptors in human corpora lutea of term pregnancies. Amer J Obstet Gynecol. 1978; 132: 581-583.
31. Mitra S, Rao ChV. Gonadotropin and prostaglandin binding sites in rough endoplasmic reticulum and golgi fractions of bovine corpora lutea. Arch Biochem Biophys. 1978; 191: 331-340.
32. Rao ChV, Carman FR Jr, Gorman RR. Prostaglandin E and F2 receptors in bovine corpora lutea: Relative affinities of products of arachidonic acid metabolism by cyclo-oxygenase. Biochem Biophys Res Comm. 1978; 85: 125-130.
33. Rao ChV, Harker CW. Prostaglandin E and F2receptors in bovine corpus luteum plasma membranes are two different macromolecular entities. Biochem Biophys Res Comm. 1978; 85: 1054-1060.
34. Rao ChV, Mitra S. Gonadotropin and prostaglandins binding sites in nuclei of bovine corpora lutea. Biochim Biophys Acta. 1979; 584: 454-466.
35. Rao ChV. Differential properties of human chorionic gonadotropin and human luteinizing hormone binding to plasma membranes of bovine corpora lutea. Acta Endocrinol. 1979; 90: 696-710.
36. Rao ChV, Estergreen VL, Carman FR Jr, Moss GE. Receptors for gonadotropins and prostaglandin F2in bovine corpora lutea of early, mid and late luteal phase. Acta Endocrinol. 1979; 91: 529-537.
37. Lin MT, Rao ChV. Ornithine decarboxylase in bovine corpora lutea. J Endocrinol Invest. 1980; 3: 131-136.
38. Rao ChV, Willcourt R, Queenan JT. Lack of subhourly variations in plasma unconjugated estriol levels in pregnant diabetics in the third trimester. Amer J Obstet Gynecol. 1980; 137: 543-546.
39. Rao ChV. Pregnancy tests for office and home. Contemporary Ob/Gyn. 1980; 16: 107-112.
40. Mitra S, Rao ChV, Fields MJ. Enzyme activities in early, mid and late luteal phase bovine corpora lutea. Biochem Biophys Res Comm. 1980; 97: 1555-1561.
41. Rao ChV, Kable WT, Yussman MA, Mitra SB. Gonadotropin binding sites in ovaries of patients with familial XY gonadal dysgenesis and Turners syndrome. Letter to Editor. Amer J Obstet Gynecol. 1981; 139: 226.
42. Rao ChV, Mitra S, Carman FR Jr. Characterization of gonadotropin binding sites in the intracellular organelles of bovine corpora lutea and comparison with those in plasma membranes. J Biol Chem. 1981; 256: 2628-2634.
43. Rao ChV, Mitra S, Sanfilippo J, Carman FR Jr. The presence of gonadotropin binding sites in the intracellular organelles of human ovaries. Amer J Obstet Gynecol. 1981; 139: 655-660.
44. Cole LA, Hussa RO, Rao ChV. Discordant synthesis and secretion of human chorionic gonadotropin and subunits by cervical carcinoma cells. Cancer Res. 1981; 41: 1615-1619.
45. Andersen NH, Imamoto S, Subramanian N, et al() Molecular basis for prostaglandin potency. III. Tests of the significance of the hairpin conformation in biorecognition phenomena. Prostaglandins. 1981; 22: 841-856.
46. Andersen NH, Subramanian N, De B, McCrae DA, Tynan SS, Rao ChV. Methyl esters of prostaglandin F2and I2. Prostaglandins and Medicine. 1981; 6: 345-357.
47. Rao ChV. Pregnancy tests for office and home. Ortho Forum. 1981; 1: 10-13.
48. Rao ChV, Hussa RO. A simple way to determine non-specific effects of plasma and serum components in radio receptor assays and radioimmune assays for human chorionic gonadotropin. Amer J Obstet Gynecol. 1982; 142: 153-158.
49. Rao ChV, Fields MJ, Chen TT, Abel JH Jr, Edgerton LA. Changes in gonadotropin binding sites in intracellular organelles and plasma membrane during luteal growth, development and regression. Exp Cell Res. 1983; 144: 285-295.
50. Rao ChV, Hussa RO, Carman FR Jr, Rinkle ML, Cook CL, Yussman MA. Stability of human chorionic gonadotropin and its alpha subunit in human blood. Amer J Obstet Gynecol. 1983; 146: 65-68.
51. Cook CL, Rao ChV, Yussman MA. Plasma gonadotropin and sex steroid hormone levels during early, mid follicular and mid luteal phases of women with luteal phase defects. Fertil Steril. 1983; 40: 45-48.
52. Hofmann GE, Rao ChV, Barrows GH, Sanfilippo JS. Topography of human uterine prostaglandin E and F2receptors and their profiles during pathological states. J Clin Endocrinol Metab. 1983; 57: 360-366. doi: http://dx.doi.org/10.1210/jcem-57-2-360
53. Rao ChV, Edgerton LA. Dissimilarity of corpora lutea within the same ovaries of those from right and left ovaries of pigs during the oestrus cycle. J Reprod Fertil. 1984; 70: 61-66.
54. Hofmann GE, Rao ChV, Barrows GH, Rossano LT, Sanfilippo JS. Prostaglandin E and F2receptors in human uterine leiomyomas. J Clin Endocrinol Metab. 1984; 58: 454-457.
55. Rao ChV, Ireland JJ, Roche JF. Decrease of various luteal enzyme activities during prostaglandin F2induced luteal regression in bovine. Mol Cell Endocrinol. 1984; 34: 99-103.
56. Chegini N, Rao ChV, Carman FR Jr. Internalization of 125I-human choriogonadotropin in luteal slices. A biochemical study. Exp Cell Res. 1984; 151: 466-482.
57. Chegini N, Rao ChV, Cobbs G. A quantitative electron microscope autoradiographic study on 125I-human choriogonadotropin internalization in bovine luteal slices. Exp Cell Res. 1984; 151: 483-493.
58. Hofmann GE, Rao ChV, Barrows GH, Schultz GS, Sanfilippo JS. Binding sites for epidermal growth factor in human uterine tissues and leiomyomas. J Clin Endocrinol Metab. 1984; 58: 880-884.
59. Rao ChV, Carman FR Jr, Chegini N, Schultz GS. Binding sites for epidermal growth factor in human fetal membranes. J Clin Endocrinol Metab. 1984; 58: 1034-1042.
60. Chegini N, Ramani N, Rao ChV. Morphological and biochemical characterization of small and large bovine luteal cells during pregnancy. Mol Cell Endocrinol. 1984; 37: 89-102.
61. Chegini N, Rao ChV, Cobbs G. A quantitative electron microscope autoradiographic study on 3H-prostaglandin E1 and F2internalization in bovine luteal slices. Mol Cell Endocrinol. 1984; 38: 117-129.
62. Hofmann GE, Rao ChV, DeLeon FD, Toledo AA, Sanfilippo JS. Human endometrial prostaglandin E2 receptors and their profiles during the menstrual cycle and pathological states. Amer J Obstet Gynecol. 1985; 151: 369-375.
63. Rao ChV, Ramani N, Chegini N, Stadig B, Carman FR Jr, Woost P, Schultz G, Cook CL. Topography of human placental binding sites for epidermal growth factor. J Biol Chem. 1985; 260: 1705-1710.
64. Chegini N, Rao ChV. Epidermal growth factor binding to human amnion, chorion, decidua and placenta from mid and term pregnancy. Quantitative light microscope autoradiographic studies. J Clin Endocrinol Metab. 1985; 61: 529-535.
65. Chegini N, Rao ChV, Wakim N, Sanfilippo J. Prostaglandin binding to different cell types of human uterus: Quantitative light microscope autoradiographic study. Prostaglandins, Leukotrienes and Medicine. 1986; 22: 129-138.
DeLeon FD, Vijayakumar R, Brown M, Rao ChV, Yussman MA, Schultz G. Peritoneal fluid volume, estrogen, progesterone, prostaglandin and epidermal growth factor concentrations in patients with and without endometriosis. Obstet Gynecol. 1986; 68: 189-194.
66. Ramani N, Chegini N, Rao ChV, Woost P, Schultz G. The presence of epidermal growth factor binding sites in the intracellular organelles of term human placenta. J Cell Sci. 1986; 84: 19-40.
67. Chegini N, Rao ChV. Quantitative electron microscope autoradiographic studies on 125I-epidermal growth factor internalization in term human placenta. J Cell Sci. 1986; 84: 41-52.
68. Chegini N, Rao ChV, Wakim N, Sanfilippo J. Binding of 125I-epidermal growth factor to human uterus. Cell and Tissue Res. 1986; 246: 543-548.
69. Rao ChV, Carman FR Jr.The nature of reversible and not readily reversible bovine corpus luteum plasma membrane bound human chorionic gonadotropin. J Endocrinol Invest. 1986; 9: 403-406.
70. Wolfe WM, Rao ChV, McCracken EM, Demers LM, Huang KC, Tsueda K. Peripheral plasma levels of prostaglandin metabolites, cortisol and prolactin in women undergoing falope ring application and tubal cautery. Prostaglandins, Leukortrienes and Medicine. 1986; 25: 31-38.
71. Patsner B, Day TG, Rao ChV. Potential usefulness of monoclonal antibodies in invasive ovarian adenocarcinoma. J KY Med Assoc. 1986; 84: 613-615.
72. Chegini N, Rao ChV. A histochemical demonstration of 3- hydroxy steroid dehydrogenase in cells of human amnion, chorion, decidua and placenta from mid and term pregnancy. IRCS Med Sci. 1986; 14: 978-979.
73. Wakim NG, Ramani N, Rao ChV. Triiodothyronine receptors in porcine granulosa cells. Amer J Obstet Gynecol. 1987; 156: 237-240.
74. Ramani N, Rao ChV () Direct stimulation of nucleoside triphosphatase activity in bovine luteal nuclear membranes by human chorionic gonadotropin. Endocrinology. 1987; 120: 2468-2473.
75. Wolfe WM, Rao ChV, McCracken EM, Demers LM. Peripheral prostaglandin metabolite levels in women undergoing therapeutic abortions in the first trimester with and without treatment with prostaglandin synthetase inhibitor. Prostaglandins, Leukotrienes and Medicine. 1987; 28: 53-59.
76. Toledo A, Ramani N, Rao ChV. Direct stimulation of nucleoside triphosphatase activity in human ovarian nuclear membranes by human chorionic gonadotropin. J Clin Endocrinol Metab. 1987; 65: 305-309.
77. Chegini N, Rao ChV. Dynamics of nuclear associated granules in bovine luteal cells following treatment in vitro with prostaglandin F2. Endocrinology. 1987; 121: 1870-1878.
78. DeLeon FD, Vijayakumar R, Rao ChV, Yussman MA. Prostaglandin F2and E2 Release by peritoneum with and without endometriosis. Int J Fertil. 1988; 33: 48-51.
79. Chegini N, Rao ChV. The presence of leukotriene C4 and prostacyclin binding sites in nonpregnant human uterine tissue. J Clin Endocrinol Metab. 1988; 66: 76-87.
80. Hofmann GE, Rao ChV, Brown MJ, Murray LF, Schultz GS, Siddiqi TA. Human epidermal growth factor concentrations in urine of nonpregnant and pregnant women throughout pregnancy and at delivery. J Clin Endocrinol Metab. 1988; 66: 119-123.
81. Williams RS, Rao ChV, Yussman MA. Interference in the measurement of CA-125 in peritoneal fluid. Fertil Steril. 1988; 49: 547-550.
82. Chegini N, Rao ChV. Increase of nuclear bodies in bovine luteal cells following treatment with human chorionic gonadotropin. Biol Reprod. 1988; 38: 453-461.
83. Chegini N, Rao ChV. Quantitative light microscope autoradiographic study on (3H)-leukotriene C4 binding to nonpregnant bovine uterine tissue. Endocrinology. 1988; 122: 1732-1736.
84. Hofmann GE, Rao ChV, Carman FR Jr, Siddiqi TA. 125I-human epidermal growth factor specific binding to placentas and fetal membranes from various pregnancy states. Acta Endocrinol. 1988; 117: 485-490.
85. Chegini N, Rao ChV. The presence of leukotriene C4 binding sites in bovine corpora lutea of pregnancy. Biol Reprod. 1988; 39: 929-935.
86. Chegini N, Rao ChV. The presence of prostacyclin binding sites in nonpregnant bovine uterine tissue. Prostaglandins Leukotrienes and Essential Fatty Acids. 1989; 38: 75-79.
87. Oechsli M, Rao ChV, Chegini N. Human chorionic gonadotropin increases chromatin solubility in isolated bovine and human luteal nuclei. Biol Reprod. 1989; 41: 753-760.
88. Reshef E, Lei ZM, Rao ChV, Pridham DD, Chegini N, Luborsky JL. The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes and decidua. J Clin Endocrinol Metab. 1990; 70: 421-430.
89. Pridham D, Lei ZM, Chegini N, Rao ChV, Yussman MA, Cook CL. Light and electron microscope immunocytochemical localization of 5-and 12-lipoxygenase and cyclooxygenase enzymes in human granulosa cells from preovulatory follicles. Prostaglandins Leukotrienes and Essential Fatty Acids. 1990; 39: 231-238.
90. Chegini N, Lei ZM, Rao ChV. Cellular distribution of prostacyclin synthase and specific prostacyclin binding sites in bovine corpora lutea of pregnancy. Mol Cell Endocrinol. 1990; 70: 133-140.
91. Rao ChV, Yussman MA, Hussa RO. Stability of human chorionic gonadotropin and its -subunit. Amer J Obstet Gynecol. 1990; 163: 1098-1099.
92. Rao ChV, Reshef E, Lei ZM. Gonadotropin receptors in nongonadal reproductive tissues. Assisted Reproductive Technology/Andrology. 1990; 1: 241-253.
93. Chegini N, Lei ZM, Rao ChV, Bischof P. The presence of pregnancy associated plasma protein-A in human corpora lutea: cellular and subcellular distribution and dependence on reproductive state. Biol Reprod. 1991; 44: 201-206.
94. Mitchell DE, Lei ZM, Rao ChV. The enzymes in cyclooxygenase and lipoxygenase pathways of arachidonic acid metabolism in human corpora lutea: dependence on luteal phase, cellular and subcellular distribution. Prostaglandins Leukotrienes and Essential Fatty Acids. 1991; 43: 1-12.
95. Stoelk E, Chegini N, Rao ChV, Bryant-Greenwood G, Sanfilippo J. Immunocytochemical localization of relaxin in human corpora lutea: cellular and subcellular distribution and dependence on reproductive state. Biol Reprod. 1991; 44: 1140-1147.
96. Lei ZM, Chegini N, Rao ChV. Quantitative cell composition of human and bovine corpora lutea from various reproductive states. Biol Reprod. 1991; 44: 1148-1156.
97. Chegini N, Lei ZM, Rao ChV. Nuclear volume and chromatin conformation of small and large bovine luteal cells: effect of gonadotropins and prostaglandins and dependence on luteal phase. Cell Tissue Res. 1991; 264: 453-460.
98. Bibbins PE Jr, Rao ChV, Carman FR, Chegini N, Lei ZM. Role of luteal cell nucleus in the expression of gonadotropin action. J Endocrinol Invest. 1991; 14: 391-400.
99. Chegini N, Lei ZM, Rao ChV, Hansel W. Cellular distribution and cycle phase dependency of gonadotropin and eicosanoids binding sites in bovine corpora lutea. Biol Reprod. 1991; 45: 506-513.
100. Lei ZM, Rao ChV. The expression of 15-lipoxygenase gene and the presence of functional enzyme in cytoplasm and nuclei of pregnancy human myometria. Endocrinology. 1992; 130: 861-870.
101. Indrapichate K, Meehan D, Lane TA, et al. Biological actions of monoclonal LH/hCG receptor antibodies. Biol Reprod. 1992; 46: 265-278.
102. Lei ZM, Rao ChV, Ackerman DM, Day TG. The expression of human chorionic gonadotropin/human luteinizing hormone receptors in human gestational trophoblastic neoplasms. J Clin Endocrinol Metab. 1992; 74: 1236-1241.
103. Swanson ML, Lei ZM, Swanson PH, Rao ChV, Narumiya S, Hirata M. The expression of thromboxane A2 synthase and thromboxane A2 receptor gene in human uterus. Biol Reprod. 1992; 47: 105-117.
104. Lei ZM, Rao ChV, Chakraborty C. Expression of thromboxane A2 receptor gene and thromboxane A2 synthase in bovine corpora lutea. Biol Reprod. 1992; 47: 233-244.
105. Lei ZM, Rao ChV. Expression of epidermal growth factor (EGF) receptor and its ligands, EGF and transforming growth factor-, in human fallopian tubes. Endocrinology. 1992; 131: 947-957.
106. Lei ZM, Reshef E, Rao ChV. The expression of human chorionic gonadotropin/luteinizing hormone receptors in human endometrial and myometrial blood vessels. J Clin Endocrinol Metab. 1992; 75: 651-659.
107. Lincoln S, Lei ZM, Rao ChV, Yussman MA. The expression of human chorionic gonadotropin/human luteinizing hormone receptors in ectopic human endometrial implants. J Clin Endocrinol Metab. 1992; 75: 1140-1144.
108. Lei ZM, Rao ChV. Gonadotropin receptors in human fetoplacental unit: Implications for hCG as an intracrine, paracrine and endocrine regulator of human fetoplacental function. Trophoblast Res. 1992; 6: 213-224 .
109. Shi QJ, Lei ZM, Rao ChV, Lin J. Novel role of human chorionic gonadotropin in differentiation of human cytotrophoblasts. Endocrinology. 1992; 132: 1387-1395.
110. Lei ZM, Rao ChV, Lincoln S, Ackermann DM. Increased expression of human chorionic gonadotropin/human luteinizing hormone receptors in adenomyosis. J Clin Endocrinol Metab. 1992; 76: 763-768.
111. Lei ZM, Rao ChV, Kornyei JL, Licht P, Hiatt ES. Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain. Endocrinology. 132: 2262-2270. 112. Sanfilippo JS, Blotcky AJ, Rao ChV. Selenium in peritoneal fluid. J Reprod Med . 1992; 38: 422-126.
113. Toth P, Rao ChV. Direct novel regulation of cyclooxygenase and prostacyclin synthase by human chorionic gonadotropin in the human amnion. Trophoblast Res. 1992; 8: 503-514. 114. Bolli JAN, Doering DL, Bosscher JR, Day Jr TG, Rao ChV, Owens K, Kelly B, Goldsmith J. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix. Gyn Oncol. 1994; 55: 169-173.
115. Lin J, Lei ZM, Lojun S, Rao ChV, Satyaswaroop PG, Day Jr TG. Increased expression of luteinizing hormone/human chorionic gonadotropin receptor gene in human endometrial carcinomas. J Clin Endocrinol Metab. 1994; 79: 1483-1491. doi: http://dx.doi.org/10.1210/jcem.76.3.7680356
116. Eta E, Ambrus G, Rao ChV. Direct regulation of human myometrial contractions by human chorionic gonadotropin. J Clin Endocrinol Metab. 1994; 79: 1582-1586. doi: http://dx.doi.org/10.1210/jcem.79.6.7989459
117. Ambrus G, Rao ChV. Novel regulation of pregnant human myometrial smooth muscle cell gap junctions by human chorionic gonadotropin. Endocrinology. 1994; 135: 2772-2779.
118. Rao ChV, Li X, Toth P, Lei ZM. Expression of epidermal growth factor, transforming growth factor alpha and their common receptor and its functional relevance to eicosanoid biosynthetic pathway in human umbilical cords. J Clin Endocrinol Metab. 80: 1012-1020.
119. Lukacs H, Hiatt ES, Lei ZM, Rao ChV. Peripheral and intracerebroventricular administration of human chorionic gonadotropin alters several hippocampus associated behaviors in cycling female rats. Hormones and Behavior. 1995; 29: 42-58.
120. Komatsu T, Konishi I, Mandai M, et al. Peritoneal serious papillary carcinoma arising in an infertile woman during ovulation-induction therapy: immunohistochemical expression of LH/hCG receptors. Gynecol Oncol. 1995; 56: 470-474.
121. Lei ZM, Rao ChV. Signaling and transacting factors in the transcriptional inhibition of gonadotropin releasing hormone gene by human chorionic gonadotropin in immortalized hypothalamic GT1-7 neurons. Mol Cell Endocrinol. 1995; 109: 151-157.
122. Cao H, Lei ZM, Bian L, Rao ChV. Functional nuclear epidermal growth factor receptors in human choriocarcinoma JEG-3 cells and normal human placenta. Endocrinology. 1995; 136: 3163-3172.
123. Cao H, Lei ZM, Rao ChV. Consequences of antisense human chorionic gonadotropin-subunit cDNA expression in human choriocarcinoma JAR cells. J Mol Endocrinol. 1995; 14: 337-347.
124. Lin J, Lojun S, Lei ZM, Wu WX, Peiper SC, Rao ChV. Lymphocytes from pregnant women express human chorionic gonadotropin / luteinizing hormone receptor gene. Mol Cell Endocrinol. 1995; 111: R13-R17.
125. Tao YX, Lei ZM, Woodworth SH, Rao ChV. Novel expression of luteinizing hormone/chorionic gonadotropin receptor gene in rat prostates. Mol Cell Endocrinol. 1995; 111: R9-R12.
126. Tao Y-X, Lei ZM, Hofmann GE, Rao ChV. Human intermediate trophoblasts express chorionic gonadotropin / luteinizing hormone receptor gene. Biol Reprod. 1995; 53: 899-904.
127. Singh M, Zuo J, Li X, Ambrus G, Lei ZM, Yussman MA, Sanfilippo JS, Rao ChV. The decreased expression of functional human chorionic gonadotropin/luteinizing hormone receptor gene in human uterine leiomyomas. Biol Reprod. 1995; 53: 591-597.
128. Kornyei J, Li X, Lei ZM, Rao ChV. Analysis of epidermal growth factor action in human myometrial smooth muscle cells. J Endocrinol. 1995; 146: 261-270.
129. Huang ZH, Lei ZM, Rao ChV. Immortalized anterior pituitary T3 gonadotropes contain functional luteinizing hormone/human chorionic gonadotropin receptors. Mol Cell Endocrinol. 1995; 114: 217-222.
130. Rodway MR, Rao ChV. A novel perspective on the role of human chorionic gonadotropin during pregnancy and in gestational trophoblastic disease. Early Pregnancy: Biology and Medicine. 1995; 1: 176-187.
131. How H, Huang ZH, Zuo J, Lei ZM, Spinnato II JA, Rao ChV. Myometrial estradiol and progesterone receptor changes in preterm and term pregnancies. Obstet Gynecol. 1995; 86: 936-940.
132. Hill JB, Jiminez AL, Passmore JC, Rao ChV. Effect of human chorionic gonadotropin on reproductive organ blood flow in cycling rats. Proc Soc Exptl Biol Med. 1996; 211: 94-99.
133. Toth P, Li X, Lei ZM, Rao ChV. Expression of human chorionic gonadotropin (hCG) / luteinizing hormone (LH) receptors and regulation of cyclooxygenase-1 gene by exogenous hCG in human fetal membranes. J Clin Endocrinol Metab. 1996; 81: 1283-1288.
134. Li X, Lei ZM, Rao ChV. Human chorionic gonadotropin down-regulates the expression of gonadotropin releasing hormone receptor gene in GT1-7 neurons. Endocrinology. 1996; 137: 899-904.
135. Kornyei JL, Li X, Lei ZM, Rao ChV. Restoration of human chorionic gonadotropin response in human myometrial smooth muscle cells by treatment with follicle stimulating hormone (FSH): Evidence for the presence of FSH receptors in human myometrium. Eur J Endocrinol. 1996; 134: 225-231.
136. Han SW, Lei ZM, Rao ChV. Up-regulation of cyclooxygenase-2 gene expression by chorionic gonadotropin during the differentiation of human endometrial stromal cells into decidua. Endocrinology. 1996; 137: 1791-1797.
137. Pabon JE, Li X, Lei ZM, Sanfilippo J, Yussman MA, Rao ChV. Novel presence of human luteinizing hormone/chorionic gonadotropin receptors in the human adrenal glands. J Clin Endocrinol Metab. 1996; 81: 2397-2400.
138. Han SW, Lei ZM, Rao ChV. Up-regulation of cyclooxygenase-2 gene expression by chorionic gonadotropin in mucosal cells from human fallopian tubes. Endocrinology. 1996; 137: 2929-2937. dio: http://dx.doi.org/10.1210/endo.137.7.8770916
139. Pabon JE, Bird JS, Li X, Huang Z-H, Lei ZM, Sanfilippo J, Yussman MA, Rao ChV. Human skin contains luteinizing hormone/chorionic gonadotropin receptors. J Clin Endocrinol Metab. 1996; 81: 2738-2741.
140. Hu Y, Lei ZM, Rao ChV. Cis-acting elements and trans-acting proteins in the transcription of chorionic gonadotropin/luteinizing hormone receptor gene in choriocarcinoma cells and placenta. Endocrinology. 1996; 137: 3897-3905.
141. Rao ChV. The beginning of a new era in reproductive biology and medicine: Expression of low levels of functional luteinizing hormone/human chorionic gonadotropin receptors in nongonadal tissues. J Physiol and Pharmacol. 1996; 47: 41-53.
142. Tao Y-X, Bao S, Ackermann DM, Lei ZM, Rao ChV. Expression of luteinizing hormone/human chorionic gonadotropin receptor gene in benign prostatic hyperplasia and in prostate carcinoma in humans. Biol Reprod. 56: 67-72.
143. Hill JB, Alsip NL, Rao ChV, Asher EF. Human chorionic gonadotropin directly and indirectly alters the uterine arteriolar diameters in cycling rats. Am J Obstet Gynecol. 1997; 176: 150-157.
144. AL-Hader AA, Lei ZM, Rao ChV. Novel expression of functional luteinizing hormone/chorionic gonadotropin receptors in cultured glial cells from neonatal rat brains. Biol Reprod. 1997; 56: 501-507.
145. Rao ChV, Sanfilippo JS. New understanding in the biochemistry of implantation: potential direct roles of luteinizing hormone and chorionic gonadotropin. Endocrinologist. 1997; 7: 107-111.
146. Tao Y-X, Lei ZM, Rao ChV. The presence of luteinizing hormone/ human chorionic gonadotropin receptors in lactating rat mammary glands. Life Sciences. 1997; 60: 1297-1303.
147. Rao ChV. Potential novel roles of luteinizing hormone and human chorionic gonadotropin during early pregnancy in women. Early Pregnancy: Biology and Medicine. 1997; 3: 1-9.
148. AL-Hader AA, Lei ZM, Rao ChV. Neurons from fetal rat brains contain functional luteinizing hormone/chorionic gonadotropin receptors. Biol Reprod. 1997; 56: 1071-1076.
149. Lei ZM, Rao ChV. Cis-acting elements and trans-acting proteins in the transcriptional inhibition of gonadotropin releasing hormone gene by human chorionic gonadotropin in immortalized hypothalamic GT1-7 neurons. J Biol Chem. 1997; 272: 14365-14371.
150. Han SW, Lei ZM, Rao ChV. Homologous down-regulation of luteinizing hormone/chorionic gonadotropin receptors by increasing the degradation of receptor transcripts in human uterine endometrial stromal cells. Biol Reprod. 1997; 57: 158-164. dio: 10.1095/biolreprod57.1.158
151. Konishi I, Koshiyama M, Mandai M, et al. Increased expression of LH/hCG receptors in endometrial hyperplasia and carcinoma in anovulatory women. Gynecol Oncol. 1997; 65: 273-280.
152. Huang Z-H, Lei ZM, Rao ChV. Novel independent and synergistic regulation of gonadotropin -subunit gene by luteinizing hormone/human chorionic gonadotropin and gonadotropin releasing hormone in the T3-1 gonadotrope cells. Mol Cell Endocrinol. 1997; 130: 23-31.
153. Sun T, Lei ZM, Rao ChV. A novel regulation of the oviductal glycoprotein gene expression by luteinizing hormone in bovine tubal epithelial cells. Mol Cell Endocrinol. 1997; 131: 97-108.
154. Rao ChV. Immunocytochemical localization of gonadotropin and gonadal steroids in human pineal glands. A letter to the editor. J Clin Endocrinol Metab. 1997; 82: 2756-2757.
155. Lojun S, Bao S, Lin J, Lei ZM, Rao ChV. The presence of functional luteinizing hormone/ chorionic gonadotropin (hCG) receptors in human breast cell lines: Implications supporting the premise that hCG protects women against breast cancer. Biol Reprod. 1997; 57: 1202-1210.
156. Mandai M, Konishi I, Kuroda H, Fukumoto M, Komatsu T, Yamamoto S, Nanbu K, Rao ChV, Mori T. Messenger ribonucleic acid expression of LH/hCG receptor gene in human ovarian carcinomas. Eur J Cancer. 1997; 33: 1501-1507.
157. Kuroda H, Konishi I, Nanbu K, Mandai M, Matsushita K, Hamid AA, Yura Y, Rao ChV, Mori T. Ovarian cancer in infertile women during or after ovulation-induction therapy; expression of LH/hCG receptors and sex steroid receptors. Intl J Gynecologic Cancer. 1997; 7: 451-457.
158. AL-Hader AA, Tao Y-X, Lei ZM, Rao ChV. Fetal rat brains contain luteinizing hormone/human chorionic gonadotropin receptors. Early Pregnancy: Biology and Medicine. 1997; 3: 323-329.
159. Topilko P, Schneider-Maunoury S, Levi G, Trembleau A, Gourdji D, Driancourt M-A, Rao ChV, Charnay P. Multiple pituitary and ovarian defects in Krox-24 (NGF1-A, Egr-1)-targeted mice. Mol Endocrinol 12: 107-122.
160. Bird J, Li X, Lei ZM, Sanfilippo J, Yussman MA, Rao ChV. Luteinizing hormone and human chorionic gonadotropin decrease type 2 5-reductase and androgen receptor protein levels in womens skin. J Clin Endocrinol Metab 83: 1776-1782.
161. Tao Y-X, Lei ZM, Rao ChV . Seminal vesicles are novel site of luteinizing hormone/human chorionic gonadotropin receptor gene expression. J Androl. 1998; 19: 343-347. dio: 10.1002/j.1939-4640.1998.tb02014.x
162. Bian L, Lei ZM, Rao ChV. Mitogen activated protein kinase is involved in epidermal growth factor regulated protein phosphorylation in nuclear membranes isolated from JEG-3 human choriocarcinoma cells. Eur J Biochem. 1998; 253: 545-551.
163. Thompson DA, Othman MI, Lei ZM, Li X, Huang ZH, Eadie DM, Rao ChV. Localization of the receptor for luteinizing hormone/chorionic gonadotropin in neural retina. Life Sci. 1998; 63: 1057-1064.
164. Hu YL, Lei ZM, Rao ChV. Analysis of the promoter of luteinizing hormone/human chorionic gonadotropin receptor gene in neuroendocrine cells. Life Sci. 1998; 63: 2157-2165.
165. Tao Y-X, Heit M, Lei ZM, Rao ChV. The urinary bladder of a woman is a novel site of luteinizing hormone-human chorionic gonadotropin receptor gene expression. Am J Obstet Gynecol. 1998; 179: 1026-1031.
166. Han SW, Lei ZM, Rao ChV. Treatment of human endometrial stromal cells with chorionic gonadotropin induces their morphological and functional differentiation into decidua. Mol Cell Endocrinol. 1999; 147: 7-16.
167. Skipor J, Bao S, Grzegorzewski W, Wsowska B, Krzymowski T, Rao ChV. The inhibitory effect of hCG on counter current transfer of GnRH and the presence of LH/hCG receptors in the perihypophysial cavernous sinus-carotid rete vascular complex of ewes. Theriogenology. 1999; 51: 899-910.
168. Hu YL, Lei ZM, Huang ZH, Rao ChV. Determinants of transcription of the chorionic gonadotropin/ luteinizing hormone receptor gene in human breast cells. The Breast J. 1999; 5: 186-193.
169. Kornyei JL, Vertes ZS, Oszter A, Kovacs KA, Rao ChV, Vertes M. Opioid peptides inhibit the action of oestradiol on human myometrial cells in culture. Mol Human Reprod. 1999; 5: 566-572.
170. Rao ChV . No mRNAs for the LH/hCG receptor in human endometrium? Letter to the Editor. Fertil Steril. 1999; 72: 374-375.
171. Rao ChV . A paradigm shift on the targets of luteinizing hormone/human chorionic gonadotropin actions in the body. The Journal of the Bellevue Obstetrical & Gynecological Society. 1999; XV: 26-32.
172. Zhou XL, Lei ZM, Rao ChV. Treatment of human endometrial gland epithelial cells with chorionic gonadotropin/luteinizing hormone increases the expression of cyclooxygenase-2 gene. J Clin Endocrinol Metab. 1999; 84: 3364-3377.
173. Zhang W, Lei ZM, Rao ChV. Immortalized hippocampal neurons contain functional luteinizing hormone/human chorionic gonadotropin receptors. Life Sci. 1999; 65: 2083-2098.
174. Kurtzman, JT, Spinnato JT, Goldsmith LJ, et al. Human chorionic gonadotropin exhibits potent inhibition of preterm delivery in a small animal model. Am J Obstet Gynecol. 1999; 181: 853-857.
175. Lei ZM, Taylor DD, Gercel-Taylor C, Rao ChV. Human chorionic gonadotropin promotes tumorigenesis of choriocarcinoma JAR cells. Trophoblast Res. 1999; 13: 147-159.
176. Jauniaux E, Bao S, Eblen A, Li X, Lei ZM, Meuris S, Rao ChV . Human chorionic gonadotropin concentration and receptor gene expression in placental tissue from trisomy 18 and 21. Mol Human Reprod. 2000; 6: 5-10.
177. Bugalho MJM, Li X, Rao ChV, Soares J, Sobrinho LG. Presence of a GS mutation in an adrenal tumor expressing LH/hCG receptors and clinically associated with Cushings syndrome. Gynecol Endocrinol. 2000; 14: 50-54.
178. Danikas D, Goudas VT, Rao ChV, Brief DK. Luteinizing hormone receptor expression in leiomyomatosis peritonealis disseminata. Obstet Gynecol. 2000; 95: 1009-1011.
179. Akerman FM, Lei ZM, Rao ChV, Nakajima ST. A case of spontaneous ovarian hyper-stimulation syndrome with a potential mutation in hCG/LH receptor gene. Fertil Steril. 2000; 74: 403-404.
180. Corley DR, Li X, Lei ZM, Rao ChV. Potential regulation of gonadotropin releasing hormone gene by steroidogenic factor-1-like protein. Mol Human Reprod. 2000; 6: 671-676. dio: 10.1093/molehr/6.8.671
181. Rao ChV . Does full-term pregnancy at young age protect women against breast cancer through hCG? Obstet Gynecol. 2000; 96: 783-786.
182. Lei ZM, Mishra S, Zou W, Xu B, Foltz M, Li X, Rao ChV . Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene. Mol Endocrinol. 2001; 15: 184-200
183. Rao ChV . An overview of the past, present and future of nongonadal LH/hCG actions in reproductive biology and medicine. Sem Reprod Med. 2001; 19: 7-17.
184. Kurtzman J, Wilson H, Rao ChV . A proposed role for hCG in clinical obstetrics. Sem Reprod Med. 2001; 19: 63-68.
185. Rao ChV, Alsip NL . Use of rat model to study hCG/LH effects on uterine blood flow. Sem Reprod Med. 2001; 19: 75-85.
186. Lei ZM, Rao ChV . Neural actions of luteinizing hormone and human chorionic gonadotropin. Sem Reprod Med. 2001; 19: 103-109.
187. Eblen A, Bao S, Lei ZM, Nakajima ST, Rao ChV . The presence of functional luteinizing hormone/chorionic gonadotropin receptors in human sperm. J Clin Endocrinol Metab. 2001; 86: 2643-2648.
188. Rao ChV . The role of hCG and cAMP/PKA signaling in the differentiation of human endometrial stromal cells. A letter to the editor, J Clin Endocrinol Metab. 2001; 86: 4000-4001.
189. Rao, ChV. Multiple novel roles in luteinizing hormone. Fertil Steril. 2001; 76: 1097-1100.
190. Toth P, Lukacs H, Gimes G, Sebestyen A, Pasztor N, Paulin F, Rao ChV . Clinical importance of vascular LH/hCG receptors – A review. Reprod Biol. 2001; 1: 5-11.
191. Rao CV, Lei ZM. Consequences of targeted inactivation of LH receptors. Mol Cell Endocrinol. 2002; 187: 57-67.
192. Albert C, Garrido N, Mercader A, Rao CV, Remohi J, Simon C, Pellicer A. The role of endothelial cells in the pathogenesis of ovarian hyperstimulation syndrome. Mol Human Reprod. 2002; 8: 409-418.
193. Rao ChV. Gonadotropins and the uterus. Is there a gonad - independent pathway. A letter to the editor. J Soc Gynecol Invest. 2002; 9: 181.
194. Akerman F, Lei ZM, Rao ChV. Human umbilical cord and fetal membranes co-express leptin and its receptor genes. Gynecol Endocrinol. 2002; 16: 299-306.
195. Wy LA, Carlson HE, Kane P, Li X, Lei ZM, Rao ChV . Pregnancy-associated Cushings syndrome secondary to an LH/hCG receptor-positive adrenal carcinoma. Gynecol Endocrinol. 2002; 16: 413-417.
196. Zygmunt M, Herr F, Keller-Schoenwetter S, Kunzi-Rapp K, Munstedt K, Rao ChV, Lang U, Preissner KT. Characterization of human chorionic gonadotropin as a novel angiogenic factor. J Clin Endocrinol Metab. 2002; 87: 5290-5296.
197. Bhatnagar KP, Li X, Lei ZM, Rao ChV. Human pineal luteinizing hormone receptors. Biotechnic & Histochem. 2002; 77: 223-228. 198. Rao CV. RecepteursalaLH : folliculeetendometre. J Gynecol Obstet Biol Reprod. 2002; 31: 1S7-1S11.
199. Goodarzi MO, Dawson D, Li X, Lei ZM, Shintaku P, Rao ChV, Van Herle AJ . Virilization in bilateral macronodular adrenal hyperplasia controlled by the luteinizing hormone receptor. J Clin Endocrinol Metab. 88: 73-77.
200. Rao SC, Li X, Rao ChV, Magnuson DSK . Human chorionic gonadotropin/luteinizing hormone receptor expression in the adult rodent spinal cord. Neurosci Lett. 2003; 336: 135-138.
201. Zhang YM, Rao ChV, Lei ZM. Macrophages in human reproductive tissues contain luteinizing hormone/chorionic gonadotropin receptors. Am J Reprod Immunol. 2003; 49: 93-100.
202. Lei ZM, Zou W, Mishra S, Li X, Rao ChV . Epididymal phenotype in LH receptor knockout animals and its responses to testosterone replacement therapy. Biol Reprod. 2003; 68: 888-895.
203. Yang M, Lei ZM, Rao ChV . The central role of human chorionic gonadotropin in the formation of human placental syncytium. Endocrinology. 2003; 144: 1108-1120.
204. Mishra S, Lei ZM, Rao ChV . A novel role of luteinizing hormone in the embryo development in cocultures. Biol Reprod. 2003; 68: 1455-1462.
205. Than NG, Itakura A, Rao ChV, Nohira T, Toth P, Mansell JP, Isaka K, Nishi H, Takayama M, Than GN . Clinical applications of pregnancy-related proteins - A Workshop Report. Trophoblast Research. 2003; 17: S60-S64.
206. Lin PC, Li X, Lei ZM, Rao ChV . Human cervix contains functional luteinizing hormone/ human chorionic gonadotropin receptors. J Clin Endocrinol Metab. 2003; 88: 3409-3414.
207. Abdallah MA, Lei ZM, Li X, Greenwold N, Nakajima ST, Jauniaux E, Rao ChV . Human fetal nongonadal tissues contain human chorionic gonadotropin/luteinizing hormone receptors. J Clin Endocrinol Metab. 2004; 89: 952-956.
208. Rao ChV, Li X, Manna SK, Lei ZM, Aggarwal BB . Human chorionic gonadotropin decreases proliferation and invasion of breast cancer MCF-7 cells by inhibiting NF-B and AP-1 activation. J Biol Chem. 2004; 279: 25503-25510.
209. Carlson HE, Kane P, Lei ZM, Li X, Rao ChV . Presence of luteinizing hormone/human chorionic gonadotropin receptors in male breast tissues. J Clin Endocrinol Metab. 2004; 89: 4119-4123.
210. Rao ChV, Zhou XL, Lei ZM . Functional luteinizing hormone/chorionic gonadotropin receptors in human adrenal cortical H295R cells. Biol Reprod. 2004; 71: 579-587.
211. LO KC, Lei ZM, Rao ChV, Lamb DJ . De novo testosterone production in luteinizing hormone receptor knockout mice after transplantation of Leydig stem cells. Endocrinology. 2004; 145: 4011-4015.
212. Baal N, Reisinger K, Jahr H, Bohle RM, Liang O, Munstedt K, Rao CV, Preissner KT, Zygmunt MT. Expression of transcriptional factor Oct-4 and other embryonic genes in CD133 positive cells from human umbilical cord blood. Throm Haemost. 2004; 92: 767-775. 213. Lei Z, Mishra S, Ponnuru P, Li X, Yang ZW, Rao ChV . Testicular phenotype in luteinizing hormone receptor knockout animals and the effect of testosterone replacement therapy. Biol Reprod. 2004; 71: 1605-1613. 214. Lin DX, Lei ZM, Li X, Rao ChV . Targeted disruption of LH receptor gene revealed the importance of uterine LH signaling. Mol Cell Endocrinol. 2005; 234: 105-116.
215. Than NG, Nagai A, Sharma S, Meiri H, Mouzon SH, Sadvosky Y, Rao ChV . Applications of pregnancy-related proteins in prenatal and tumor diagnostics - A workshop report. Trophoblast Res. 2005; 19: S110-S113.
216. Lin DX, Lei ZM, Rao ChV . Dependence of uterine cyclooxygenase-2 expression on luteinizing hormone signaling. Biol Reprod. 2005; 73: 256-260.
217. Filicori M, Fazleabas AT, Huhtaniemi IT, Licht P, Rao ChV, Tesarik J, Zygmunt M . Novel concepts of human chorionic gonadotropin reproductive system interactions and potential in the management of infertility. Fertil & Steril. 2005; 84: 275-284.
218. Soukhova-OHare G, Lei ZM, Falcone JC, Barati MT, Feitelson JBA, Rao ChV Fleming JT . Bone medullary arterioles from ovariectomized rats have smaller baseline diameters, but normal eNOS expression and NO – mediated dialation. Life Sci. 2005; 77: 1799-1812.
219. Chudgar D, Lei ZM, Rao ChV . Orthotopic transplantation of LH receptor knockout and wild-type ovaries. Life Sci. 2005; 77: 2656-2662.
220. Amigh KS, Mayhew BA, Montero F, Schiavi F, White PC, Rao ChV, Rainey WE . Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas. J Clin Endocrinol Metab. 2006; 91: 1136-1142.
221. Rao CV. Physiological and pathological relevance of human uterine LH/hCG receptors. J Soc Gynecol Invest. 2006; 13: 77-78.
222. Yuan FP, Lin DX, Rao ChV, Lei ZM . Crytorchidism in LH receptor knockout animals and the effect of testisterone replacement therapy. Hum Reprod. 2006; 21: 936-942.
223. Ticconi C, Belmonte A, Piccione E, Rao ChV . Feto-placental communication system with myometrium in pregnancy and parturition: the role of hormones, neurohormones, inflammatory mediators and locally active factors. J Matern Fetal Neonatal Med. 2006; 19: 125-133.
224. Ticconi C, Piccione E, Belmonte A, Rao, Ch V. HCG - A new kid on the block in the prematurity prevention. J Matern Fetal Neonatal Med. 2006; 19: 687-692.
225. Lei ZM, Yang M, Li X, Takikawa O, Rao ChV . Upregulation of placental indoleamine 2,3- dioxygenase by human chorionic gonadotropin. Biol Reprod. 2007; 76: 639-644.
226. Rao ChV, Lei ZM . The past, present and future of nongonadal LH/hCG actions in reproductive biology and medicine. Mol Cell Endocrinol. 2007; 269: 2-8.
227. Casadesus G, Milliken EL, Webber KM, Bowen RL, Lei ZM, Rao, CV, Atwood CS, Nilson JH, Perry G, Keri RA, Smith MA. Declines in cognitive performance are associated with increased luteinizing hormone levels in mice. Mol Cell Endocrinol. 2007; 269: 107-111.
228. Ticconi C, Zicari A, Belmonte A, Realacci M, Rao ChV, Piccione E. Pregnancy – promoting actions of hCG in human myometrium and fetal membranes. Placenta. 2007; 28: Supplement A, S137-S143.
229. Herrmann-Lavoie C, Rao CV, Akoum A. Chorionic gonadotropin downregulates the expression of the decoy inhibitory interleukin 1 receptor type 11 in human endometrial epithelial cells. Endocrinology. 2007; 148: 5377-5384.
230. Sukhova-O Hare GK, Shah ZA, Lei ZM, Nozdrachev AD, Rao CV, Gozal D. Erectile dysfunction in a murine model of sleep apnea. Am J Respir Crit Care Med. 2008; 178: 644- 650.
231. Rask E, Schvarcz E, Hellman P, Hennings J, Karlsson A, Rao CV. ACTH – independent Cushings syndrome in pregnancy related to overexpression of adrenal LH/hCG receptors. J Endocrinol Invest. 2009; 33: 313-316.
232. Rahman N, Rao CV. Recent progress in luteinizing hormone/human chorionic gonadotrophin hormone research. Mol Human Reprod. 2009; 15: 703-711.
233. Lin J, Li X, Yuan FP, Lin L, Rao CV, Cook CL, Lei ZM. Genetic ablation of luteinizing hormone receptor improves the amyloid pathology in a mouse model of Alzheimer disease. J Neuropathol Exp Neurol. 2010; 69: 253-261.
234. Yuan FP, Li X, Lin J, Schwabe C, Bullesbach EE, Rao CV, Lei ZM. The role of RXFP2 in mediating androgen-induced inguinoscrotal testis descent in LH receptor knockout mice. Reproduction. 2010; 139: 759-769.
235. Rao CV. Human adrenal LH/hCG receptors and what they could mean for adrenal physiology and pathology. Mol Cell Endocrinol. 2010; 329: 33-36.
236. Yu Y, Yuan FP, Li X, Lin D, Lan Z, Rao CV, Lei ZM. Luteinizing hormone receptor deficiency increases the susceptibility to alkylating agent- induced lymphomagenesis in mice. Hormones and Cancer. 2010; 5: 256-264.
237. Morris LF, Park S, Daskivich T, Churchill BM, Rao CV, Lei ZM, Martinez DS, Yeh MW. Virilization of female infant by a maternal adrenocortical carcinoma. Endocrine Practice. 2011; 17: e26-e31.
238. Bourdiec A, Shao R, Rao CV, Akoum A. Human chorionic gonadaotropin triggers angiogenesis via the modulation of endometrial stromal cell responsiveness to Interleukin-1. A new possible mechanism underlying implantation. Biol Reprod. 2012; 87: 1-10.
239. Bourdiec A, Bedard D, Rao CV, Akoum A. Human chorionic gonadotropin regulates endothelial cell responsiveness to interleukin 1 and amplifies the cytokine-mediated effect on cell proliferation,migration and release of angiofenic factors. Am J Reprod Immunol. 2013; 70: 127-138.
240. Bourdiec A, Calvo E, Rao CV, Akoum A. Transcriptome analysis reveals new insights into the modulation of endometrial stromal cell receptive phenotype by embryo-derived signals interleukin-1 and human chorionic gonadotropin. Possible involvement in early embryo implantation. PLoS One. 2013; 8: e64829, 1-18.
241. Rao CV. Uphill battle on the paradigm shift on the targets of human chorionic gonadotropin/luteinizing hormone actions. An editorial. Enliven: Gynecol Obstet. 2014; 1(1): e001.
242. Rao CV. Uphill battle: The saga of hCG research that led to paradigm shift. Ind J Med Res. 2014.
243. Rao CV, Ticconi C. Why does human chorionic gonadotropin have such a broad regulatory roles in the body and are they totally unexpected. J Reprod Health and Med. 2014.
244. Rao CV. Potential Therapy of HIV/AIDS and Ebola Outbreak with Pregnancy Hormone, Human Chorionic Gonadotropin. HIV/AIDS Res Treat Open J. 2014; 1(1): e5-e6.
Department of Infectious Diseases
School of Medicine
University of Buenos Aires
Dr. Troncoso is Professor, Department of Microbiology and Infectious Diseases at the University of Buenos Aires. He is also a of the Department for Specific Prophylaxis and Tropical Medicine Univ. Buenos Aires. Dr. Troncoso received his medical degree from the University of La Plata with Honors. He completed his internship and his residency at Infectious Diseases Francisco Muñiz Hospital, Buenos Aires, as well as the University of Buenos Aires Medical Center. He did postgraduate work in Internal Medicine and Infectious Diseases at Univ. Buenos Aires, and Clinical Tropical Medicine at the La Plata School of Medicine. He has received numerous honors and has held medical society positions worldwide. He has participated over 15 years in workshop presentations, lectures, conferences and on specialist professional committees of the Microbiology, Infectious Diseases and Tropical Medicine. Dr. Troncoso is currently the Principal or Senior Investigator on over a dozen studies, including several multicenter clinical trials. Dr. Troncoso has been very active in teaching and infectious diseases research in recent years, having published more than 100 peer-reviewed articles and 23 books in the past 9 years. He has worked over 10 years on HIV/AIDS infection and other infectious diseases. He currently serves on the Editorial Boards of Asian Pacific Journal of Tropical Medicine, and half a dozen other journals, and on the Advisory Board of the Infectious Diseases Journals. He is a renowned senior lecturer in the fields of travel and tropical medicine. In recent times, he has been guest lecturer on a programme of visits to Universities and conferences across Latin America and Europe. He is currently working on development of new clinical services and education students to support care of patients with infectious and Tropical diseases.
His research interests include: Infectious Diseases, Microbiology, Public Health, Tropical Medicine, Epidemiology.
• Argentina Best Doctors (2013)
• Cesar Milstein Distinguished Achievement Award (2012)
• NTD Distinguished Service Award (2011)
• Teacher of the Year (2012)
• Molecular Microbiology Early Distinguished Career Award (2010)
• Best Research Paper (2009)
• Robert Jauregui for the Physician of the Year (2000)
• First Prize Durand Hospital (1997)
• Merit of Excellence from the International University of Colombo-Sri Lanka-(1997)
1. Bava J, Troncoso A, Clausen CR. Giemsa and Grocott in the recognition of Histoplasma capsulatum in blood smears. Asian Pac J Trop Biomed. 2013; 3(5): 418-420.doi: 10.1016/S2221-1691(13)60088-X
2. Amadeo B, Bava J, Cecilia D, Troncoso A, Drisscoll R. Adult female of Strongyloides stercoralis in respiratory secretions. Asian Pac J Trop Biomed. 2013; 3(4): 311-313.doi: 10.1016/S2221-1691(13)60069-6.
3. Garberi J, Labrador J, Garberi F, et al. Rapid and biosecure diagnostic test for tuberculosis. Cell Biochem. Biophys. 2013; 65(2): 173-179.doi: 10.1007/s12013-012-9413-7.
4. Troncoso A. Making darkness visible: breaking the silence on HIV travel restrictions. Asian Pac J Trop Biomed. 2012; 2(10): 757-758.doi: 10.1016/S2221-1691(12)60224-X
5. Gonzalez L, Seley C, Martorano J, Garcia- Moreno I, Troncoso A. Infections and inequalities: anemia in AIDS, the disadvantages of poverty. Asian Pac J Trop Biomed. 2012; 2(6): 485-8.doi: 10.1016/S2221-1691(12)60081-1.
6. Javier B, Susana L, Santiago G, Troncoso A. Pulmonary coinfection by Pneumocystis jiroveci and Cryptococcus neoformans. Asian Pac J Trop Biomed. 2012; 2(1): 80-82.doi: 10.1016/S2221-1691(11)60195-0.
7. Garberi J, Labrador J, Garberi F, et al. Diagnosis of Mycobacterium tuberculosis using molecular biology technology. Asian Pac J Trop Biomed. 2011; 1(2): 89-93.doi: 10.1016/S2221-1691(11)60002-6
8. Bava J, Lucia G , Celeste M , Gisela P , Troncoso A. A case report of cutaneous larva migrans in Argentina. Asian Pac J Trop Biomed. 2011; 1(1): 81-82.doi: 10.1016/S2221-1691(11)60074-9
9. González LJ, Martinex FN, Rossi L, Tornese M, Troncoso A. Risk analysis of foodborne diseases: microbial risk assessment. Rev Chilena Infectol. 2010;27(6):513-524.doi: /S0716-10182010000700004
10. Troncoso A, Bava J. Images in clinical medicine. Chromoblastomycosis. N Engl J Med. 2009; 361(22): 2165.doi: 10.1056/NEJMicm0807060.
11. Amadeo Bava J, Troncoso A. Strongyloides stercoralis hyperinfection in a patient with AIDS. J Int Assoc Physicians AIDS Care (Chic) 2009; 8(4):235-238.doi: 10.1177/1545109709336882
12. Rebagliati V, Philppi R, Tornese M, Paiva A, Rossi L, Troncoso A. Food-borne botulism in Argentina. J Infect Dev Ctries 2009; 3(4): 250-254.doi: 10.3855/jidc.120
13. Amadeo Bava J, Troncoso A. Detection of Cryptococcus neoformans in faecal matter: a novel presentation of disseminated cryptococcosis. J Infect Dev Ctries. 2009; 3(7): 572-4.doi: 10.3855/jidc.478
14. Rossi L, Watson D, Escandarani S, Miranda A, Troncoso A. Radiation on the dining table. Rev Chilena Infectol. 2009; 26(4): 318-330.doi: /S0716-10182009000500003
15. Rebagliati V, Philppi R, Rossi M, Troncoso A. Prevention of foodborne listeriosis. Indian J Pathol Microbiol. 2009; 52(2): 145-149.doi: 10.4103/0377-4929.48903
16. Trombetta L, Oliva A, Galache V, Bava J, Troncoso A. Cutaneous myiasis due to Cochliomyia hominivorax in a drug user. J Infect Dev Ctries. 2009; 3(11): 873-876.doi: 10.3855/jidc.170
17. M Rossi L, Paiva A, Tornese M, Chianelli S, Troncoso A. Listeria monocytogenes outbreaks: a review of the routes that favor bacterial presence. Rev Chilena Infectol. 2008; 25(5): 328-35.doi: /S0716-10182008000500002
18. Bava J, Solari R, Isla G, Troncoso A. Atypical forms of Cryptococcus neoformans in CSF of an AIDS patient. J Infect Dev Ctries. 2008;2(5):403-405.doi: 10.3855/jidc.207
19. Tornese M, Rossi L, Coca F, Cricelli C, Troncoso A. Epidemiology and risk factors associated to foodborne and infant botulism: where and when? Rev Chilena Infectol. 2008; 25(1): 22-27.doi: /S0716-10182008000100004
20. Vanzani MC, Lacono RF, Caccuri RL, Troncoso A, Berria MI. Regional differences in astrocyte activation in HIV-associated dementia. Medicina (B Aires). 2006; 66(2): 108-112.
21. Troncoso A, Gulotta H, Benetucci J, Ríos ER. Genital manifestations in women with AIDS. J Int Assoc Physicians AIDS Care (Chic). 2005; 4(1): 16-19.
22. Troncoso A, Toller M, Bava J. CNS cryptococcoma in an HIV-positive patient. J Int Assoc Physicians AIDS Care (Chic). 2002; 1(4): 131-133. doi: 10.1177/154510970200100404
23. Troncoso A, Olenchuck A, Bava J. Laryngeal histoplasmosis as a manifestation of AIDS. Enferm Infecc Microbiol Clin. 2003; 21(5): 273-4.
24. Fumagalli J, Bonifacio C, Shinzato R, Troncoso A. Bacterial endocarditis: a role for Mycobacterium tuberculosis? AIDS. 2002; 16(13): 1845-1846.
25. Troncoso A. "J’accuse": a matter of genocide plea for access to cure hepatitis C. HIV/ AIDS Res Treat Open J. 2015; 2(4): 90-91. doi: 10.17140/HARTOJ-2-115
Clinical Assistant Professor
Division of Infectious Diseases
Hospital of the University of Pennsylvania
Jonathan Lax Treatment Center, Philadelphia FIGHT
Philadelphia, PA, USA
Dr. Koenig completed Internal Medicine residency and Infectious Diseases fellowship at the Hospital of the University of Pennsylvania, and received an MPH degree at Johns Hopkins Bloomberg School of Public Health. She currently practices at the Jonathan Lax Treatment Center, part of the AIDS service organization Philadelphia FIGHT, which serves 1700 HIV-positive adults in urban Philadelphia. Dr. Koenig oversees the primary care and HIV specialty care of approximately 600 HIV patients at the Lax Center, including those with multi-drug resistant strains of HIV and Hepatitis C/HIV co-infection. She serves as the Medical Director for the Womens Center for HIV which provides HIV care tailored to women by providing co-localized womens health services, the Medical Director for our Pre-exposure prophylaxis (PrEP) program for young men of color who have sex with men, and the Program Director for students, residents and fellows who rotate at the Lax Center. She has promoted innovative population-level HIV prevention and treatment interventions in order to advance current health care service delivery models, and serves on the Quality Management Committee at the Lax Center. She is an Assistant Professor at the Hospital of the University of Pennsylvania, where she see patients with infectious diseases on a weekly basis, and serves on the inpatient Infectious Diseases consult service several weeks per year.
Her research interests include: HIV, HIV-hepatitis C coinfection, Treatment of multi-drug resistant HIV, HIV prevention.
AWARDS, HONORS AND MEMBERSHIPS IN HONORARY SOCIETIES
• 2012, 2014 Letter from the editor of Annals of Internal Medicine citing me as a top reviewer for the journal
• 2008 The David Paton Scholarship in Preventive Medicine
• 2008 Granted copyright for Acute Respiratory Distress Syndrome surveillance software program design
• 2007 Monetary gift given to Lankenau Hospital in my name from the family of a patient under my care
• 2003 CADIE Fellowship Recipient, Infectious Diseases
• 2003 Dr. Milton B. Rosenbluth Fellow Award
• 1999 Edward J. Bloustein Scholar Award
• 1999 magna cum laude, Princeton University
MEMBERSHIPS IN PROFESSIONAL & SCIENTIFIC SOCIETIES AND OTHER PROFESSIONAL ACTIVITIES:
Membership in Professional & Scientific Societies:
• American College of Physicians (Member, 2011-present)
• American Medical Association (Member, 2001-2003 and 2008-present)
• Infectious Diseases Society of America (Member, 2008-present)
• Association for Prevention Teaching and Research (Member, 2008-2009)
• American Public Health Association (Member, 2008-2009)
• Resident/Fellow section of FOCUS on Health & Leadership for Women , University of Pennsylvania (Founder and Chair, 2008-2010)
• Infectious Diseases Book Discussion Group, University of Pennsylvania Health System (Founder and Member, 2008-2013)
Other Professional Activities:
• 2010 Legislative Lead, Office of Chronic Disease Prevention, Maryland, Department of Health and Mental Hygiene, Baltimore, MD
• 2009-2010 Program Evaluator, STD/HIV Prevention Program, Baltimore City, Health Department, Baltimore, MD
• 2009 Research Assistant/Consultant, Agency for Healthcare Research and Quality (AHRQ), HHS, Rockville, MD
• 2009 Vaccine Safety Evaluator, U.S. Food and Drug Administration (FDA), Rockville, MD
• 2008-2009 Program Coordinator, Harford County Health Department (HCHD), Harford County, MD
• 2008 Expert Consultant, Johns Hopkins Center for Public Health Preparedness, Fairfax, VA
• 2006 Staff Physician, Princess Marina Hospital, Gabarone, Botswana 2003 Expert Consultant, CADIE Foundation, Buenos Aires, Argentina
• 1999 Adolescent Counselor, Chestnut Hill Hospital, NJ 1997 Science and Medical Litigation Intern, McCarter & English Law Firm, Newark, NJ
RESEARCH PUBLICATIONS, PEER REVIEWED:
1. Chou R, Croswell JM, , Koenig HC, et al. Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2011; 155: 762-771. doi: 10.7326/0003-4819-155-11-201112060-00375.
2. Koenig HC, Sutherland A, Izurieta HS, McGonagle D. Application of the immunological disease continuum to study autoimmune and other inflammatory events after vaccination. Vaccine. 2011; 29(5): 913-919. doi: 10.1016/j.vaccine.2010.10.044.
3. Koenig HC, Finkel BB, Khalsa SS, et al. Performance of an automated electronic acute lung injury screening system in intensive care unit patients. Crit Care Med. 2011; 39(1): 98-104. doi: 10.1097/CCM.0b013e3181feb4a0.
4. Mabry-Hernandez IR, Koenig HC. Screening and treatment for major depressive disorder in children and adolescents. Am Fam Physician. 2010; 82(2): 185-186.
5. Azzam HC, Khalsa SS, Urbani R, et al. Validation Study of an Automated Electronic Acute Lung Injury Screening Tool. J Am Med Inform Assoc. 2009; 16(4): 503-508. doi: 10.1197/jamia.M3120.
6. Azzam HC, Gahunia MK, Sae-Tia S, Santoro J. Mycobacterium avium-avium-associated typhlitis mimicking appendicitis in an immunocompetent host. Am J Med Sci. 2009; 337(3): 218-220. doi: 10.1097/MAJ.0b013e31818457a3.
RESEARCH PUBLICATIONS, PEER-REVIEWED REVIEWS:
1. Koenig HC, Garland JM, Weissman D, Mounzer K. Vaccinating HIV Patients: Focus on Human Papillomavirus and Herpes Zoster Vaccines. AIDS reviews. 2013; 15(2): 77-86.
Associate Research Scientist
Department of Infectious Diseases
College of Veterinary Medicine
University of Georgia
Athens, GA 30602 USA
• 2006 Ph.D. Microbiology, Immunology & Biochemistry
• 2000 M.S. Biotechnology
• 1998 B.S. Life Sciences
RESEARCH WORK EXPERIENCE
• 2011- Present: Associate Research Scientist, Department of Infectious Diseases, College of veterinary Medicine, University of Georgia, Athens, GA, USA
o Interaction between Mycobacteria and host immune cells
o Alteration of macrophage function during TB and HIV co-infection.
o Modulation of PAMPs mediated immune response by HIV1-Nef protein in human macrophages.
o Modulation the Function of regulatory T cells by HIV1-Nef protein.
• 2009 - 2011: Research Associate, Department of Microbiology & Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
o Role of Ets transcription factor Elf-1 in the development of NKT cells and NK cells.
o Role of human group 1 CD1 molecule in transgenic murine model of Mycobacterium tuberculosis infection.
• 2006 - 2009: Postdoctoral Research Associate, Department of Biological Sciences, University of Notre Dame, Notre Dame, IN, USA (PI; Dr. Jeff Schorey)
o Exosomes released by mycobacterial-infected macrophages activate antigen-specific T cell immunity.
o Proteomic analysis of exosomes from Mycobacterium tuberculosis infected and culture filtrate protein-treated macrophages.
• 2001 - 2006: Ph.D, Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh, India
o Evaluation of new generation Th1 adjuvants for the development of anti-tuberculous mucosal vaccine based on Mycobacterium tuberculosis Ag85 complex proteins.
His research interests include: Vaccine development, adjuvant formulation, assay development, bioengineered Exosomes, immunology and inflammation, animal models of disease, animal experimentation (various surgeries and other less-invasive procedures), protein biochemistry, Bio-safety level-3 (BSL-3), systems and integrative biology, cell deaths, cell cycle, signaling networks, microRNA, mRNA and miRNA expression at single live cell level using SmartFlare RNA detection probes, in vitro human primary cell models, in vivo adoptive cell transfer, immunotherapy, Bioplex/Luminex and Quansys platform, multiparameter flow cytometry, cell purification by autoMACS, intracellular signaling pathways in human and mouse cells. Passionate about mentoring and teaching.
HONORS & AWARDS
• Recipient of Senior Research Fellowship of Indian council of Medical Research (ICMR), Gov. of India, New Delhi [2004-2006].
• Recipient of Junior Research Fellowship of Indian council of Medical Research (ICMR), Gov. of India, New Delhi [2002-2004].
• Qualified, National Eligibility Test of Council of Scientific and Industrial Research (CSIR) Govt. of India, New Delhi. [Dec. 2001].
• Member- Society of Mucosal Immunology, USA
• Member- The American Association of Immunologists, USA
1. Giri PK, Sharma A, Estes DM. Is A20 a suitable target to enhance dendritic cell antigen presentation? Immunotherapy. 2011; 3(11): 1289-1290. doi: 10.2217/imt.11.128.
2. Giri PK, Sharma A, Estes DM. New players in immune regulation. Immunotherapy. 2011; 3(11): 1290-1291.
3. Giri PK, Sharma A, Estes DM. mRNA-29: a governor of IFN-γ production by T cells. Immunotherapy. 2011; 3(11): 1291-1292.
4. Choi HJ, Geng Y, Cho H, Li S, Giri PK, Felio K, Wang CR. Differential requirements for the Ets transcription factor Elf-1 in the development of NKT cells and NK cells. Blood. 2011; 117(6):1880-1887 doi: 10.1182/blood-2010-09-309468.
5. Giri PK, Kruh N, Dobos-Elder KM, Schorey JS. Proteomic analysis identifies highly antigenic proteins in exosomes from M. tuberculosis-infected and culture filtrate protein-treated macrophages . Proteomics. 2010; 10(17): 3190-3202. doi: 10.1002/pmic.200900840.
6. Giri PK, Verma I and Khuller GK. Adjunct immunotherapy with Ag85 complex proteins based subunit vaccine in a murine model of Mycobacterium tuberculosis infection. Immunotherapy. 2009; 1(1): 31-37. doi: 10.2217/1750743X.1.1.31.
7. Giri PK. How could we have better vaccines against TB? Expert Opin Biol Ther. 2008; 8(11):1759-1772.
8. Giri PK, Schorey JS. Exosomes derived from M. bovis BCG infected macrophages activate antigen-specific CD4+ and CD8+ T cells in vitro and in vivo. PLoS ONE. 2008; 3(6): e2461. doi: 10.1371/journal.pone.0002461.
9. Giri PK, Khuller GK. Is intranasal vaccination a feasible solution for tuberculosis? Expert Rev Vaccines. 2008; 7(9): 1341-1356. doi: 10.1586/14760522.214.171.1241.
10. Giri PK, Verma I and Khuller GK. Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex proteins based vaccine against airway Mycobacterium tuberculosis challenge following intranasal administration. FEMS Immunol Med Microbiol. 2006; 47(2): 233-241.
11. Giri PK, Verma I and Khuller GK. Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice. Journal of Infection. 2006; 53(5): 350-356.
12. Giri PK, Sable SB, Verma I and Khuller GK. Comparative evaluation of intranasal and subcutaneous route of immunization for development of mucosal vaccine against experimental tuberculosis. FEMS Immunol Med Microbiol. 2005; 45(1): 87-93.
Head of the Department
Department of Infectious Diseases and Epidemiology
Pavlov State Medical University6/8 Lev Tolstoy st.
St. Petersburg, 197022, Russia
Dr. Lioznov is the Head, Department of Infectious Diseases and Epidemiology, at Pavlov State Medical University, St. Petersburg, Russia.
Dr. Lioznov received his Medical Degree at Pavlov in 1994. He also was trained at Cornell University, New York City; at Public Health Summer Institute, the University of Alabama at Birmingham; at the Graduate Summer Institute of Epidemiology and Biostatistics, Bloomberg School of Public Health, The John Hopkins University; and during HIV/AIDS Research Ethics Seminar organized by Medical College of Wisconsin in Warsaw, Poland. He has been involved in clinical trials since 2005 in the area of infectious diseases (viral hepatitis, herpes infections, influenza, HIV, food-borne diseases) and vaccination (influenza, HIV, VZV).
His research interests include: HIV, viral hepatitis, and food-borne diseases.
HONORS AND AWARDS
• 1998 Scholarship of President of Russian Federation
• 1999 Russian Ministry of Public Health Award
• 2002 Scholarship of the Arthur Ashe Endowment for the Defeat of AIDS, USA
• 2009 A.A. Likhachev Memorial Medal, Valdman Institute of Pharmacology, St. Petersburg, Russia
OTHER EXPERIENCE AND PROFESSIONAL MEMBERSHIPS
• 1998 Scholarship of President of Russian Federation
• 1999 Russian Ministry of Public Health Award
• 2002 Scholarship of the Arthur Ashe Endowment for the Defeat of AIDS, USA
• 2009 A.A. Likhachev Memorial Medal, Valdman Institute of Pharmacology, St. Petersburg, Russia
SELECTED PUBLICATIONS (SELECTED FROM 96)
1. Antonova TV, Kostereva EM, Vetrov TA, Esaulenko EA, Lioznov DA. The course of viral hepatitis C in the groups with high risk of infection. Mediterranean Journal of Infectious and Parasitic Diseases. 1999; 14: 21-23.
2. Lioznov D. Clinical and Pathogenic Features of Shigellosis Flexneri in Alcohol Abuse Patients. Proceedings of the St.Petersburg Pavlov State Medical University. 2000; 7(1): 95-97.
3. Krupitsky E, Zvartau E, Lioznov D, et al. Co-morbidity of infectious diseases and substance abuse in St. Petersburg, Russia. Russian Journal of HIV / AIDS and Related Problems. St.-Petersburg. 2003; 7(2): 62-63. doi:10.1159/000088578
4. Krupitsky E, Horton NJ, Williams EC, et al. Alcohol use and HIV risk behaviors among HIV-infected hospitalized patients in St. Petersburg, Russia. Drug and Alcohol DepS¨dence. Drug and Alcohol Dependence. 2005; 79(2): 251-256. doi: http://dx.doi.org/10.1016/j.drugalcdep.2005.01.015
5. Zvartau E, Krupitsky E, Lioznov D, et al. Co-morbidity of addictive diseases and socially significant infections in St. Petersburg and the Leningrad region, Russia. Voprosi narkologii (Problems of Narcrology). 2005; 2: 68-73.
6. Krupitsky EM, Zvartau EE, Lioznov DA, et al. Co-morbidity of infectious and addictive diseases in St. Petersburg and the Leningrad Region, Russia. European Addiction Research. 2006; 12: 12-19. doi: 10.1159/000088578
7. Marseille E, Dandona L, Marshall, et al. HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries. BMC Health Services Research. 2007; 7: 108. doi:10.1186/1472-6963-7-108
8. Zagdin Z, Brazhenko N, Brazhenko O, et al. Comorbidity TB, Alcoholism and drug addiction. Pulmonology. 2007; 2: 40-43.
9. Lioznov D, Lapotnikov VA, Petrov VN. Acute respiratory viral infections. Nurse. 2010; (4): 9-12.
10. Lioznov D, Nikolaenko S, Zhigalov A, Gorchakova O, Sabadash N, Alekseeva E. Stigma in HIV-infected patients with comorbid opioid addiction. HIV-infection and Immunosuppressive Disorders. 2012; 4(3): 52-56.
11. Pace CA, Lioznov D, Cheng DM, et al. Sexually transmitted infections among HIV-infected heavy drinkers in St. Petersburg, Russia. Int J STD AIDS. 2012; 23(12): 853-858. doi: 10.1258/ijsa.2012.012004.
12. Lioznov D, Nikolaenko S, Gorchakova O, Diachkov A. Quality of life of young patients with chronic hepatitis C. Jurnal Infektologii. 2012; 4(2): 56-59.
13. Lioznov D, Sayfullina S, Kuznetsova I, Nikolaenko S, Zhurkin A. Experience of using vegetal enterosorbent in the treatment of acute intestinal infections. Jurnal Infektologii. 2012; 4(4): 42-45.
14. Lunze K, Cheng DM, Quinn E, et al. Nondisclosure of HIV infection to sex partners and alcohol’s role: a Russian experience. AIDS and Behavior. 2013; 17(1): 390-398. doi: 10.1007/s10461-012-0216-z.
15. Vasquez C, Lioznov D, Nikolaenko S, et al. Gender Disparities in HIV Risk Behavior and Access to Health Care in St. Petersburg, Russia. AIDS Patient Care STDS. 2013; 27(5): 304-310. doi: 10.1089/apc.2013.0019.
16. Antonova TV, Zhevnerova NS, Romanova MA, Kholodnaya AN, Lioznov DA. Leptin and Adiponectin Levels in Patients with Chronic Hepatitis C with Carbohydrate and Lipid Metabolism Disorders. Jurnal Infectologii. 2014; 6(3): 71-78.
17. Zagdin Z, Lioznov D, Shilova N, Dugin S. Model of an Integrated Patient-Oriented System Providing TB Care to Patients with HIV (in the North-West Federal District). Tuberculosis and Lung Diseases. 2014; 91(9): 20-21.
18. Samet JH, Raj A, Cheng DM, et al. HERMITAGE – A Randomized Controlled Trial to Reduce Sexually Transmitted Infections and HIV-risk Behaviors among HIV-infected Russian Drinkers. . Addiction. 2014. doi:10.1111/add.12716
19. Edelman EJ, Cheng DM, Krupitsky EM, et al. Heroin Use and HIV Disease Progression: Results from a Pilot Study of a Russian Cohort. AIDS Behav. 2014.
20. Pecoraro A, Mimiaga M, OCleirigh C, et al. Depression, substance use, viral load, and CD4+ count among patients who continued or left antiretroviral therapy for HIV in St. Petersburg, Russian Federation. AIDS Care. 2014; 29: 1-7. doi: 10.1080/09540121.2014.959464
Senior Research Fellow
Centre for Social Research in Health
John Goodsell Building
UNSW Arts and Social Sciences
University of New South Wales
Sydney, NSW 2052, Australia
• 1999 to 2002 PhD, UNSW
• 1998 to 1999 Master of Education Administration, UNSW
• 1991 to 1996 Bachelor of Medicine, Fudan University, P.R.China
Dr. Mao is a Senior Research Fellow at the Centre for Social Research in Health, UNSW Australia, She has been working in HIV-related research over the past 14 years. Dr. Mao has received extensive training in medicine, public health, social psychology, education and social sciences.
Her research interests include: Terms of antiretroviral treatment (ART) for HIV include factors associated with treatment uptake, adherence and failure, promotion of early treatment initiation, treatment as prevention, and impact of ART on behavioural change on key populations (esp. gay and other men who have sex with men).
• July 2014-: The Albion Centre, WHO Collaborating Centre for Capacity Building and health Care Worker Training in HIV/AIDS Care, Treatment and Support, technical consultant
• Feb-March 2011: NSW BBVSS expert technical advisory group on goals and targets for the revised national HIV strategy.
• January 2010– June 2011: contracted by the Australian AIDS Projects Management Group Pty Ltd (APMG) and United States Agency for International Development (USAID) to provide technical support to the project titled “Study of Outcomes of the Comprehensive Package of Services (CPS) Model for Injecting Drug Users (IDU): Yunnan and Guangxi”, funded by the USAID Health Policy Initiative in the Greater Mekong Region
• 10th-11th June 2005: I was invited to Durban, South Africa by the Socio-behavioural Working Group of the South African AIDS Vaccine Initiative (SAAVI), sponsored by the International AIDS Vaccine Initiative (IAVI), to provide advice on social and behavioural research issues related to HIV vaccines
EXPERT REVIEWER FOR CONFERENCES AND GRANTS
• 20th International AIDS Conference, Melbourne, 20-25 July, 2014
• 13th Social Research Conference on HIV, Hepatitis C and related diseases: promises & limitations: biomedical treatment and prevention in the real world, 20-21st February 2014, Sydney. (& Conference Panel Chair)
• 2013 Australasian HIV & AIDS Conference, 21-23 October, 2013, Darwin
• 2nd International HIV Social Sciences and Humanities Conference, 7-10 July 2013, Paris, France
• The Australian National Health and Medical Research Council (NHMRC) Project Grant 2012
• The Australian Research Council (ARC) Future Fellowships 2011-2012, Discovery Project 2014
• 12th Social Research Conference on HIV, Hepatitis C and Related Diseases: Silence and articulation, Sydney, 12-13th April, 2012 (Member of the conference organising committee, panel chair and peer reviewer)
• Population Health Congress Conference, Adelaide, 10-12 September, 2012
• XIX International AIDS Conference, Washington DC, 22-27 July, 2012, The Netherlands AIDS Fonds
• 2011-2014 The US Creative and Novel Ideas in HIV Research (CNIHR) Developmental Grant Program, a collaboration between the International AIDS Society, the University of Washington and University of Alabama Centers for AIDS Research (CFAR) and the Institute of Translational Health Sciences. 2010
• 20th Annual Australasian Society for HIV Medicine Conference (ASHM), 17-20 September 2008
• XVII International AIDS Conference, Mexico City, 3-8 August 2008
• 4th International AIDS Society (IAS) Conference, Sydney, 22-25 July 2007
• 7th International Congress on AIDS in Asian and the Pacific (ICAAP), Kobe, Japan, 1-5 July 2005
PEER-REVIEWED JOURNAL ARTICLES
1. Newman CE, de Wit J, Persson A, et al. Understanding concerns about HIV treatment-as-prevention among people with HIV who are not using antiretroviral therapy. AIDS and Behavior. 2014. doi: 10.1007/s10461-014-0959-9
2. Swart A, Meagher N, van Leeuwen MT, et al. Examining the quality of name code record linkage: What is the impact on death and cancer risk estimates? A validation study. ANZJPH. 2014. doi: 10.1111/1753-6405.12287.
3. Mao L, de Wit JB, Kippax SC, Prestage G, Holt M. Younger age, recent HIV diagnosis, no welfare support And no annual sexually transmissible infection screening are associated with non-use of antiretroviral treatment among HIV-positive gay men in Australia. HIV Medicine. 2014. doi: 10.1111/hiv.12169.
4. Zablotska IB, Holt M, de Wit, J, Mao L, Down I, Prestage D. At home and away: gay men and high risk sexual practices. AIDS and Behavior. 2014. doi: 10.1007/s10461-013-0635-5
5. Treloar C, McLeod R, Yates K, Mao L. Whats the cost of finding the right fit? The cost of conducting NSP business in a range of modalities. Contemporary Drug Problems. 2014; 41(1): 41-56.
6. Holt M, Hull P, Lea T, et al. Comprehensive testing for and diagnosis of sexually transmissible infections among Australian gay and bisexual men: findings from repeated Cross-sectional behavioural surveillance, 2003-2012. Sexually Transmitted Infections. 2014; 90: 208-215. doi: 10.1136/sextrans-2013-051294
7. Lea T, Lee E, Mao L, de Wit J, Holt M. HIV/HCV coinfection among homosexually active men in Sydney and association with sexual and drug use practices. Sexual Health. 2013; 10(5): 448-451. doi: 10.1071/SH13042.
8. Mao L, de Wit JBF, Adam PCG, et al. Australian Prescribers perspectives on ART initiation in the era of “Treatment as Prevention”. AIDS Care. 2013; 25(11): 1375-1379.
9. Zablotska IB, Prestage G, de Wit J, Grulich AE, Mao L, Holt M. The informal use of antiretroviral medications for pre-exposure prophylaxis(PrEP) of HIV among gay men in Australia. Journal of Acquired Immune Deficiency Syndrome. 2013; 62(3): 334-338.
10. Jin J, Grulich A, Mao L, et al. Sexual partners age as a risk factor for HIV seroconversion in a cohort of HIV-negative homosexual men in Sydney. AIDS and Behavior. 2013; 17(7): 2426-2429. doi: 10.1007/s10461-012-0350-7.
11. Mao L, Adam P, Kippax S, et al. HIV-negative mens perceived HIV risk hierarchy: imaginary or real? AIDS and Behavior. 2013; 17(4):1362-1369. doi: 10.1007/s10461-012-0406-8.
12. Lea T, Mao L, Bath N, et al. Injecting drug use among gay and bisexual men in Sydney: prevalence and associations with sexual risk practices and HIV and Hepatitis C infection. AIDS and Behavior. 2013; 17(4): 1344-1351. doi: 10.1007/s10461-013-0409-0
13. Lea T, Costello M, Mao L, et al. Elevated reporting of unprotected anal intercourse and injecting drug use but no difference in HIV prevalence among Indigenous men who have sex with men compared with their Anglo-Australian peers. Sexual Health. 2013; 10(2) 146-155 . doi: 10.1071/SH12097
14. Lea T, Prestage G, Mao L, Zablotska I, de Wit J, Holt M. Trends in drug use among gay and bisexual men in Sydney, Melbourne and Queensland Australia. Drug and Alcohol Review. 2013; 32(1) 39-46. doi: 10.1111/j.1465-3362.2012.00494.x
15. Holt M, Lee E, Prestage G, Zablotska-Manos I, de Wit J, Mao L. The converging and diverging characteristics of HIV-positive and HIV-negative gay men in the Australian Gay Community Periodic Surveys, 2000-2009. AIDS Care. 2013; 25(1): 28-37. doi: 10.1080/09540121.2012.686598
16. Swart A, Burns L, Mao L, et al. Cancer risk and blood-borne viruses among people registered for opioid substitution therapy: a population-based cohort study. BMJ Ope.n 2012; 2(5): e001755. doi: 10.1136/bmjopen-2012-001755.
17. Zablotska I, Holt M, de Wit J, McKechnie M, Mao L, Prestage G. Gay men who are not getting tested for HIV. AIDS and Behavior. 2012; 16(7): 1887-1894. doi: 10.1007/s10461-012-0184-3
18. Guy R, Wand H, Holt M, et al. High annual syphilis testing rates among gay men in Australia, but insufficient re-testing. Sexually Transmitted Diseases. 2012; 39(4): 268-275. doi: 10.1097/OLQ.0b013e3182471ff0
19. Holt M, Bryant J, Newman CE, et al. Patterns of alcohol and other drug use associated with major depression among gay men attending general medical practices in Australia. Journal of Mental Health & Addiction. 2012; 10: 141-151.
20. Zablotska IB, Prestage G, Holt M, et al. Australian gay men who have taken nonoccupational postexposure prophylaxis for HIV are in need of effective HIV prevention methods. Journal of Acquired Immune Deficiency Syndromes. 2011; 58(4): 424-428. doi: 10.1097/QAI.0b013e318230e885.
21. Mao L, Kippax, S, Holt M, Prestage G, Zablotska I, de Wit J. Rates of condom and non-condom based anal intercourse practices among homosexually active men in Australia: deliberate HIV risk reduction? Sexually Transmitted Infections. 2011; 87(6): 489-493. doi: 10.1136/sextrans-2011-050041
22. Körner, H, Newman C, Mao L, Kidd, M, Saltman D, Kippax, S. The black dog just came and sat on my face and built a kennel: Gay men making sense of depression. Health. 2011; 15(4): 417-436. doi: 10.1177/1363459310372511
23. Körner, H, Newman C, Kippax, S, Mao L, Kidd, MR, Saltman D Discourses of depression of Australian general practitioners working with gay men. Qualitative Health Research. 2011; 21(8): 1051-1064. doi: 10.1177/1049732311404030
24. Vajdic CM, Mao L, van Leeuwen, MT, Kirkpatrick, P, Grulich AE, Riminton S. Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency? Blood. 2010; 116(8): 1228-1234. doi: 10.1182/blood-2010-03-272351
25. Newman CE, Kippax, SC, Mao L, Saltman DC, Kidd MR. Roles ascribed to general practitioners by gay men with depression. Australian Family Physician. 2010; 39(9): 667-671.
26. Newman CE, Mao L, Canavan PG, Saltman DC, Kidd MR, Kippax SC. HIV generations? Generational discourse in interviews with Australian general practitioners and their HIV positive gay male patients. Social Science & Medicine. 2010; 70(11): 1721-1727. doi: 10.1016/j.socscimed.2010.02.006
27. Templeton DJ, Jin F, Mao L, Prestage GP, Donovan, B, Imrie J, Kippax S. Kaldor JM. Grulich AE. Circumcision and risk of HIV infection in Australian homosexual men. AIDS. 2009; 23(17): 2347-2351. doi: 10.1097/QAD.0b013e32833202b8.
28. Prestage G, Mao L, Kippax S, Jin F, et al . Use of viral load to negotiate condom use among gay men in Sydney Australia. AIDS and Behavior. 2009; 13(4): 645-651. doi: 10.1007/s10461-009-9527-0
29. Poynten IM, Jin F, Mao L, et al. Non-occupational post-exposure prophylaxis, subsequent risk behaviour and HIV incidence in a cohort of Australian homosexual men. AIDS. 2009; 23(9): 1119-1126. doi: 10.1097/QAD.0b013e32832c1776
30. Mao L, Newman CE, Kidd MR, Saltman DC, Rogers G, Kippax SC. Self-reported sexual difficulties and their association with depression and other factors among gay men attending high HIV-caseload general practices in Australia. Journal of Sexual Medicine. 2009; 6(5): 1378-1385. doi: 10.1111/j.1743-6109.2008.01160.x
31. Mao L, Kidd MR, Rogers G, et al. Social factors associated with Major Depressive Disorder in homosexually active Gay men attending general practices in urban Australia. Australian and New Zealand Journal of Public Health. 2009; 33(1): 83-86. doi: 10.1111/j.1753-6405.2009.00344.x.
32. Newman CE, Kippax SC, Mao L, Rogers G, Saltman DC, Kidd MR. Features of the management of depression in gay men and men with HIV from the perspective of Australian general practitioners. Family Practice. 2009; 26(1): 27-33. doi: 10.1093/fampra/cmn089
33. Körner H, Newman C, Mao L, Kippax S, Kidd MR, Saltman D. Its really a myriad of different signals, not just the textbook: the complexities of diagnosing depression in gay men in general practice. Mental Health in Family Medicine. 5(3): 167-175.
34. Mao L, Kippax SC, Newman CE, et al. Rates of depression among men attending high-HIV-caseload general practices in Australia. Mental Health in Family Medicine. 2008; 5(2): 79-83.
35. Saltman DC, Newman CE, Mao L, Kippax SC, Kidd MR. Experiences in managing problematic crystal methamphetamine use and associated depression in gay men and HIV positive men: in-depth interviews with general practitioners in Sydney Australia. BioMed Central Family Practice. 2008; 9: 45. doi: 10.1186/1471-2296-9-45
36. Newman CE, Kippax SC, Mao L, Saltman DC, Kidd MR. GPs understanding of how depression affects gay and HIV positive men. Australian Family Physician. 2008; 37, 678-680.
37. Templeton DJ, Mao L, Prestage GP, Jin,F, Kaldor JM, Grulich AE. Self-report is a valid measure of circumcision status in homosexual men. Sexually Transmitted Infections. 2008; 84: 187-188.
38. Mao L, Templeton DJ, Crawford J, et al. Does circumcision make a difference to the sexual experience of gay men? Findings from the Health in Men(HIM) cohort. Journal of Sexual Medicine. 2008; 5(11) 2557-2561. doi: 10.1111/j.1743-6109.2008.00845.x
39. Prestage G, Mao L, Grulich A, Jin F, Kaldor J, Kippax S. Sex work and risk behaviour among HIV-negative gay men. AIDS Care. 2007; 19(7): 931-934. doi: 10.1080/09540120701203386
40. Jin F, Prestage GP, Mao L, et al. Incidence and risk factors for urethral and anal gonorrhoea and chlamydia in a cohort of HIV negative homosexual men: the HIM study. Sexually Transmitted Infections. 2007; 83(2): 113-119.
41. Jin F, Prestage G, Mao L, et al. Transmission of herpes simplex types 1 and 2 in a prospective cohort of HIV negative homosexual men: the HIM study. Journal of Infectious Diseases. 2006; 194(5): 561-570.
42. Templeton DJ, Mao L, Prestage G, Kaldor JM, Kippax S, Grulich AE. Demographic predictors of circumcision status in a community-based sample of homosexual men in Sydney Australia. Sexual Health. 2006; 3: 191-193.
43. Mao L, Crawford J, Van de Ven P, et al. Differences between men who report frequent, occasional or no unprotected anal intercourse with casual partners(UAIC) among a cohort of HIV-seronegative gay men in Sydney Australia. AIDS Care. 2006; 18(8): 942-951. doi: 10.1080/09540120500343144
44. Mao L, Crawford JM, Hospers HJ, et al. Serosorting in casual anal sex of HIV-negative gay men is noteworthy and is increasing in Sydney Australia. AIDS. 2006; 20(8): 1204-1206. doi: 10.1097/01.aids.0000226964.17966.75
45. Abelson J, Rawstorne P, Crawford J, Mao L, Prestage G, Kippax S. HIV optimism does not explain increases in high-risk sexual behaviour among gay men of positive or negative HIV status In Sydney Australia. AIDS. 2006; 20(8): 1215-1216. doi: 10.1097/01.aids.0000226972.42622.95
Crawford J, Kippax S, Mao L, et al. Number of risk acts by relationship status and partner serostatus: data from the HIM cohort of homosexually active men in Sydney Australia. AIDS and Behavior. 2006; 10(3): 325-331. doi: 10.1007/s10461-005-9057-3
46. Prestage G, Mao L, McGuigan D, et al. HIV risk and communication between regular partners in a cohort of HIV-negative gay men. AID Care. 2006; 18(2): 166-172. doi: 10.1080/09540120500358951
47. Prestage G, Mao L, Fogarty A, et al. How has the sexual behaviour of gay men changed since the onset of AIDS: 1986-2003. Australian and New Zealand Journal of Public Health. 2005; 29(6): 530-535. doi: 10.1111/j.1467-842X.2005.tb00245.x
48. Van de Ven P, Mao L, Crawford J, et al. Willingness to participate in HIV vaccine trials among HIV-negative gay men in Sydney Australia. International Journal of STD & AIDS. 2005; 16: 314-317. doi: 10.1258/0956462053654212
49. Van de Ven P, Mao L, Fogarty A, et al. Undetectable viral load is associated with sexual risk taking in HIV serodiscordant gay couples in Sydney. AIDS. 2005; 19(2): 179-184.
50. Prestage G, Van de Ven P, Mao L, Grulich A, Kippax S, Kaldor J. Contexts for last occasions of unprotected anal intercourse among HIV-negative gay men in Sydney: the Health in Men(HIM) cohort. AIDS Care. 2005; 17(1): 23-32.
51. Mao L, McCormick J, Van de Ven P. Individualism-collectivism, self-efficacy and other factors associated with risk-taking among gay Asian and Caucasian men. AIDS Education and Prevention. 2004; 16(1): 55-67.
52. Van de Ven P, Mao L, Prestage G. Gay Asian men in Sydney resist international trend: no change in rates of unprotected anal intercourse, 1999-2002. AIDS Education and Prevention. 2004; 16(1): 1-12.
53. Mao L, McCormick J, Van de Ven P. Ethnic and gay identification: gay Asian men dealing with the divide. Culture, Health and Sexuality. 2002; 4(4): 419-430.
54. Wang K, Qian X, Mao L, Ni P. Advocating for informed choices and promoting reproductive health [in Chinese]. Chinese Primary Health Care [Zhonghua Yu Fang Yi Xue Za Zhi]. 1997; 11(5): 32-33.
55. Mao L, Wang K, Qian X. An analysis on factors associated with Expanded Planned Immunization(EPI) service utilization [in Chinese]. Chinese Primary Health Care [Zhonghua Yu Fang Yi Xue Za Zhi]. 1997; 11(4): 30-31.
56. Mao L, Deng C, Liu J, Qian X. Problem-based learning: a teaching method reform for undergraduates majoring in maternal and child health in Mainland China [in Chinese]. Maternal and Child Health Care of China [Zhongguo Fuyu Baojian]. 1995; 10(5): 285-286.
Director of Scholarly Affairs
Capstone College of Nursing
The University of Alabama
Tuscaloosa, AL 35487, USA
Dr. Dalmida is a board certified Nurse Practitioner, specialized in HIV/AIDS, immunology and oncology. She obtained her PhD from Emory University and completed a postdoctoral fellowship at Duke University. Her area of research focus is on spirituality and coping with stress and its relationship to mental and physical health among people living with HIV/AIDS and the role of religion and cognition among people at risk for HIV. Her chapter on Religion and HIV/AIDS, is featured in a new book published by Oxford Press entitled, Religion as a Social Determinant of Health.. Earlier, she is an currently an Assistant Professor at the Nell Hodgson Woodruff School of Nursing and Adjunct Faculty at the Latin American and Caribbean Studies and African American Studies departments at Emory University. Dr. Dalmida, Currently, an Associate Professor and Director of Scholarly Affairs at the Capstone College of Nursing, The University of Alabama. She conducted a study entitled "Spirituality, Religion, Coping, and Health Among People with HIV/AIDS", funded by the Templeton Foundation. The principal aim of the study was to examine the interconnections between religious coping, depression, perceived stress, CD4 count, social support, and health-related quality of life (HRQOL) in 292 HIV-positive outpatients and to test the idea that religious coping explains a significant amount of the variance in HRQOL. During her doctoral training, Dr. George Dalmida received NIH funding to test a model based on psychoneuroimmunology that included spiritual components and examined the interrelationships among the study variables and the contribution of existential well-being to the mental health and physical health composites of HRQOL beyond usual sources of variance. She also conducted a qualitative study of the lived spiritual experience of 20 women living with HIV/AIDS. She recently completed a study that examined the roles of prefrontal cortex function and religiosity in HIV-associated sexual risk behavior among Black adolescent girls.
Her research interests include: Spirituality/Religiosity, Meaning-making, Mental Health, Immunology, Health-related Quality of Life, Medication Adherence, Sexual Risk Behavior, Decision-making and Cognitive Function.
HONORS AND AWARDS
• (2013) Best Poster Award, “Dalmida, S.G. Cognition and Sexual Risk Behavior among African American Girls”. International Conference on Sexually Transmitted Diseases and AIDS, October 24-25, 2013, Orlando, FL.
• (2012) Carl Storm Underrepresented Minority (CSURM) Fellowship for the 2012 Neurobiology of Cognition Gordon Research Conference • (2011) Community Builders Award, Emory University
• (2010) Atlanta Public Schools Career and Technical Education Business and Community Partner Award
• (2005-2006) Ruth L. Kirschstein National Research Service Award – Postdoctoral Fellow
• (1999) Nursing Faculty Award
• (1999) Magna Cum Laude Graduate
• (1997) Cum Laude Graduate
• (2013-2015) Leadership Succession Committee, Sigma Theta Tau, International (STTI) Honor Society for Nursing, Elected Member
• (2013-Present) Board of Directors, Healthy Nation, LLC, Board Member
• (2013-Present) Board of Directors, Healthy Nation Fund, Board Member
• (2012-2013) Board of Directors, Family Health Enterprise, Board Member
• (2012) BRAIN Program, Center for Behavioral Neuroscience, Mentor
• (2012-Present) International AIDS Society (IAS), Member
• (2012-Present) Society for Adolescent Health and Medicine (SAHM), Member
• (2012-Present) Society for Research on Adolescence (SRA), Member
• (2012-Present) American Academy of Health Behavior (AAHB), Member
• (2012-2014) Advisory Board, Health Occupations Students of America (HOSA), Benjamin Banneker High School, Co-Chair
• (2011-2013) Region 7 Conference Planning Committee, STTI, Co-Chair
• (2011-2012) International Service Taskforce, STTI, United States Health Management Institute (USHMI), STTI, Alpha Epsilon Chapter, Chair
• (2011-Present) Society for Neuroscience (SFN), Member
• (2011-Present) Center for Mind, Brain, and Culture, Emory University, Affiliate
• (2011-Present) Virgin Islands Community Aids Resource & Education, Inc. (VICARE), Member/Donor
• (2010-2012) Research Committee, STTI Alpha Epsilon Chapter, Co-Chair
• (2008-Present) Atlanta Clinical and Translational Science Institute, Member
• (2007-Present) American Association of Colleges of Nursing, Member
• (2007-Present) National League for Nursing (NLN), Member
• (2007-Present) American Academy of Religion (AAR), Member
• (2007-Present) Society for Spirituality, Theology and Health, Member
• (2007-Present) Center for AIDS Research (CFAR), Emory University, Member
• (2002-Present) American Nurses Association (ANA), Member
• (2002-Present) Southern Nursing Research Society (SNRS), Member
• (2001-2002) Chapters Committee, ANAC, Member
• (2001-Present) STTI, Member
• (2000-Present) Association of Nurses in AIDS Care (ANAC), Member
• (1997-1999) National Foreign Language Honor Society, Member
ORIGINAL ARTICLES IN PEER-REVIEWED JOURNALS
1. Dalmida SG, Koenig HK, Holstad MM, Thomas TL. Religious and psychosocial covariates of health-related quality of life in people living with HIV/AIDS. HIV/AIDS Research and Treatment Open Journal. 2015; 1(1): 1-15. doi: 10.17140/HARTOJ-1-110
2. Delaney A, Dalmida SG, Gaydos L. When its not postpartum depression: Stress and mental health experiences and needs of new, first-time mothers. Issues in Mental Health Nursing. 2015; 36(6): 416-423.
3. Ejaz K, Shuaib W, Dalmida SG, et al. Evidence-Based practice: Best neuroimaging practice in non-traumatic headaches. Journal of Emergency Nursing. 2015. doi: 10.1016/j.jen.2014.09.010
4. Thomas TL, Yarandi HN, Dalmida SG, Frados A, Klienert K. Cross-Cultural Differences and Sexual Risk Behavior of Emerging Adults. Journal of Transcultural Nursing. 2015; 26(2): 64-72. doi: 10.1177/1043659614524791
5. Gaydos LM, Blake SC, Gazmararian JA, Woodruff W, Thompson WW, Dalmida SG. Revisiting Safe Sleep Recommendations for African-American Infants: Why Current Counseling is Insufficient. Maternal and Child Health Journal. 2014; 1-8. doi: 10.1007/s10995-014-1530-z
6. Dalmida SG. Neurocognitive correlates of HIV/STI-associated sexual decision-making in AA girls. Journal of AIDS Clinical Research. 2013; 4: 9. doi: 10.4172/2155-6113.S1.002
7. Dalmida SG. The growing HIV/AIDS epidemic in Americas paradise: Examining HIV risk. Journal of AIDS Clinical Research. 2013; 4: 9.
8. Dalmida SG, Koenig HG, Holstad MM, Wirani MM. The psychological well-being of people living with HIV/AIDS and the role of religious coping and social support. International Journal of Psychiatry in Medicine. 2013; 46(1): 57-83.
9. Gazmararian J, Dalmida SG, Merino Y, Blake S, Thompson W, Gaydos L. What new mothers need to know: Perspectives from women and providers. Maternal and Child Health Journal.2013. doi: 10.1007/s10995-013-1308-8.
10. Dalmida SG, Holstad MM, DiIorio CK, Laderman G. The meaning and use of spirituality among African American women with HIV/AIDS. Western Journal of Nursing Research. 2012; 34(6): 736-764. doi: 10.1177/0193945912443740
11. Bail K, Foster J, Dalmida SG, et al. The impact of invisibility on the health of migrant farmworkers in the southeastern United States: A case study from Georgia. Nursing Research and Practice. 2012; 2012: 8. doi: 10.1155/2012/760418
12. Dalmida SG, Holstad MM, DiIorio CK, Laderman G. Spiritual well-being and health-related quality of life among African American women with HIV/AIDS. Applied Research in Quality of Life. 2010; 4: 1-19.
13. Dalmida SG, Robertson B, Carrion MM, et al. Spirituality, religiousness, psychosocial factors and maternal-infant outcomes in Latina mothers. Southern Online Journal of Nursing Research. 2010; 10(3): 1-19.
14. Din E, Kelly S, Burnley K, et al. Gateway to holistic healing. American Holistic Nurses Association Faculty/Student ENews. 2010; 2(3): 1-6.
15. Dalmida SG, Holstad MM, DiIorio CK, Laderman G. Spiritual well-being, depressive symptoms, and immune status among women living with HIV/AIDS. Women and Health. 2009; 49(2): 119-143. doi: 10.1080/03630240902915036.
16. Dalmida SG. Spirituality, mental health, and health-related quality of life among women with HIV/AIDS: Integrating spirituality into mental health care. Issues in Mental Health Nursing. 2006; 27: 185-198. doi: 10.1080/01612840500436958
1. Dalmida SG, Thurman S. Religion and the HIV/AIDS Epidemic. In: Idler E, ed. Religion as a social determinant of health. New York: Oxford University Press. 2014.
2. Dalmida SG, Lewis RL, Waldrop-Valverde D. Prevention counseling and other strategies in the HIV care setting. In: Metsch L, Goldstein M, eds. Encyclopedia of AIDS. New York: Springer Science.
Professor of Social Research
Department of Social Research
School of Social Sciences
University of Hull
Hull HU6 7RX
Dr. Monica is a Professor of Social Research in the School of Social Sciences, University of Hull. Her academic background is in Social Statistics and Demography, having done her PhD in Social Statistics (University of Southampton, 1999), MSc in Demography (University of Nairobi, 1989) and BEd in Mathematics and Statistics (Kenyatta University, 1987). Monicas research focuses on international population health, especially reproductive health in sub-Saharan Africa, including maternal/child health, HIV/AIDS, and adolescent sexual and reproductive health. She has published extensively in these areas. With a background in Statistics and Demography, she has an inclination towards quantitative research methods, including multilevel modelling. However, she has experience in qualitative social research as well, and has implemented a number of reproductive health research projects utilizing mixed methods.
Her research interest include: Specific areas of research interest focus on international population health and include: HIV/AIDS in sub-Saharan Africa, Adolescent sexual and reproductive health, Maternal, newborn and child health, Reproductive health research in sub-Saharan Africa, including family planning and unintended fertility.
Research methods expertise includes: Statistical modelling, including multilevel analysis, Quantitative secondary analysis of large-scale surveys, including longitudinal data, Survey research design and evaluation research.
RESEARCH GRANTS/ AWARDS AND FELLOWSHIPS/ SCHOLARSHIPS
• (2007-2010) HIV/AIDS and well-being of children in sub-Saharan Africa a cross-national comparative analysis Research grant by the UK Medical Research Council (MRC). I was the Principal Investigator. (GB£ 313,574)
• (2005-2006) The Link between HIV/AIDS and Fertility Patterns in Kenya Research grant from USAID, through the Measure Evaluation project of the University of North Carolina, USA. I was the Principal Investigator. (US$ 60,000)
• (2005-2006) Timing and sequence of familial transitions and the risk of Poverty in Europe, sponsored by the Euro Panel Users Network (EPUNET)
• (2002-2005) Adolescent Safe Motherhood Study in the South Nyanza Region of Kenya World Health Organization (WHO) research grant to the African Population and Health Research Center. I was the principal investigator on the project. (US$ 75,000)
• (1999-2001) Two-year Population Council Post-doctoral Fellowship (The Population Council / African Population and Health Research Center, Nairobi, Kenya)
• (1998-1999) The Population Council Fellowship for PhD dissertation writing (University of Southampton, UK)
• (1996-1998) Research Studentship by the Faculty of Social Sciences, University of Southampton (UK) for MPhil/PhD program
• (1994-1995) Kenya Maternal Mortality Baseline Survey 1994. Research grant to the Population Studies and Research Institute of the University of Nairobi by UNICEF, Kenya Country Office. I developed the proposal and coordinated the project
• (1994-1995) Status of Women and Infant/Child Health in Kenya with particular reference to the High Mortality Zone in Nyanza Province. Research award by the Union for African Population Studies Small Grants Programme on Population and Development
• (1991-1992) The Impact of AIDS on some Urban Households in Kenya with particular reference to Female Headed Households Funded through research grant by the Overseas Development Group and Ford Foundation
• (1990-1991) Attitudes of Medical Personnel in Nairobi, Kenya Towards Abortion Research grant by the Population Council
• (1987-1989) The University of Nairobi Scholarship for the MSc. programme in Population Studies
1. Magadi, MA, Uchudi J. Onset of sexual activity among adolescents in HIV/AIDS-affected households in sub-Saharan Africa. Journal of Biosocial Science. 2014. doi: 10.1017/S0021932014000200
2. Magadi MA. Migration as a risk factor of HIV infection among youths in sub-Saharan Africa: Evidence from the DHS. The Annals of the American Academy of Political and Social Science. 2013; 648: 136-158. doi: 10.1177/0002716213482440
3. Magadi MA. The Disproportionate High Risk of HIV Infection Among the Urban Poor in Sub-Saharan Africa. AIDS and Behaviour. 2013; 17(5): 1645-1654. doi: 10.1007/s10461-012-0217-y.
4. Uchudi J, Magadi M, Mostazir M. A multilevel analysis of the determinants of high risk sexual behavior in sub-Saharan Africa. Journal of Biosocial Science. 2012; 44: 289-311. doi: 10.1017/S0021932011000654
5. 6. Magadi MA. Household and community HIV/AIDS status and child malnutrition in sub-Saharan Africa . Social Science & Medicine. 2011; 73: 436-446. doi: 10.1016/j.socscimed.2011.05.042
7. Magadi MA. Understanding the gender disparity in HIV infection in sub-Saharan Africa: evidence from the DHS. Sociology of Health and Illness. 2011; 33(4): 522-539.
8. Magadi MA. A cross-national analysis of the risk factors of malnutrition among children made vulnerable by HIV/AIDS in sub-Saharan Africa: evidence from the DHS. Tropical Medicine & International Health. 2011; 16(5): 570-578.
9. Magadi MA, Desta M. A multilevel analysis of the determinants and cross-national variations of HIV seropositivity in sub-Saharan Africa: evidence from the DHS Health and Place. 2011; 17(5): 1067-1083. doi: 10.1016/j.healthplace.2011.06.004
10. Magadi MA, Olayo R. Household HIV/AIDS status and sexual debut among adolescents in Kenya . African Population Studies. 2011; 25(2): 457-470.
11. Magadi MA, Agwanda A. Investigating the association between HIV/AIDS and recent fertility patterns in Kenya . Social Science and Medicine. 2010; 71(2): 335-344. doi: 10.1016/j.socscimed.2010.03.040
12. Magadi MA. The Risk Factors of Severe Child Poverty in the UK. Journal of Social Policy. 2010; 39(2): 297-316. doi: http://dx.doi.org/10.1017/S0047279409990651
13. Magadi MA, Agwanda A . Determinants of transitions to first sexual intercourse, marriage and pregnancy among female adolescents: Evidence from South Nyanza, Kenya. Journal of Biosocial Science. 2009; 41(3): 409-427. doi: 10.1017/S0021932008003210
14. Magadi MA, Agwanda A, Obare F. A comparative analysis of the use of maternal health services between teenagers and older mothers in sub-Saharan Africa: evidence from Demographic and Health Surveys (DHS). Social Science and Medicine. 2007; 64: 1311-1325.
15. Magadi MA, Agwanda A, Obare F, Taffa N. Size of newborn and Caesarean section deliveries among teenagers in sub-Saharan Africa . Journal of Bio social Science. 2007; 39: 175-187. doi: http://dx.doi.org/10.1017/S0021932006001313
16. Magadi MA., Poor pregnancy outcomes among adolescents in the South Nyanza region of Kenya . African Journal of Reproductive Health. 2006; 10(1): 26-38.
17. Amuyunzu-Nyamongo MK, Magadi MA. Sexual privacy and early sexual debut in Nairobi informal settlements . Community, Work and Family. 2006; 9(2): 143-158.
18. Obare F, Agwanda A, Magadi MA. Gender-Role Attitudes and Reproductive Health Communication among Female Adolescents in South Nyanza, Kenya. African Population Studies. 2006; 21(1): 37-54.
19. Kandala NB, Magadi MA,Madise NJ. An Investigation of District Spatial Variations of Childhood Diarrhoea and Fever Morbidity in Malawi . Social Science and Medicine. 2006; 62(5): 1138-1152. doi: 10.1016/j.socscimed.2005.07.028
20. Magadi MA. Maternal and child health among the urban poor in Nairobi, Kenya. African Population studies Supplement B, Population and Health Issues in Africa. 2004; 19: 179-198.
21. Magadi MA, Diamond I, Madise N, Smith P. Pathways of the Determinants of Unfavourable Birth Outcomes in Kenya Journal of Biosocial Science. 2004; 36(2): 153-176.
22. Magadi MA, Zulu E, Brockerhoff M. The Inequality of Maternal Health in Urban sub-Saharan Africa . Population Studies. 2003; 57(3): 349-368.
23. Ngom P, Magadi MA, Owuor T. Parental Presence and Adolescent Reproductive Health among the Nairobi Urban Poor. Journal of Adolescent Health. 2003; 33(5): 369-377. doi: http://dx.doi.org/10.1016/S1054-139X(03)00213-1
24. Magadi MA, Curtis S. Trends and Determinants of Contraceptive Method Choice in Kenya. Studies in Family Planning. 2003; 34(3): 149-159.
25. Magadi MA. Unplanned Childbearing in Kenya: The Socio-demographic Determinants and the Extent of Repeatability among Women . Social Science and Medicine. 2003; 56: 167-178.
26. Magadi MA, Diamond I, Madise N. Factors Associated with Unfavourable Birth Outcomes in Kenya . Journal of Biosocial Science. 33(2): 199-225. Also published in Digest: Hollander, D(2001) In Kenya, the Risk of poor Birth Outcomes is Highest for a Womans First Child. International Family Planning Perspectives. 2001; 27(3): 156-157.
27. Magadi MA, Diamond I, Madise N. Analysis of Factors Associated with Maternal Mortality in Kenyan Hospitals. Journal of Biosocial Science. 2001; 33(3): 375-391. doi: http://dx.doi.org/DOI:10.1017/S0021932001003753
28. Magadi MA, Diamond I, Rodrigues R. The Determinants of Delivery Care in Kenya . Social Biology. 2000; 47(3-4): 164-188.
29. Magadi MA, Madise N, Rodrigues R. Frequency and Timing of Antenatal Care in Kenya: explaning the variations between women of different communities . Social Science and Medicine. 2000; 51(4): 551-561. doi: 10.1016/S0277-9536(99)00495-5
30. Magadi MA. The Impact of AIDS on some Urban Households in Kenya with particular reference to Female Headed Households . African Urban Quarterly. 1992; 7(3&4): 285-288.
31. Magadi,M, Mostazir M. Sexual Behaviour Risk Factors of HIV Infection Across Countries and Regions in Sub-Saharan Africa. (Ed) Leon V. Berhardt Advances in Medicine and Biology. 2011; 28: 229-248.
32. Magadi M, Middleton S. Severe Child Poverty in the UK. Save the Children Fund, London, UK. 2007.
33. Pound EY, Chzen M, Magadi VH, et al. Evaluation of the Adult Learning Grant Cohort 2 (Wave 2) Learning and Skills Council. National Office, Coventry. 2007.
34. Magadi M, Beckhelling J. The use of the Discretionary Social Fund across families: evidence from the Expenditure and Food Surveys. CRSP Research Report 4. 2006.
35. Magadi MY, Chzen E, Pound VH, et al. Evaluation of the Adult Learning Grant Cohort 1 (Waves 1 and 2) Learning and Skills Council. National Office, Coventry. 2006.
36. Pound EY, Chzen M, Magadi VH, et al. Evaluation of the Adult Learning Grant Cohort 2 (Wave 1) Learning and Skills Council. National Office, Coventry. 2006.
37. Legge KE, Magadi MA, Phung V, et al. New Deal for Disabled People: Survey of Registrants - report of Cohort 3, Corporate Document Services, Leeds. 2006.
38. Legge K, Hartfree Y, Stafford B, et al. The Social Fund: Current role and future direction. Joseph Rowntree Foundation. 2006.
39. Roberts S, Ivaldi A, Magadi M, Phung V, Stafford B. The Public Sector and Equality for Disabled People. Department for Work and Pensions. 2006; 343.
40. Magadi M, Middleton S. Britains Poorest Children Revisited: Evidence from the BHPS (1994-2002), CRSP Research Report 3, Save the Children, CRSP. Loughborough University. 2005.
41. Magadi M. Zulu EM, Ezeh AC, Curtis S. Contraceptive Use Dynamics in Kenya: Further Analysis of Demographic and Health Survey (DHS) Data. African Population and Health Research Center (APHRC) and MEASURE Evaluation Project. Nairobi, Kenya. 2001.
42. Magadi M. Socio-cultural, Economic and Demographic Characteristics of AIDS Patients in Kenya in ABC. (Ed) Ayayo O. Population Health and Development in Africa: Anthropological Perspectives. P.S.R.I. University of Nairobi, Kenya. 2001; 127-132.
43. Magadi M. Involving Men in Family Planning in Africa: Lessons for Kenyan Family Planning Programme. (Eds) Oucho JO. Population and Development in Kenya. Population Studies and Research Institute, University of Nairobi, Kenya. 2000; 77-105.
44. Magadi M. Analysis of Data with Hierarchical Structure in Kenyas Population Prospects: Now and beyond - Selected Papers from the Second Population Association of Kenya Conference, Nairobi, January 2000. Population Association of Kenya, Nairobi, Kenya. 2000; 47-55.
45. Magadi M. Status of Women and Infant/Child Health in Kenya with Particular Reference to the High Mortality Zone in Nyanza Province. Union for African Population Studies - Study Report Number 26. Dakar - Ponty, Senegal. 1997.
46. Magadi M, Kuyoh M. Abortion: Attitudes of Medical Personnel in Nairobi in Khama Rogo. (Eds) Leonard A, Muia E. Unsafe Abortion in Kenya. Findings from Eight Case Studies. Population Council, Nairobi, Kenya. 1996.
47. Magadi MA. HIV/AIDS and contraceptive method choice: Demographic and socio-economic correlates of contraceptive method choice among HIV-positive women practising family planning in Kenya. HIV/AIDS Res Treat Open J. 2016; 3(1): 1-12. doi: 10.17140/HARTOJ-3-119
Fellow, HDR Convenor
Australian Demographic and Social Research Institute
Head of the Indonesian Diaspora Network ACT
The Australian National University
Canberra ACT 0200, Australia
Dr. Utomo is a Fellow and PhD Convenor at the Australian Demographic and Social Research Institute, Australian National University. She teaches Social Research Design and Gender and Population for postgraduate students as well as supervising Master and PhD students. She has experiences in designing and running survey and qualitative interviews on reproductive health matters and sexuality. Before she became a Fellow she was working at the Indonesian Ministry of Population and Environment and the Population and Family Planning Coordinating Board/BKKBN. She has strong ties and network with the Indonesian stake holders, policy makers, parliamentarians and senate as well as NGOs working on gender, sexuality and reproductive health issues. She leads two big projects: The Greater Jakarta Transition to Adulthood Survey funded by ARC, WHO, Ford Foundation and National University of Singapore and the Indonesian Gender and Reproductive Health Study (Funded by AusAID). Her most recent publication is on “Young people’s understanding of domestic violence: evidence from a school based survey of Grade 6 and Grade 12 students in Indonesia” (2014, Genus, v. 70, n. 2-3, ISSN 2035-5556).
Her research interests include: Gender empowerment, gender depiction in school textbooks, curriculum and school system, reproductive health and sexuality, sexual health, transition to adulthood and life course in Indonesia, and her research experience has extended to Indonesia, Timor Leste, PNG, Thailand, Mozambique and South Africa.
RESEARCH AND RELEVANT EXPERIENCE
Her interdisciplinary background –psychology, population studies and demography– translates into more than two decades of professional activities across sectors. In Indonesia, she has wide networks and has presented keynote addresses at the Indonesian Parliament, Senate (DPRD) and KOMAS Perempuan on Gender Depiction in school textbooks and curriculum and violence against women, sexual harassment and domestic violence. Her research on Gender and Reproductive Health in Indonesia has become a background academic paper for the Indonesian draft bill on gender equality. She has been awarded as outstanding ANU women award; best supervisor; ANU Inspiring Women and nominated for the 2014 and 2015 Vice-Chancellor’s Awards for Excellence in Teaching and Supervision. Her research is focused in Indonesia but has extended to Timor Leste, PNG, Thailand, Mozambique and South Africa. She has strong interpersonal communication skill and collaboration with policy makers in Indonesia; experiences in designing and leading workshops on gender, research design, population policy and development and reproductive health issues. She is also strong in designing and winning proposal as well as managing big project. Currently she is working on two books, Gender and reproductive health education in Indonesia and Transition to Adulthood in Greater Jakarta.
• 1997, Freeport Paper Prize Competition, Berkeley University
• 2010, Outstanding ANU Women Award
• 2010, Best Supervisor, ANU Award
• 2012, ANU Inspiring Women Award
• 2012, Pfizer Price Paper Competition Award-Indonesia
• 2013, Community: Indonesian Diaspora ACT-Head
1. Utomo ID, McDonald P, Reimondos A, Utomo A, Hull TH. Sex Education (2013): Do primary students understand how pregnancy can occur? A comparison of students in Jakarta, West Java, West Nusa Tenggara and South Sulawesi, Indonesia. Sex Education: Sexuality, Society and Learning. doi: 10.1080/14681811.2013.833503
2. Utomo A, Reimondos A, Utomo I, et al. What happens after you drop out? Transition to adulthood among early school-leavers in urban Indonesia. Demographic Research. 2014; 30(41): 1189-1218. doi: 10.4054/DemRes.2014.30.41
3. Utomo A, Reimondos A, Utomo I, et al. Digital inequalities and young adults in Greater Jakarta: A socio-demographic perspective. International Journal of Indonesian Studies. 2013; 1: 79-109.
4. Utomo A, Reimondos A, Utomo ID, McDonald P, Hull T. Female Migrants and the Transition to Adulthood in Greater Jakarta. The ANNALS of the American Academy of Political and Social Science. 2013; 648(1): 70-86. doi: 10.1177/0002716213483427
5. McDonald P, Utomo ID, Utomo A, Reimondos A, Hull T. Migration and Transition to Adulthood: Education and Employment Outcomes among Young Migrants in Greater Jakarta. Journal of Asian Population Studies. 2013; 9(1): 4-27. doi: 10.1080/17441730.2012.736700
6. Wienta D, Utomo ID, Neeman T, Oktavian A. Beyond sexual desire and curiosity: sexuality among senior high school students in Papua and West Papua Provinces (Indonesia) and implications for HIV prevention. Culture, Health & Sexuality. 2011; 13(9):1047-1060 doi: 10.1080/13691058.2011.599862
7. Hull T, Martin Hilber A, Chersich MF, et al. Prevalence, motivations and adverse effects of vaginal practices in Africa and Asia: findings of a multi-country household survey. Journal of Womens Health. 2011; 20(7): 1097-1109. doi: 10.1089/jwh.2010.2281
8. Tangmunkongvorakul A , Banwell C, Carmichael G, Utomo ID, Sleigh A. Birth control, pregnancy and abortion among adolescents in chiang mai, Thailand. Asian Population Studies. 2011; 7: 1, 15 -34. doi: 10.1080/17441730.2011.544902
9. Tangmunkongvorakul A , Banwell C, Carmichael G, Utomo ID, Sleigh A. Sexual identities and lifestyles among non-heterosexual urban Chiang Mai youth: implications for health. Culture, Health & Sexuality. 2010 ;12(7):827-841; doi: 10.1080/13691058.2010.499150.
10. Tangmunkongvorakul A , Banwell C, Carmichael G, Utomo ID, Sleigh A. Sexual perceptions and practices of young people in Northern Thailand. Journal of Youth Studies. 2010. doi: 10.1080/13676261.2010.522562
11. Hilber AM, Hull T, Preston-Whyte E, et al. A cross cultural study of vaginal practices and sexuality: Implications for sexual health. Social Science & Medicine. 2010; 70: 392-400. doi: 10.1016/j.socscimed.2009.10.023
12. Utomo ID, McDonald P. Adolescent Reproductive Health in Indonesia: Contested Values and Policy Inaction. Studies in Family Planning. 2009; 40(2): 133-146.
13. Widyantoro N, Lestari H, Hanifah L, Utomo ID, Putranti BD, Subagya YT. Gender, Sexuality and Vaginal Practices Qualitative Findings in Yogyakarta 2005. Mitra Inti Foundation, Jakarta, in English and Bahasa. 2007.
14. Utomo ID. Young and single as non-sexual being: politics of reproductive health in Indonesia. Journal of Population. 2006; 12(2): 185-199.
15. Utomo ID, Hull T. Vaginal Practices in Indonesia. Making the Connection: Sexuality and Reproductive Health, News and Views on Sexuality: Education, Health and Rights. Sexuality Information and Education Council of the United States. 2006; 4(3).
16. Utomo ID. The booming industries of vagina treatments: commercialization of the myth on tight sex (Maraknya bisnis perawatan organ intim perempuan: kommersialisasi mitos seks peret). Womens Feature, Journal Perempuan Online, Journal of Women Foundation, in Bahasa, Jakarta. 2006.
17. Utomo ID, Arsyad SS, Hasmi EN. Village family planning volunteers in Indonesia: Their role in family planning programme. Reproductive Health Matters. 2006; 14(27): 73-82. doi: http://dx.doi.org/10.1016/S0968-8080(06)27230-6
18. Utomo I. Book Review - Violence Against Women: The Health Sector Reponses. Australian Journal of Social Issues. 2006; 40(4): 573-575.
19. Utomo I. Book review - Women, Islam and Modernity: Single Women, Sexuality and Reproductive Health in Contemporary Indonesia. Bulletin of Indonesian Economic Studies. 2006; 42(1): 129-130. doi:
20. Utomo ID. Fertility and reproductive health of women in Timor-Leste: Results from the 2003 Demographic and Health Survey. Development Bulletin. 2005; 68: 87-89.
21. Utomo ID. Reproductive health education in Indonesia: school versus parents roles in providing sexuality information. RIMA (Review of Indonesian and Malaysian Affairs Journal). 2003; 37(1): 107-134.
22. Utomo ID, Robinson K. Introduction in, RIMA Special Edition on Youth, Sexuality, and Personal Life in Indonesia, with Kathy Robinson. RIMA. 2003; 37(1): 5-16.
23. Utomo ID, Robinson K. RIMA Special Edition on Youth, Sexuality, and Personal Life in Indonesia. RIMA. 2003; 37(1): 107-167.
24. Utomo ID. New Approaches in studying young people sexuality and reproductive health behaviour: how can it be measured and tracked ? (A case study of Indonesia). Journal of Population ). 2001; 7(1): 1-40.
25. Utomo ID. Sexuality among Jakarta Middle Class Young People, Asian People and Cities. Newsletter of the Asian Urban Center of KOBE (AUICK). 1999; 15-21.
26. Utomo ID. State Ideologies and Provision of Reproductive Health Education and Services: a Case Study of Indonesia. Journal of Population. 1999; 5(1): 29-66.
27. Utomo ID, McDonald P. Middle class young people and their parents in Jakarta: generational differences in sexual attitudes and behavior. Journal of Population. 1997; 2(2): 169-201.
28. Utomo ID. Sexual violence: the spread of STDs/AIDS among young people (Kekerasan seksual: penularan PMS/AIDS di kalangan remaja). Indonesian AIDS Newsletter. 1997; 4.
29. Utomo ID, Utomo A, Reimondos A, McDonald P, Hull T. Young people’s understanding of domestic violence: evidence from a school based survey of Grade 6 and Grade 12 students in Indonesia. Genus, Journal of Population Science. 2014; 70(2-3):35-57. http://scistat.cilea.it/index.php/genus/article/view/544/285
30. Tangmunkongvorakul A, Banwell C, Carmichael G, et al. Use and perceptions of sexual and reproductive health services among young northern Thai people. Southeast Asian Journal Tropical Medicine Public Health. 2012; 43 (2): 479-500. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732782/pdf/emss-53775.pdf
Master of Public Health Program
Department of Health Professions
School of Health Sciences and Human Services
Hofstra Dome 126
Hempstead, New York, USA
Dr. Santella is an Assistant Professor in the Department of Health Professions and teaches in the Master of Public Health and Master of Science in Community Health programs. His post-doctoral experience includes Director of HIV Policy, Planning and Implementation at the New York City Department of Health and Mental Hygiene; Assistant Professor and Master of Public Health Program Director at the Brooklyn Campus of Long Island University and most recently Lecturer of HIV, STIs and Sexual Health at the University of Sydney in Australia.
Dr. Santella is a public health scientist and health services researcher specializing in HIV and STI prevention and sexual health. His research interests include exploring the role of dental professionals (dentists and dental hygienists), community pharmacists and health educators in conducting rapid HIV and STI testing. This research takes place in the U.S., Australia, India, China and Vietnam. Additionally, he has done work in the sexual health of suburban men who have sex with men (MSM). Dr. Santella has received grants from the Foundation, University, and Government sectors and has presented his work at local, national and international conferences. He is also a reviewer for several public health and HIV journals.
His research interests include: Rapid HIV Testing, Sexual Health of MSM, HIV Health Promotion, Oral health of PLHW.
• Recipient, U.S. Public Health Traineeship
• Recipient, Jack R. Aron Public Health Scholarship
• Member, Delta Omega Honor Society
• Member, Alpha Eta Honor Society
• Member, American Public Health Association
• Member, Delta Omega National Honorary Public Health Society
• Member, Public Health Association of New York City
• Member, Community-Campus Partnerships for Health
1. Wang L, Santella AJ, Huang R, et al. Knowledge of HIV and Willingness to Conduct Oral Rapid HIV Testing among Dentists in Xian China. PLOS One. 2014.
2. Santella AJ, Fraser J, Prehn AW. The Role of Health Education Specialists in Conducting Rapid HIV Testing. American Journal of Health Studies. 2014; 29 (1): 13-18.
3. Santella AJ, Pollack A, Harrison C, Sawleshwarkar S, Britt H, Hillman RJ. Management of Sexually Transmitted Infections by Australian General Practitioners, 2000-2012. Sexual Health. 2014; 11(1): 52-57. doi: http://dx.doi.org/10.1071/SH13179
4. Spierer D. Blanding N, Santella AJ. Energy Drink Consumption and Associated Health Behaviors among University Students in an Urban Setting. Journal of Community Health. 2014; 39:132-138. doi: 10.1007/s10900-013-9749-y
5. Santella AJ, Krishnamachari B, Davide S, Cortell M, Furnari W, Watts B. Dental Hygienists Knowledge of HIV, Attitudes toward People Living with HIV and Willingness to Conduct HIV Testing. Int J Dent Hygiene. 2013; 11: 287-292. doi: 10.1111/idh.12022
6. Santella AJ, Davide S, Furnari W, Tuthill J, Cortell M. The Role of a Dental Hygienist in Rapid HIV Testing. Journal of Dental Hygiene. 2012; 86(4): 265-271.
7. Santella AJ, Laraque F, Hilger J, Camhi E. Development and Implementation of an HIV Care and Treatment Services Prioritization Tool. Journal of Community Health. 2011; 162: 325-336.
8. Santella AJ, Shi L, Campbell C. Length of Stay among HIV Infected Patients in Louisiana, 2000-2006. Journal of the Louisiana State Medical Society. 2010; 36(1): 158-165.
9. Santella AJ, Clark J, Sumner K. World AIDS day: a call to action. HIV/AIDS Res Treat Open J. 2015; 2(4): e18-e21. doi: 10.17140/HARTOJ-2-e002
School of Interdisciplinary Health Programs
College of Health & Human Services
Western Michigan University
1903 West Michigan Avenue
Kalamazoo, MI 49008, USA
Dr. Rowe is a Medical Anthropologist and Assistant Professor in the School of Interdisciplinary Health Services, College of Health and Human Services at Western Michigan University. She earned a PhD in cultural anthropology at Michigan State University, an MA in medical anthropology at Wayne State University and an MPH in health education and behavior at Tulane University School of Public Health and Tropical Medicine. In the past, Dr. Rowe held an NIMH postdoctoral fellowship at the Center for Mental Health Services Research (CMHSR) at Washington University in St. Louis, served as an ethnographic consultant for the National HIV Behavioral Survey Heterosexuals at Risk of HIV Infection (NHBS-HET) Study at Virginia Commonwealth University and was a visiting Research Education Institute for Diverse Scholars (REIDS) scholar at the Center for Interdisciplinary Research on AIDS (CIRA) at Yale University. Her areas of expertise are rural African American people living with HIV/AIDS (PLWHA) and frontline service providers. Recent publications have appeared in The Encyclopedia of African American History; Health Education and Behavior; Journal of Black Studies, Social Service Review and Administration and Policy in Mental Health and Mental Health Services Research.
Her research interests include: health disparities in African American Communities, African American and mixed-race communities in the Old Northwest, mental health services and HIV/AIDS.
HONORS & AWARDS
• 2012-2014 REIDS Scholar, Center for Interdisciplinary Research on AIDS (CIRA), Yale University, New Haven, CT
• 2005-2007 National Center on Minority Health Disparities Scholar, Department of Health & Human Services, Public Health Service, National Institute of Health, Bethesda, MD
• National Council for Black Studies (NCBS)-2012 to present
• Association for the Study of African American Life and History (ASALH)-2011 to present
• Society of Public Health Educators (SOPHE)-2006 to present
• Association for the Study of the World-Wide African Diaspora (ASWAD)-2007 to present
• American Anthropological Association (AAA) - 1998 to present
• Association of Black Anthropologists (ABA) - 1998 to present
• Society for the Anthropology of North America (SANA)-1998 to present
• Society for Medical Anthropology (SMA)-1998 to present
• Society for Cultural Anthropology (SCA)-1998 to present
• Society for Applied Anthropology (SfAA)-1997 to present
• American Public Health Association (APHA)-1995 to present
1. Rowe JE. Review of Mattingly C. The Paradox of Hope: Journeys Through a Clinical Borderland. Ethos. 2012; 40(2): 1-2.
2. Rowe JE. Voices From the Inside: African American Womens Perspectives on Diet, Exercise and Nutrition. Health Education & Behavior. 2010; 37(6): 789-800. doi: 10.1177/1090198110365992
3. Rowe JE. Mixing It Up: Early African American Settlements in Northwestern Ohio. Journal of Black Studies. 2009; 39(6): 924-936. doi: 10.1177/0021934707305432
4. Fedoravicius N, McMillen C, Rowe J, Kagotho N, Ware N. Funneling Child Welfare Consumers into and through the Mental Health System: Assessment, Referral and Quality Issues. Social Service Review. 2008; 82(2): 273-290. doi: 10.1086/589780
5. McMillen C, Fedoravicius N, Rowe J, Zima B, Ware N. A Crisis of Credibility: Professionals Concerns about the Psychiatric Care Provided to Clients of the Child Welfare System. Administration and Policy in Mental Health and Mental Health Services Research. 2006; 34(3): 203-212. doi: 10.1007/s10488-006-0096-5
6. Whitten P, Rowe-Adjibogoun J. Researching Communication Technology Intervention Projects: The Challenge of Achieving Utilization Levels Sufficient for Evaluation. Journal for Technology in Human Services. 2003; 22(3): 1-16. doi: 10.1300/J017v22n02_01
7. Whitten P, Rowe-Adjibogoun J. Success and Failure in a Michigan Telepsychiatry Programme. Journal of Telemedicine and Telecare. 2002; 8(Suppl. 3): S3: 75-77. doi: 10.1258/13576330260440943
8. Rowe JE. Connecting PLWHA in rural virginia to health and mental health care-perspectives from the life worlds of frontline health workers and PLWHA. HIV/AIDS Res Treat Open J. 2015; 2(1): e9-e11. doi: 10.17140/HARTOJ-2-e004
8. Rowe JE. Out of care: perspectives from rural southern people living with HIV/AIDS (PLWHA) and frontline service workers. Journal of HIV/AIDS & Infectious Diseases, SP. 2015; 101: 1-9.
Director of Clinical Research
Whitman Walker Clinic
1701 14th Street Northwest
Washington, DC 20009, USA
Dr. Elion joined Whitman-Walker in 2006 as Clinical Research Director. He has been active in HIV care and research for 28 years, and he currently leads a team at Whitman-Walker that is focused on cutting-edge research initiatives in prevention and treatment of HIV/AIDS, Hepatitis C, and other STDs. Dr. Elion’s tenure at Whitman-Walker has coincided with the organization being selected in 2013 as part of the AIDS Clinical Trials Group by the National Institutes of Health (NIH), a distinguished honor for Whitman-Walker, and rare for a community health center.
Prior to joining Whitman-Walker Health, Dr. Elion served as co-director of HIV services at Washington Free Clinic, in private practice in Washington, D.C., and in various research and clinical capacities in New York and in Washington.
Dr. Elion received a bachelor’s degree in English and Psychobiology from Tufts University and a medical degree from Temple University. He completed his internship and residency at Duke University. He also holds a Master’s in Counseling and Spiritual Psychology from University of Santa Monica. In addition to his duties at Whitman-Walker, he is currently an associate clinical professor of Internal Medicine at George Washington University and at Johns Hopkins University.
His research interests include: HIV, Primary Medical Care.
PROFESSIONAL ORGANIZATIONS AND SOCIETIES
• American Medical Association
• American Public Health Association
• American Academy of Family Practice
• National Acupuncture Detoxification Association
• Community Research Initiative Alliance on AIDS
• American Academy of Medical Acupuncture (Founding Member)
1. Behrens G, Rijnders B, Nelson M, et al. Rilpivirine verses efavirenz with emtricitabine. Tenofovir disoproxil fumarate in treatment-naïve HIV-1-infected patients with HIV-1 RNA<= 100,000 copies/mL: Week 96 pooled ECHO/THRIVE subanalysis. AIDS Patient Care STDS. 2014; 28(4): 168-175.
2. Soliman EZ, Roediger MP, Duprez DA, et al. Protease inhibitors and cardiac autonomic function in HIV- infected patients: across-sectional analysis from the strategies for management of antiretroviral therapy (smart) trial. BMJ Open. 2013; 3(3): e002523. doi: 10.1136/bmjopen-2012-002523
3. Elion R, Molina JM, Ramón Arribas López J, et al. A randomized phase 3 study comparing once daily elvitegravir with twice daily raltegravir in treatment experienced subjects with HIV-1 infection 96-week results. J Acquir Immune Defic Syndr. 2013; 63(4): 494-497. doi: 10.1097/QAI.0b013e318298469c
4. Elion R, Molina JM, Ramón Arribas López J, et al. A randomized phase 3 study comparing once-daily elvitegravir with twice-daily raltegravir in treatment experienced subjects with HIV+infection 96-week results report. J Acquir Immune Defic Syndr. 2013; 63(4): 494-497.
5. Nelson M, Amaya G, Clumeck N, et al. Efficacy and safety of rilpivirine naive HIV-1 infected patients with hepatitis B virus/ hepatitis C virus coinfection enrolled in the phase iii randomized double blind ECHO and THRIVE trials. J Antimicrob Chemother. 2012; 67(8): 2020-2028. doi: 10.1093/jac/dks130
6.Elion R,Cohen C,Gathe J,et al.Phase 2 study of cobicistat versus ritonavir each with once-daily atazanavir and fixed-dose emtricitabine/tenofovir df in the initial treatment of HIV infection. AIDS. 2011; 25(15): 1881-1886. doi: 10.1097/QAD.0b013e32834b4d48
7.Cohen C,Elion R,Ruane P,et al.Randomized,phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection.AIDS2011; 25(6): F7-F12.doi: 10.1097/QAD.0b013e328345766f
8. Palella FJ Jr, Gange SJ, Benning L, et al. Inflammatory biomarkers and abacavir use in the womens interagency HIV study and the multicenter AIDS cohort study. AIDS. 2010; 24(11): 1657-1665. doi: 10.1097/QAD.0b013e3283389dfa
9. Ross LL, Rouse E, Gerondelis P, et al.Low-abundance HIV species and their impact on mutational profiles in patients with virological failure on once-daily abacavir/lamivudine and atazanavir after discontinuation of ritonavir. J Antimicrob Chemother. 2010; 65(2): 307-315.
10. Elion R, Berger D, Richmond G, et al. Simplified maintenance therapy with abacavir/lamivudine and atazanavir after discontinuation of ritonavir. HIV Clin Trials. 2010; 11(3): 170-173. doi: 10.1310/hct1103-170
11. Ross LL, Rouse E, Gerondelis P, et al. Low abundance HIV species and their impact on mutational profiles in patients with virological failure on once-daily abacavir/lamivudine/zidovudine and tenofovir. J Antimicrob Chemother. 2010; 65(2): 307-315. doi: 10.1093/jac/dkp419
12. Baker J, Plankey M, Josayma Y, et al. The prevalence of rectal, urethral, and pharyngeal neisseria gonorrheae and chlamydia trachomatis among asymptomatic men who have sex with men in a prospective cohort in Washington, D.C. AIDS Patient Care STDS. 2009; 23(8): 585-588. doi: 10.1089/apc.2008.0277
13. Ross L, Elion R, Lanier R, et al. Modulation of K65R selection by zidovudine inclusion: Analysis of HIV resistance selection in subjects with virologic failure receiving once-daily abacavir/lamivudine/zidovudine and tenofovir DF (study COL40623). AIDS Res Hum Retroviruses. 2009; 25(7): 665-672. doi: 10.1089/aid.2008.0302
14. Boyle BA, Cohen CJ, DeJesus E, et al. Select updates from the 16th CROI: Treatment-related cardiovascular risk, pharmacokinetic issues, and interleukin-2 use. AIDS Read. 2009; 19(4): 158-160.
15. Boyle BA, Cohen CJ, DeJesus E, et al. Antiretroviral therapy update from the 48th ICAAC/46th IDSA annual meeting. AIDS Read. 2009; 19(1): 22-31.
16. Boyle B, Cohen C, DeJesus E, et al. Antiretroviral treatment update from the 17th international AIDS conference. AIDS Read. 2008; 18(11): 570-579.
17. Elion R, Cohen C, Ward D, et al. Evaluation of efficacy, safety, pharmacokinetics, and adherence in HIV-1-infected, antiretroviral-naive patients treated with ritonavir-boosted atazanavir plus fixed-dose tenofovir DF/Emtricitabine given once daily. HIV Clin Trials. 2008; 9(4): 213-224. doi: doi: 10.1310/hct0904-213. http://www.ncbi.nlm.nih.gov/pubmed/18753116
18. Gathe Jr. JC, Elion R. Antiretroviral rounds, resistance: What you dont know -- cant hurt you? AIDS Clin Care. 2008; 20(6): 51-52.
19. Elion R, Dejesus E, Sension M, et al. Once-daily abacavir/lamivudine and ritonavir-boosted atazanavir for the treatment of HIV-1 infection in antiretroviral- naive patients: A48-week pilot study. HIV Clin Trials. 2008; 9(3): 152-163. doi: 10.1310/hct0903-152
20. Boyle BA, Elion R, Cohen CJ, DeJesus E, Hawkins T, Moyle GJ. Advances in HIV therapeutics: News from the 4th interenational AIDS society conference. AIDS Read. 2007; 17(10): 484-490.
21. Boyle BA, Elion R, Cohen CJ, Moyle GJ, Sax P, Frank I. Advances in HIV therapeutics: The 14th CROI. AIDS Read. 2007; 17(5): 268-270, 272-274, 283-286.
22. Elion R, Cohen C, DeJesus E, et al. Once-daily abacavir/lamivudine/zidovudine plus tenofovir for the treatment of HIV-1 infection in antiretroviral-naive subjects: A 48-week pilot study. HIV Clin Trials. 2006; 7(6): 324-333.
23. DeJesus E, Berger D, Markowitz M, et al. Antiviral activity, pharmacokinetics, and dose response of the HIV-1 integrase inhibitor GS-9137 (JTK-303) in treatment-naive and treatment-experienced patients. J Acquir Immune Defic Syndr. 2006; 43(1): 1-5.
24. Appelbaum JS, Elion R, Henry K, Newman MD, Saag MS, Sax PE. Roundtable, who should be providing HIV care? AIDS Clinical Care. 2006; 18(3): 21-24.
25. Boyle BA, Elion RA, Moyle GJ, Cohen CJ. Considerations in selecting protease inhibitor therapy. AIDS Rev. 2004; 6(4): 218-225.
26. Cohen C, Elion RA, Frank I, et al. Once-daily antiretroviral therapies for HIV infection: Consensus statement of an advisory committee of the international association of physicians in AIDS care. J Int Assoc Physicians AIDS Care (Chic). 2002; 1(4): 141-145.
27. Carter GM, Elion R, Kuebel M, et al.Supplementing antiretroviral therapy. Science. 2002; 297(5585): 1276.
28. Elion R, Kaul S, Knupp C, et al. The safety profile and antiviral activity of the combination of stavudine, didanosine, and nelfinavir in patients with HIV infection. Clin Ther. 1999; 21(11): 1853-1863.
29. Elion R, Green L, Cohen C, et al. An open-label trial of stavudine, lamivudine and efavirenz in the treatment of HIV-positive, treatment-naive patients, and implications for clinical practice. Antivir Ther. 1999; 4 (Suppl 3): 89-91.
30. Wheeler DA, Gibert CL, Launer CA, et al. Weight loss as a predictor of survival and disease progression in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18(1): 80-85.
31. Elion RA, Cohen C. Complementary medicine and HIV infection. Prim Care. 1997; 24(4): 905-919.
32. Gay GR, Newmeyer JA, Elion RA, Wieder S. The sensuous hippie. Drug/sex practice in the haight ashbury. 1977; 6(1): 27-47.
Aaron Diamond AIDS Research Center
455 1st Avenue #7, NY 10016, USA
• Sep 2009-Jul 2012: Doctor of Medicine, Division of Research on Virology and Immunology, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention
• Sep 2006-Jul 2009: Master of Medicine, Department of Nutrition and Food Hygiene, the Fourth Military Medical University
• Sep 2001-Jul 2006: Bachelor of Medicine, Department of Clinical Medicine, Jin Zhou Medical College
Her research interests include: Monoclonal neutralizing antibody isolation and characterization against HIV and influenza, Broadly neutralizing antibody development, Antibody-dependent cell-mediated cytotoxicity (ADCC) against HIV, T cell and NK cell function in HIV.
• (Dec 2011-Dec 2011), VRC (Vaccine Research Center), NIH, Washington DC, US
Content: Training for specific single B cell sorting and specific antibodies cloning for one week
• (Jul 2011-Dec 2011), Fred Hutchinson Cancer Research Center, Seattle, WA, US
Content: Learn advanced techniques which is used in the investigation of HIV immunology, including intracellular immune assay, sorting in flow cytometry, ELISPOT for specific immune to HIV-1, and peptides matrix
1. Liang H, Jia M, Li D, Shao Y. Analysis of the phenotypes and the function of CD56＋ T cells during primary HIV-1 infection. Chinese Journal of Microbiology and Immunology. 35(3): 161-165.
2. Jia M, Cheng-Mayer C, Wu X. Sequential SHIV-Env Clones with Neutralization Sensitivity for Breadth Development. 2015. Conference on Retroviruses and Opportunistic Infections, CROI, Seattle, 2015: 23-26.
3. He X, Liang H, Hong K, et al. The Potential Role of CD16+ Vγ2Vδ2 T Cell-Mediated Antibody-Dependent Cell-Mediated Cytotoxicity in Control of HIV Type 1 Disease. AIDS Research and Human Retroviruses. 2013; 29(12):1562-1570. doi: 10.1089/AID.2013.0111
4. Jia M, Li D, He X, et al. Impaired natural killer cell- induced antibody-dependent cell-mediated cytotoxicity is associated with HIV-1 disease progression. Clin Exp Immunol. 2013; 171(1): 107-116. doi: 10.1111/j.1365-2249.2012.04672.x.
5. Jia M, Li D, He X, et al. Investigating the distribution of natural killer cell subsets and expression of receptors in HIV-1 infection transmission MSM cohort. Chinese Journal of Viral Diseases. 2012; 2(3): 162-168.
6. Jia M, Li D, Shao Y. Advance research on relationship between NK cells and human immunodeficiency virus infection. Chinese Tropical Medicine. 2012; 12(4): 537-541.
7. Jia M, Xue N, Cao Z, Liu H, Ji A, Wang F. Effects of dietary different ratios of n-3 to n-6 polysaturated fatty acids on AMPK expression of SD rats. Acta Nutrimenta Sinica. 2009; 31(5): 437-440.
8. Jia M, Xue N, Cao Z, Liu H, Ji A, Wang F. Effects of dietary different ratios of n-3 to n-6 polysaturated fatty acids influence lipid metabolism and appetite of SD rats. Journal of Hygiene Research. 2009; 38(2): 175-178.
9. Jia M, Xue N, Cao Z, et al. Effects of dietary different ratios of n-3 to n-6 polysaturated fatty acids influence lipid metabolism of rats. Chinese Journal of Public Health. 2009; 25(3): 348-350.
10. Jia M, Wang F. The function research of gama-GLA. Foreign Medical Sciences (Section Hygiene). 2008; 35(1): 44-47.
11. Li D, Jia M , Liang H, et al. Loss of balance between T helper type 17/regulatory T cells in HIV infected Chinese patients. Clin Exp Immunol. 2011; 6(2): 65-71. doi: 10.1111/j.1365-2249.2011.04435.x
12. Xue N, Jia M, Hou X, et al. Effect of dietary genistein on rats development exposure after their weaning. Journal of Hygiene Research. 2009; 38(2)L 180-183
13. Xue N, Juia M, Hou X, et al. Effect of early administration of dietary genistein on reproductive development in two generational rats. Acta Nutrimenta Sinica. 2009; 31(4): 375-378.
14. Xue N, Jia M, Hou X, et al. Effect of dietary genistein on reproductive system in rats. Chinese Journal of Public Health. 2009; 25(6): 678-679.
Department of Health and Nutrition Sciences
College of Education and Human Services
Montclair State University
University Hall, Room 4192
1 Normal Avenue
Montclair, NJ 07043-1624, USA
Dr. Amutah received her PhD in Public Health with a focus on Maternal and Child Health at the University of Maryland, College Park School of Public Health in 2010. She received her Masters in Public Health from The George Washington University School of Public Health and Health Services in Maternal and Child Health in 2005. Her dissertation focused on infant mortality in Washington, DC and it specifically examined neighbourhood level disadvantage, social determinants of health, and race/ethnicity as predictors of infant mortality. Dr. Amutah also received a BS in Public Health and BA in Africana Studies from Rutgers, The State University of NJ.
Originally from Trenton NJ, Amutah has a long standing commitment to public health that spans over 10 years of Public Health experience. Additionally, Amutah holds membership on the Board of Trustees for The Womens Collective, is an active member of Delta Omega, Omega chapter public health honor society, and is the President of The Society of African American Public Health Issues (SAAPHI)
Dr. Amutah also holds Membership in the Society for Public Health Education (SOPHE), the International Society for Urban Health (ISUH), Big Brothers, Big Sisters of American, Association and the Society for Pediatric and Perinatal Research.
Dr. Amutah is a Certified Health Education Specialist .She has taught courses on Program Planning and Evaluation, Research Methods, Adolescent Health, and Minority Womens Health. Dr. Amutah has worked as a researcher in community-based research settings in a variety of areas including maternal and child health, health disparities, and HIV/AIDS. She has published and presented both domestically and internationally in the area of HIV/AIDS and infant mortality in urban communities.
Formerly, Dr. Amutah completed the Kellogg Community Health Scholar post-doctoral fellowship at Morgan State University. Her research study titled DRUMMing Up Data: A Maternal and Child Health Community Based Participatory Research focused on examining the family planning practices, beliefs, and aptitude for women ages 18-45 in Baltimore City.
Currently, Dr. Amutah is an Assistant Professor at Montclair State University in the Department of Health and Nutrition Sciences. In this capacity her research focuses on adverse birth outcomes for women of color, HIV/AIDS and women of color in an urban context, and community based participatory research.
Her current research interests include: Health disparities, Reproductive health, Infant mortality and HIV/AIDS in ethnic minority populations.
AWARDS AND RECOGNITION
• Amutah N. Ernest E. Just - Keynote Lecture and Prize awarded by the Medical University of South Carolina and the Avery Research Center for African American History and Culture (2014)
• Amutah N. Academy Health Minority Scholars Award, Boston, MA. (June 2010)
• Amutah N. National Black Graduate Students Association. Willie Lawson Memorial Award. San Diego, CA (March 2010)
• Amutah N. Association of Maternal and Child Health Program. Student Fellowship to attend methods workshop. Washington DC. (November 2009)
• Amutah N. Senior Maternal and Child Health Fellow. American Public Health Association Philadelphia, PA. (November 2009)
• Amutah N. Goldhaber Travel Award. University of Maryland, College Park (November 2009)
ASSOCIATION MEMBERSHIPS AND ACTIVITIES
• Member, HIV/AIDS Section, American Public Health Association, (2013-Present)
• President, Society for the Analysis of African American Public Health Issues, (2012-Present)
• Section Councilor, Maternal and Child Health Section, American Public Health Association, (2012-Present)
• Board of Directors Member, The Womens Collective, (2011-Present)
• Member, Delta Omega, Public Health Honorary Society, Omega Chapter 2010 Inductee
• Member, Association of Teachers of Maternal and Child Health, (2007-Present)
• Member, Society of Public Health Education, (2007-Present)
• Member, Society for Pediatric and Perinatal Epidemiologic Research, (2007-Present)
• Big Brothers Big Sisters Program, (2006-Present)
• Member, The George Washington University Public Health Alumni Association, (2006-2010) • Member, Maternal and Child Health Section American Public Health Association, (2003-Present)
• Member, International Society for Urban Health, (2003-Present)
• Member, Zeta Phi Beta Sorority Incorporated (2003-Present)
Published Journal Articles and Book Chapters (Peer-Reviewed)
1. Whembolua G, Amutah N, Abiero B, Oladeinde-Sofolahan Y. Role of Parental Nativity in Breastfeeding of Black Children in the United States. Journal of Race and Policy. 2014; 10(1): 84-94.
2. Mahedevan M. Amutah N, Ramos L, et al. Project Thanks: A Socio-Ecological Framework for an Intervention Involving HIV-Positive African American women with comorbidities. Journal of Health Disparities Research and Practice. 2014; 5(3): 1-21.
3. Mendez DD, Almario DD, Amutah NN, et al. Neighborhood and individual socioeconomic determinants of gestational weight gain: implications for racial disparities. Journal of Maternal and Child Health. 2014; 18(5):1095-1103.
4. Doamekpor L, Amutah N, Ramos L. Fathers Matter: Paternal Age Influences on Infant Mortality. American Journal of Mens Health. 2014; 8(2): 175-182.
5. Grieb SMD, Amutah N, Smith H, Hammonds K, Stowers J, Rhodes SD. Preventing HIV through social inclusion using community-based participatory research. In: Taket A, Crisp B, Goldingay S, Graham M, Hanna L, Wilson L (eds). Practising Social Inclusion. Oxford, England, Routledge. 2013; 2013: 193-204.
6. Edwards LV, Irving SM, Amutah NN, Sydnor KD. Am I My Mothers Keeper? The Social Support Needs of Children with HIV positive mothers. Journal of Black Studies. 2012; 43(5): 571-595. doi: 10.1177/0021934712440171
7. Amutah NN. African American Women: The Face of HIV/AIDS. The Qualitative Report. 2012; 47(92): 1-15.
7. Amutah NA. HIV/AIDS and African American women: research opportunities to stem the epidemic. HIV/ AIDS Res Treat Open J. 2015; 2(3): e16-e17. doi: 10.17140/HARTOJ-2-e006
Department of Obstetrics and Gynecology
Eastern Virginia Medical School
604 Fairfax Avenue, Norfolk, VA 23507, USA
Dr. Gabelnick is currently Professor Emeritus in the Department of Obstetrics and Gynecology at Eastern Virginia Medical School. Dr. Gabelnick received B.S. and M.S. degrees from MIT and his Ph.D. from PrincetonUniversity. After some industrial experience, he joined the Biomedical Engineering Branch at the National Institutes of Health where he worked in the intramural laboratories for a number of years. He then joined the Contraceptive Development Branch at NIH where he stayed until moving to CONRAD at its inception in 1986 and became the Director of CONRAD in 1990 and was the Executive Director until August 2012 and was Senior Advisor until the end of 2013. CONRAD has as its mission the improvement of reproductive health with emphasis on developing countries. Funding for the development of new contraceptive technology and microbicides to prevent HIV/AIDS and other STI transmission came from USAID and several private foundations including the Bill & Melinda Gates Foundation. He has been an advisor to UNDP, WHO, and many of the Institutes of NIH and has served on the editorial boards of several journals. He is a vice-president of the Board of Trustees of the Egon and Ann Diczfalusy Foundation. He was also on the board of the Alliance for Microbicide Development and has served on the boards of the International Partnership for Microbicides and Biosyn, Inc. He was the chair of the Population, Reproductive and Sexual Health Section of the APHA for 2010-2011. He was made a Lifetime Member of the Indian Society for the Study of Reproduction and Fertility in 2004 and received a Lifetime Achievement Award at 5th International AIDS Congress in Chennai, India in 2006. He delivered the Annual Alan F Guttmacher Memorial Lecture in 2009 and in May 2010, he received the Lifetime Achievement Award at the International Conference on Microbicides in Pittsburgh. He has spent more than 20 years directing research on microbicides and was a member of the leadership team for the CAPRISA 004 trial.
His research interests include: HIV and other STI prevention technologies plus the qualitative issues in design of clinical trials for prevention.
HONORS AND AWARDS
• Tau Beta Pi, 1961
• Phi Lambda Upsilon, 1961
• Sigma Xi, 1961
• Graduate Fellow of the Textile Research Institute, 1966
• New York Academy of Sciences, 1966
• Eastern Virginia Medical School President’s Award, 1997
• Eastern Virginia Medical School President’s Medallion for Distinguished Service, 2001
• Elected to the Cosmos Club, Washington, DC, 2003
• Life Member of the Indian Society for the Study of Reproduction and Fertility, 2004
• Lifetime Achievement Award received at the 5th International Conference on AIDS in India, 2005
• Alan F Guttmacher Lectureship,Reproductive Health 2009, October 2, 2009, Los Angeles, CA
• Lifetime Achievement Award received at Microbicides 2010 Conference, Pittsburgh, PA
• American Association for the Advancement of Science
• American Chemical Society
• American Institute of Chemical Engineers
• American Public Health Association
• Association of Reproductive Health Professionals
• Controlled Release Society
• Global Health Council
• Society for the Advancement of Reproductive Care, Vice President 2001
• Society for the Advancement of Reproductive Care, President 2002 - 2008
• Egon and Ann Diczfalusy Foundation, Vice President, Board of Trustees, 2008 -Present
• Invited Lecturer, Annual Meeting of the Engineering Mechanics Society, Virginia Polytechnic Institute and State University, May 1971
• U.S. Department of Health Education and Welfare (DHEW) Representative to the Interagency Council for Materials, National Materials Advisory Board, National Academy of Sciences, September 1971 until its dissolution (approximately January 1974)
• U.S. Member of Task Force on Biomaterials, Organization for Economic Cooperation and Development, 1972
• United Nations Expert with United Nations Industrial Development Organization in Haifa, Israel, April to October 1973 (detailed by NIH). In addition, lectured at the Technion-Israel Institute of Technology, Haifa, and the Israel Fiber Institute, Jerusalem.
• Ad hoc member of National Institutes of Health study sections and special panels to review grant and Small Business Innovation Research (SBIR) Program proposals, 1985 to present
• Member of the Steering Committee of the World Health Organization Task Force on Long-Acting Agents for Fertility Regulation, 1978 to 1998
• Member of the World Health Organization Vaginal Ring Development Group, 1982 to 1986
• Board member, Biosyn, Inc., 1999 - 2003
• Board member, Alliance for Microbicide Development, 2001-2010
• Founding Board member and Secretary/Treasurer, International Partnership for Microbicides, 2002 - 2006
• FIGO (International Federation of Gynecology and Obstetrics) Advisory Panel on Contraception, 1998 to 2010
• American Public Health Association, Section on Population, Reproductive and Sexual Health, Chair, 2010-11
Executive Vice Dean and Chief Scientific Officer
Professor of Pathology and Laboratory Medicine
Perelman School of Medicine
University of Pennsylvania
Dr. Gaulton is the Executive Vice Dean and Chief Scientific Officer, and Professor of
Pathology and Laboratory of Medicine at the University of Pennsylvanias Perelman School of
Medicine. Dr. Gaultons responsibilities are to oversee both the Office of the Executive Vice
Dean and Chief Scientific Officer and his active research laboratory. The Executive Vice Dean
and Chief Scientific Officer leads the Schools research and research training enterprise and is
responsible for both stimulating new research endeavours and providing the optimal intellectual
and administrative support for ongoing research programs. This includes the Office of the
Executive Vice Dean and Chief Scientific Officer, Biomedical Graduate Studies, Biomedical
Postdoctoral Programs, Combined Degree and Physician Scholar Programs, Corporate Research,
Clinical Research, Global Health, Masters Programs, and Research Program Development.
Dr. Gaulton received his PhD in Biochemistry and Molecular Biology from the University of
California, Santa Barbara. He conducted Postgraduate research in Immunology at the School of
Public Health and School of Medicine at Harvard University. Dr. Gaulton was appointed
Assistant Professor of Pathology and Laboratory Medicine, in the School of Medicine at the
University of Pennsylvania, and he was subsequently appointed as Associate Professor with
Tenure and is currently full Professor. Dr. Gaulton was appointed Associate Dean and Director
of the Combined Degree and Physician Scholar Programs in 1993, Director of Biomedical
Graduate Studies in 1995, Vice Dean for Research and Research Training in 1998, and Executive
Vice Dean and Chief Scientific Officer in 2006.
Dr. Gaulton serves on the Board of Directors of two organizations, is a reviewer for nine Scholarly journals, and has been chair of four NIH study sections. Dr. Gaulton has received Numerous awards for teaching and research, including the Deans Award for Basic Science Teaching, the Berwick Memorial Teaching Award, the Lindback Award, the Harry Weaver Neuroscience Scholar Award from the National Multiple Sclerosis Society, and the Leukemia Society Scholar Award.
Dr. Gaulton has published over 100 manuscripts and texts, and directly supervised the research training of over thirty graduate students and fellows.
His research interests are in the area of viral pathogenesis. This work centers on a molecular description of the mechanisms that control a retrovirus- induced cell fusion and the detection of virus particles through nanotechnology.
HONORS AND AWARDS
• (1986-1990) National Multiple Sclerosis Society, Harry Weaver Scholar
• (1990) American Association of Immunologists
• (1991-1996) Leukemia Society of America Scholar
• (1994) University of Pennsylvania Leonard Berwick Teaching Award
• (1996) University of Pennsylvania Christian and Mary Lindback Teaching Award
Selected Peer-reviewed Publications
Additional recent publications of importance to the field (in chronological order)
1. Schwartz P, Gaulton GN. Addressing the needs of basic and clinical research: analysis of graduates of the University of Pennsylvania MD-PhD Program. JAMA. 1999; 281: 96-99. doi:
2. Chung M, Kizhatil K, Albritton LM, Gaulton GN. Induction of Syncytia by Neuropathogenic Murine Leukemia Viruses Depends on Receptor Density, Host Cell Determinants and the Intrinsic Fusion Potential of Envelope protein. J Virology. 1999; 73: 9377-9385. doi:
3. Majka M, Rozmyslowicz T, Honczarenko M, et al. Biological significance of the expression of HIV-related chemokine coreceptors (CCR5 and CXCR4) and their ligands by human hematopoietic cell lines. Leukemia. 2000; 14: 1821-1832. doi:
4. Majka M, Rozmyslowicz T, Ratajczak J, et al. The limited infectability by R5 HIV of CD34+ cells from thymus, cord and peripheral blood and bone marrow is explained by their ability to produce β−chemokines. Experimental Hematology. 2000; 28: 1334-1342. doi: http://dx.doi.org/10.1016/S0301-472X(00)00541-5
5. Rozmyslowicz T, Majka M, Kijowski J, et al. Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV. AIDS. 2003; 17: 33-42. doi:
6. Levinson AI, Zheng Y, Gaulton GN, Song D, Moore J, Pletcher H. Intrathymic Expression of Neuromuscular Acetylcholine Receptors and the Immunpathogenesis of Myasthenia Gravis. Immunol Res. 2003; 27: 399. doi: 10.1385/IR:27:2-3:399
7. Levinson AI, Zheng Y, Gaulton GN, et al. A new model linking intrathymic acetylcholine receptor expression and the pathogenesis of myasthenia Gravis. In Myasthenia gravis and related disorders. Ann. NY Acad. Sci. 2003; 998: 257-265. doi: 10.1196/annals.1254.027
8. Landers CM, Dugger N, Quadros M, Hoffman PM, Gaulton GN. Neuropathogenic murine leukemia virus TR1.3 induces selective syncytia formation of brain capillary endothelium. Virol. 2004; 321: 57-64. doi: 10.1016/j.virol.2003.12.002
9. Murphy SL, Honczarenko MJ, Dugger NV, Hoffman PM, Gaulton GN. Disparate regions of envelope protein regulate syncytium formation versus spongiform encephalopathy in neurological disease induced by murine leukemia virus TR. J Virol. 2004; 78: 8392-8399. doi: 10.1128/JVI.78.15.8392-8399.2004
10. Levinson AI, Song D, Gaulton GN, Zheng Y. The intrathymic pathogenesis of myasthenia gravis. Clin Dev Immunol. 2005; 11: 215-220. doi: 10.1080/17402520400001769
11. Lin G, Murphy, SL, Gaulton GN, Hoxie JA. Modification of a viral envelope glycoprotein cell-cell fusion assay by utilizing plasmid encoded bacteriophage RNA polymerase. J Virol Methods. 2005; 128: 135-142. doi: 10.1016/j.jviromet.2005.04.011
12. Murphy SL, Landers CM, Honczarenko MJ, Gaulton GN. Linkage of reduced receptor affinity and superinfection to pathogenesis of TR1.3 murine leukemia virus. J Virol. 2006; 80: 4601-4609. doi: 10.1128/JVI.80.9.4601-4609.2006
13. Murphy SL, Gaulton GN. TR1.3 Viral Pathogenesis and Syncytia Formation are Linked to Env- Gag Cooperation. J Virol. 2007; 81(19): 10777-10785. doi: 10.1128/JVI.00816-07
14. Rozmyslowicz T, Wroblewski K, Moodley J, Gaulton GN. A Decrease in the Cellular Phosphodiester to Phosphomonoester Lipid Ratio is Characteristic of HIV-1 Infection. Curr HIV Res. 2010; 8: 355-363. doi: 10.2174/157016210791330392#sthash.qFtFkXi2.dpuf
15. Rozmyslowicz T, Murphy SL, Conover DO, Gaulton GN. HIV-1 infection inhibits cytokine production in human thymic macrophages. Exp Hematol. 2010; 38: 1157-1166. doi: 10.1016/j.exphem.2010.08.009
16. Rozmyslowicz T, Gaulton GN. The need for a new generation of HIV diagnostics. HIV/AIDS Res Treat Open J. 2015; 1(1): e7-e8. doi: 10.17140/HARTOJ-1-e003
17. Rozmyslowicz T, Conover DO, Gaulton GN. HIV-1 infection of human thymic stromal cells and thymocytes in vitro. HIV/AIDS Res Treat Open J. 2015; 2(4): 92-96. doi: 10.17140/HARTOJ-2-116
Elder Associates Limited
30-32 Picton Street, Newtown
Port of Spain, Republic of Trinidad and Tobago, West Indies
Dr. Natalie Humphrey is a Clinical Psychologist with extensive experience in research, teaching, supervision and clinical services for people living with HIV/AIDS. She served as the Clinical Director of the Family Care Center Mental Health Program, which provided comprehensive mental health services to youth and adults living with HIV/AIDS. Dr. Humphrey was a Co-investigator for Seek, Test & Retain Linkages for Black HIV-infected, Substance-Using MSM. Her role with this study involved clinical supervision of research counselors and peer navigators who provide behavioral interventions to prevent HIV transmission among MSM living in New York City. Dr. Humphrey was appointed as a full council member with the HIV Health and Human Services Planning Council of New York, which oversaw distribution of HRSA Part A funding to meet the needs of PLWHA. She also served on the Needs Assessment Committee of the HIV Council, which evaluated the needs of special populations; such as MSMs and transgender adults affected by HIV. Additionally, Dr. Humphrey served a Faculty Trainer for the Columbia HIV Mental Health Project, which provides training to service providers throughout New York who seek to meet the needs of people affected by HIV/AIDS. Recently, Dr. Humphrey has provided consultation to studies in the Dominican Republic and Haiti concerning reducing safety risks to HIV-positive youth following disclosure of HIV status. She is currently the Clinical Director at Elder Associates Limited in Trinidad and Tobago, where she provides capacity building, training and clinical supervision to clinical psychologists who provide care in a resource limited setting. As she seeks to increase her international experience, her current research interests include HIV stigma and prevention of transmission in the Caribbean region.
Her research interests include: HIV stigma and prevention of transmission in the Caribbean region.
• 2012 - 2014 Full Council Member in HIV Health and Human Services Planning Council of New York
• 2011- 2014 Needs Assessment Committee Member in HIV Health and Human Services Planning Council of New York
1. Millery M, Vazquez S, Walther V, Humphrey N, Schlecht J, VanDevanter N. Pregnancies in perinatally HIV-Infected young women and implications for care and service programs. Journal of the Association of Nurses in AIDS Care. 2011; 22(5): 345-350. 10.1016/j.jana.2011.05.008
2. Humphrey N, Hughes H, Holmes D. Understanding of prayer among African American children: Preliminary themes. Journal of Black Psychology. 2008; 34(3): 309-330. 10.1177/0095798408319885
3. Hughes HM, Humphrey NN, Weaver TL. Advances in Violence and Trauma: Toward Comprehensive Ecological Models. Journal of Interpersonal Violence. 2005; 20(1): 31-38. 10.1177/0886260504268116
Investigator, Obstetrician and Gynecologist
Co-Principal Investigator for Microbicides Trials Network studies
Makerere University-Johns Hopkins University Research Collaboration-MUJHU-CARE LTD
• Makerere University - Kampala, Uganda MBchB Medicine (1994)
• Makerere University -Kampala, Uganda M.med Obstetrics/Gynecology (2001)
Positions and Employment
• (1994-1995) Intern Doctor, Mulago Teaching and National Referral Hospital, Kampala, Uganda
• (1995-1998) Medical Officer Mityana District Hospital, Uganda
• (1998-2001) Senior House Officer, Ob/Gyn, Mulago Hospital, Kampala, Uganda
• (2001-2002) Registrar (Medical Officer Special Grade), Jinja Regional Referral Hospital, Uganda
• (2002-2006) Community Program Coordinator, MUJHU Research Collaboration, Kampala, Uganda
• (2002-2003) Sub Investigator HIVNET 012 study, MUJHU Research Collaboration, Kampala, Uganda
• (2003) Sub-investigator for NVP/HIVIGLOB study, MUJHU Research Collaboration, Uganda
• (2003-2006) PMTCT Coordinator, MUJHU Research Collaboration, Kampala, Uganda
• (2004) Support Supervisor, Ministry of Health National PMTCT Program, Uganda
• (2004-2006) Men Access Program Coordinator, MU-JHU Research Collaboration, Kampala, Uganda
• (2005-2006) Psychosocial Groups Coordinator, Kampala District, Uganda
• (2006) TREAT Program Physician, MUJHU Research Collaboration, Kampala, Uganda
• (2007) Sub-investigator for HPTN 046 and HPTN 027 studies, MUJHU Research Collaboration, Uganda
• (2007) Co-Principal investigator Microbicide Trials Network (MTN) 001,MTN 003, MTN 015 studies, MUJHU Research Collaboration, Uganda
• (2008) MTN 016 protocol Co-chair
His Research interests include: Microbicides research for HIV Prevention, PMTCT research and Cervical cancer research.
• Award in regnition of service rendered to save the mothers project in Kiboga- Uganda by Association of Uganda obstetricians and gynaecologist in Uganda in collaboration with International Federation of obstetrician and gynaecologists (2002)
• Makerere University Johns Hopkins University Award for 10 year excellent service award
• (1999) Member, Uganda Society for Health Scientists, Uganda
• (1994-2001) Member, Uganda Medical Association
• (2001-2004) Member, Association of Obstetricians and Gynecologists, Uganda
• (2004-Present) Member, Action Group for Health, Human Rights, and HIV/AIDS (AGHA),Uganda
Selected peer-reviewed publications
1. Six Week Extended-Dose Nevirapine (SWEN) Study Team, Bedri A, Gudetta B, et al. Extended dose Nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomized controlled trials. SWEN study Team. Lancet. 2008: 372: 300-313. doi: 10.1016/S0140-6736(08)61114-9
2. Kabwigu S. Factors influencing voluntary counseling and testing uptake in PMTCT programme in Kampala Uganda. AIDS. 2006 – XVI International conference Abstract no CDC 1169.
3. Kabwigu S. Prevalence of HIV 1 and associated factors among women screened for the VOICE study at MUJHU Kampala site. Abstract at Microbicides 2012 conference.
4. Kabwigu S. VOICE study boosts women’s knowledge about research and Reproductive Health. Abstract at microbicides 2012 conference.
5. Kabwigu S. Strategies used in recruiting women for the VOICE study Uganda experience. Abstract at microbicides 2012 conference.
6. Kabwigu S. Participants reactions on initial administration of ACASI in VOICE study. Abstract microbicides 2012 conference.
Clinical Trial Unit
National AIDS Research Institute
Plot o 73 G-block, M I D C, Bhosari
Pune, Maharashtra 411026, India
• Medical Doctor- MBBS; DGO
• Total no. of years of experience: 31 years
• Experience in clinical trials: 15 years
• Experience in clinical research: 20 years
• Experience in social science research: 5 years
• Experience in clinical work: 10 years
• Experience as trainer- medical and paramedical workers: 8 years
• Master trainer for reproductive and child health national Programme of India
Her research interests include: Clinical trials for HIV prevention and care and treatment, Ethical and regulatory issues in clinical trials, Hetero sexual anal sex, High risk behavioural studies, HIV and cancer, Perinatally HIV infected, Prevention and management of sexually Transmitted Infections, Contraception, Reproductive and sexual health, Women’s health, Adolescents and youth sexual health.
CONFERENCES/WORKSHOPS ATTENDED/PAPERS PRESENTED:
1. Presented a poster entitled Significant Prevalence of Heterosexual Anal Sex among FSWs in India Highlights the Need for Specifically Tailored Interventions for HIV Preventionat, HIV Research for Prevention 2014: AIDS Vaccine, Microbicide and ARV-based Prevention Science (HIV R4P), Cape Town: October, 2014
2. Attended annual MTN meeting every year at Washington DC from 2008 to 2014
3. Attended and presented a short oral presentation on “Practice of Anal Sex and its Associated Factors Among Female Sex workers: Data from Survey of FSWs from Four States of India”-Microbicide 2012 conference at Sydney, Australia April, 2012
4. Organized and attendee a Consultative Meeting “Galvanizing Evidence for HIV Management ” at NARI, Pune January, 2011
5. Consultative meeting on challenges in measuring youth transitions to adulthood November, 2010
6. Poster discussion at 2010 International Microbicides Conference, in Pittsburgh, Pennsylvania on Unmet Need for Safe Sex Practice and Opportunities for Vaginal Microbicides among HIV Uninfected Female Sex Workers (FSW) in India May, 2010.
7. Poster presentation on Involving Parents: As Vehicles Of Change In Adolescent Sexual And Reproductive Health In Urban and Rural India at DFID dissemination meeting in New Delhi 2007
8. Paper presented on Pre Marital relationships in Traditional Setting in India: Underlying Factors at the Population Council dissemination meeting in New Delhi 2006
9. Paper presented on Exploring The Correlates: Pre-Marital Relationships Among Unmarried Young Women and Men In A Traditional Settings, Pune District, Maharsahtra, India at International Conference on Emerging Population Issues in the Asia Pacific Region: Challenges for the 21st Century, Mumbai 2006
10. Paper presented on Loveship and sex: Exploring formation of premarital partnerships among females and males in urban slum settings, Pune, India presented at 25th International conference of IUSSP, Tours, France. 2005
11. Paper on Exploring familial and societal factors that influence risk taking behaviour among youth in resource poor setting in Indiapresented at Conference on Asian Family convened by NSU, Singapore 2004
12. Paper on Are We Geared For Management Of Infertility? A Study Of Public And Private Health Facilities In Maharashtra, India presented at InterNational Conference on Psycho-social aspects of Childlessness, held at International Centre of Goa. 2002
13. Paper on Improving Post partum care with the aim of reducing Maternal Mortality in National level workshop at NIHFW, New Delhi. 2002
14. Policy making workshop regarding Tubectomy Death and Improving sex Ratio in Maharastra.- State Family Welfare Bureau, Maharashtra. 2001
15. Consultancy workshop for developing IEC material for adolescent boys-PATH project 2001
16. Policy making workshop on steps to implement Population Policy 2001 in Maharastra- State Family Welfare Bureau, Maharashtra 2000
17. Advocacy on Role of Village Health Workers in RCH- Conducted by Indian Institute of Management, Ahmedabad, for Population Council, New York. 1999
18. Resource person for Training in Abortion Project for Investigators from West Bengal, India. 1997
19. All India Congress of Royal College of Obstetric and Gynecology. 1989
20. FOGSI-Conference for Gynecologists, Cochin. Won a prizes for poster competition and in Sonography quiz competition. 1989
21. FOGSI-Conference for Gynecologists, Trichy. Read a paper on An Unusual case of multiple fibroids with Pregnancy. 1988
1. Alexander M, Chidrawar S, Deshpande S, Paranjape R. Significant Prevalence of Heterosexual Anal Sex among FSWs in India Highlights the Need for Specifically Tailored Interventions for HIV Prevention. AIDS Res Hum Retroviruses. 2014; 30(Suppl 1): A273-A274.
2. Alexander M, Mainkar M, Deshpande S, Chidrawar S, Sane S, Mehendale S. Heterosexual Anal Sex among Female Sex Workers in High HIV Prevalence States of India: Need for Comprehensive Intervention. PlosONE. 2014; 9(2): e88858. doi: 10.1371/journal.pone.0088858
3. Godbole SV, Mane AK, Chidrawar SR, et al. Prevalence of anal Human papillomavirus (HPV) infection among HIV-infected women from India. JAIDS . 2014; 67(3): e111-e114. doi:10.1097/QAI.0000000000000328
4. Jejeebhoy S, Acharya R, Alexander M, Garda L, Kanade S. Agency among unmarried young people in India: Levels, patterns and gender differences. Economic and Political weekly. 2010; XLV(30): 56-64.
5. Alexander M, Garda L, Jeejebhoy S, Ganatra B. Exploring The Correlates: Pre-Marital Relationships Among Unmarried Young Women and Men In A Traditional Settings, Pune District, Maharsahtra, India. International Family Planning Perspectives. 2006.
6. Kanade S, Alexander M, Garda L, Jeejebhoy S, Ganatra B. Exploring young people’s sexual behaviours in India: Addressing methodological and ethical challenges in field research. Journal Of Family Welfare. 2006.
7. Alexander M, Garda L, Kanade S, Ganatra B, Jeejebhoy S. Romance and Sex Premarital Partnership formation among Young Women and Men, Pune District, India. Reproductive Health Matters. 2006; 14(28): 1-12. doi: 10.1016/S0968-8080(06)28265-X
8. Alexander M. CD4:CD8 ratio and non AIDS defining events in virally suppressed HIV infected patients: need to look beyond CD4+ T cell counts. HIV/AIDS Res Treat Open J. 2015; 2(1): e12-e15. doi: 10.17140/HARTOJ-2-e005
Makerere University-Johns Hopkins University Research Collaboration (MU-JHU CARE LTD)
Dr. Kamateeka holds a Bachelor of Medicine and Surgery (MBChB) degree from Mbarara University of Science and Technology, Mbarara, Uganda and a Masters degree in Public Health (Global Health) from the University of Manchester, United Kingdom. She has extensive experience in clinical research, particularly in the area of Prevention of Mother to Child Transmission of HIV (PMTCT). She has worked on various large multi-site HIV prevention perinatal clinical trials at Makerere University-Johns Hopkins University (MU-JHU) Research Collaboration in Kampala, Uganda including the HIV Prevention Trials Network (HPTN) 046 study-a phase III multi-site HIV perinatal randomized clinical trial to determine the efficacy and safety of an extended regimen of nevirapine in infants born to HIV infected women to prevent vertical HIV transmission during breastfeeding , the HPTN 027 study-A phase 1 study to evaluate the safety and immunogenicity of ALVAC-HIV vCP 1521 in infants born to HIV-1 infected women in Uganda and the Six weeks extended Niverapine study (SWEN) in Uganda. She is currently working as a Junior Investigator on the PROMISE study-Promoting Maternal and Infant Survival Everywhere, a large multi site Unites States of America National Institute of Health (NIH) supported clinical trial as well as its sub-study P1084s-the bone and kidney health sub study at the MU-JHU site. She is also one of the lead Investigators on an National Institute of Health (NIH) supported PMTCT operational research study, Using enhanced peer group strategies to support PMTCT Option B+ in Uganda.
Her research interests include: HIV/AIDs research particularly in the fields of PMTCT and Tuberculosis as well as other common HIV related opportunistic infections.
• Member of the Uganda Society for Health Scientists (USHS)
• Member of African Network for Care of Children affected by HIV/AIDS(ANNECA)
1. Jim A, Glenn Fowler M, Wang J, et al. Extended prophylaxis with nevirapine and cotrimoxazole among HIV-exposed uninfected infants is well tolerated. AIDS (London, England). 2012; 26(3): 325-333. doi: 10.1097/QAD.0b013e32834e892c
2. Kamateeka M, Barlow-Mosha L, Mubiru M, Lutajumwa M, Mudiope P, Musoke PM. Immunologic and virologic responses to nevirapine based antiretroviral therapy (ART) among HIV-Tuberculosis co-infected Ugandan children on rifampicin based anti-tubercular treatment. HIV/AIDS Res Treat Open J. 2015; 2(1): 27-36. doi: 10.17140/HARTOJ-2-104
Medical Ethics Program
Peking University Health Science Center
38 Xueyuan Road, Beijing, 100191, P.R. China
• 2015: Visiting Scholar of Utrecht University, Holland
• 2009: Visiting Scholar of Duke University, U.S.A
• 2001: From March to July, beg visiting scholar Maclean Center for Clinical Medical Ethics, the University of Chicago, U.S.A
• 1995-present: Peking University Health Science Center
• 1992-1995: Department of Philosophy of Peoples University, Ph.D
• 1989-1992: Department of Philosophy of Beijing Normal University, Master
• 1985-1989: Department of Biology of Beijing Normal University, BS
• Present: Professor, Medical Ethics Program, Peking University Health Science Center, China
Her research interests include: Public health ethics, Medical professionalism, Medical ethics.
Positions and Honors
• 2011-present: Vice President, China Medical Ethics Association
• 2011-present: President, Institutional Review Board of Peking University
1. Cong Y, Hu L. Case study: The VIP floors. The Hastings Center Report. 2005; 35(1): 16-17.
2. Cong Y. Doctor-Family-Patient Relationship: the Chinese paradigm of informed consent. The Journal of Medicine and Philosophy. 2004; 29(2): 149-178. doi: 10.1076/jmep.126.96.36.199506
3. Cong Y. Who needs to change-discussion with Mr. Lei about the right transferring? The Journal of Medicine and Philosophy. 2003; 24(8): 41-43.
4. Wahlberg A, Rehmann-Sutter C, Sleeboom-Faulkner M, et al. From global bioethics to ethical governance of biomedical research collaborations. Social Science & Medicine. 2013; 98: 293-300. doi:10.1016/j.socscimed.2013.03.041
5. Li H, Cong Y. The Development and Perspectives of Chinese Bioethics. Journal International De Bioéthique. 2008; 19(4): 21-32, 159. doi: 10.3917/jib.194.0021
6. Xu J, Li B, Ma Q, Liu H, Cong Y. Human Subjects Protections in Clinical Drug Trials in China: A Focus on the Institute Level. Int J Pharm Med. 2006; 20 (6): 367-372. doi: 10.2165/00124363-200620060-00005
7. Cong Y. Development of Research Ethics in China. Turkey Klinikleri Journal of Medical Ethics, Law and History. 2004; 12: 253-255.
8. Cong Y. Artificial insemination and happiness. Eubios Journal of Asian and International Bioethics. 2004; 14(2): 48-49.
9. Cong Y. Ethical Challenges in Critical Care Medicine: A Chinese Perspective. The Journal of Medicine and Philosophy. 1998; 23 (6): 581-600. doi: 10.1076/jmep.23.6.581.2558
10. Cong Y. Push Medical Professionalism in China and US: Cooperation Perspective. Chinese Medical Journal. 2013; 93(10): P721-P723.
11. Cong Y. Human Subject Protection: China-US comparison. Journal of Peking University (Health Sciences) Medical Journal. 2010; 42(6): 625-628.
12. Cong Y. Thinking to Fifteen Years Experiences in Medical Ethics. The Journal of Medicine and Philosophy. 2010; 31(11): 14-15, 58.
13. Cong Y. Basic consideration on Framework of Public Health Ethics. Chinese Medical Humanities Review. 2008; 2.
14. Cong Y. Case study and medical ethics education. The Journal of Medicine and Philosophy. 2007; 28(3): 28-29.
15. Cong Y. The study on sustainable of biomedicine research ethics. Chinese Journal of Medical Ethics. 2005; (5): 1-5.
16. Cong Y. Applying the training knowledge into practice-medical ethics teaching consideration. The Journal of Medicine and Philosophy. 2003; 24(2): 62-64.
17. Cong Y. Talking the declaration of Helsinki in length and breadth. Chinese & International Philosophy of Medicine. 2002; 4(2).
18. Cong Y. The comparison of medical ethics education between Peking University and the University of Chicago. Chinese & International Philosophy of Medicine. 2002; 4(1): 149-166.
19. Cong Y. Medical ethics and bioethics. The Journal of Medicine and Philosophy. 2001; 22(9): 62-64.
20. Cong Y. Case discussion in Class 97-2 and 97-4 can family member donate blood to save the patient? The Journal of Medicine and Philosophy. 2001; 22(6): 58-59, 64.
21. Hu L, Cong Y. Preliminary Study on Medical Professionalism. The Journal of Medicine and Philosophy. 2007; 28(3): 10-13.
Head of Clinical Research Resource Unit
Impacta Peru Clinical Trials Unit
CRS Coordinator, Site 11301
Asociacion Civil Impacts Health and Education
Av. Almirante Miguel Grau 1010, Barranco, Lima 04, Peru
Dr. Gonzales hold his BS in Medicine (1997) and MD (1998) from Universidad Peruana Cayetano Heredia, Lima, Peru. He holds Master in Advance Studies (M.A.S.) in Clinical Research from the University of California San Francisco. He joined Association Civil Impacta Salud y Education in 2004 and have participated in several clinical trials as Co-Investigator and Investigator of Record for the HIV Prevention Trial Network (HPTN), the HIV Vaccine Trail Network (HVTN), the AIDS Clinical Trial Group (ACTG), the Microbicides Trial Network (MTN), and INSIGHT. Dr. Gonzales is the Site Principal Investigator for the MTN 017 and for the Randomized Placebo-Controlled Clinical Trial to assess the impact of extended-release naltrexone on HIV treatment outcomes among HIV-1 infected men and transgender women with alcohol use disorders in Lima, Peru. He was a member of the Network Evaluation Committee of the HVTN and a member of the Site Management and Clinical Care and the Translational and Drug Development committees, both from the ACTG research network. Currently, He is an Investigator of several ACTG, MTN, HPTN and HVTN trials and member of ACTG, HPTN and HVTN scientific committees and working groups.
His research interests include: HIV prevention: Combination prevention, PrEP, Vaccines, Treatment as Prevention, HIV treatment, HIV Comorbidities: Hepatitis and TB, Substance use and HIV.
Other Experience and Professional Memberships
• 1998: Member, Colegio Medico del Peru No. 32366 ( Peruvian Medical College)
• 2007-2009: Network Evaluation Committee member, HIV Vaccine Trials Network
• 2007-2009: Site Management and Clinical Care Committee (SMCCC) member, AIDS Clinical Trial Group(ACTG)
• 2007-2009: Translational Research and Drug Development member (SMCCC representative), ACTG
• 2011: International AIDS Society Member
• 2014: Efficacy Trials Working Group, HIV Vaccine Trial Network
• 2014: Substance Use Scientific Committee (SUSC), HIV Prevention Trial Network
• 2014: Site Management and Clinical Care Comittee (SMCCC), AIDS Clinical Trial Group
• 2014: Performace Evaluation Comitte (PEC), AIDS Clinical Trial Group
Selected Peer-reviewed Publications
1. Vagenas P, Lama JR, Ludford KT, Gonzales P, Sanchez J, Altice FL. A systematic review of alcohol use and sexual risk-taking in Latin America. Rev Panam Salud Publica. 2013; 34(4): 267-274.
2. Vagenas P, Ludford KT, Gonzales P, et al. Being unaware of being HIV-infected is associated with alcohol use disorders and high-risk sexual behaviors among men who have sex with men in Peru. AIDS Behav. 2014; 18(1):120-127. doi: 10.1007/s10461-013-0504-2
3. Tang EC, Sobieszczyk ME, Shu E, Gonzales P, Sanchez J, Lama JR. Provider attitudes toward oral preexposure prophylaxis for HIV prevention among high-risk MSM in Lima, Peru. AIDS Res Hum Retroviruses. 2013. doi: 10.1089/AID.2013.0212
4. Ludford KT, Vagenas P, Lama JR, et al. Screening for drug and alcohol use disorders and their association with HIV-related sexual risk behaviors among men who have sex with men in Peru. PLoS One. 2013; 8(8): e69966. doi: 10.1371/journal.pone.0069966
5. Michael V, Peinado J, Segura E, et al. Socialization patterns and their associations with unprotected anal intercourse, hiv, and syphilis among high-risk men who have sex with men and transgender women in peru. AIDS and Behavior. 2014; 18(10): 2030-2039. doi: 10.1007/s10461-014-0787-y.
6. Ferro EG, Weikum D, Vagenas P, et al. Alcohol use disorders negatively influence antiretroviral medication adherence among men who have sex with men in Peru. AIDS Care. 2014; 3: 1-12. doi: 10.1080/09540121.2014.963013
7. Brown SE, Vagenas P, Konda KA, et al. Men who have sex with men in peru: acceptability of medication-assisted therapy for treating alcohol use disorders. Am J Mens Health. 2015; pii: 1557988315576775. doi: 10.1177/1557988315576775